Back to GetFilings.com
========================================================================
- ------------------------------------------------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-K
(MARK ONE)
[X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2002
-----------------
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM TO
-------------- --------------
COMMISSION FILE NUMBER 001-13255
---------
SOLUTIA INC.
------------
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
DELAWARE 43-1781797
-------- ----------
(STATE OR OTHER JURISDICTION OF (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NO.)
575 MARYVILLE CENTRE DRIVE, P.O. BOX 66760, ST. LOUIS, MISSOURI 63166-6760
- --------------------------------------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
(314) 674-1000
--------------
REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE
SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
NAME OF EACH EXCHANGE
TITLE OF EACH CLASS ON WHICH REGISTERED
------------------- ---------------------
$.01 PAR VALUE COMMON STOCK NEW YORK STOCK EXCHANGE
PREFERRED STOCK PURCHASE RIGHTS NEW YORK STOCK EXCHANGE
SECURITIES REGISTERED PURSUANT TO SECTION 12(g) OF THE ACT:
NONE
INDICATE BY CHECK MARK WHETHER THE REGISTRANT: (1) HAS FILED ALL
REPORTS REQUIRED TO BE FILED BY SECTION 13 OR 15(D) OF THE SECURITIES
EXCHANGE ACT OF 1934 DURING THE PRECEDING 12 MONTHS (OR FOR SUCH SHORTER
PERIOD THAT THE REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS), AND
(2) HAS BEEN SUBJECT TO SUCH FILING REQUIREMENTS FOR THE PAST 90 DAYS.
[X] YES [ ] NO
INDICATE BY CHECK MARK IF DISCLOSURE OF DELINQUENT FILERS PURSUANT
TO ITEM 405 OF REGULATION S-K (SECTION 229.405 OF THIS CHAPTER) IS NOT
CONTAINED HEREIN, AND WILL NOT BE CONTAINED, TO THE BEST OF REGISTRANT'S
KNOWLEDGE, IN DEFINITIVE PROXY OR INFORMATION STATEMENTS INCORPORATED BY
REFERENCE IN PART III OF THIS FORM 10-K OR ANY AMENDMENT TO THIS
FORM 10-K. [X]
INDICATE BY CHECK MARK WHETHER THE REGISTRANT IS AN ACCELERATED
FILER (AS DEFINED IN RULE 12b-2 OF THE ACT). [X] YES [ ] NO
STATE THE AGGREGATE MARKET VALUE OF THE VOTING AND NON-VOTING COMMON
EQUITY HELD BY NON-AFFILIATES COMPUTED BY REFERENCE TO THE PRICE AT
WHICH THE COMMON EQUITY WAS LAST SOLD, OR THE AVERAGE BID AND ASKED
PRICE OF SUCH COMMON EQUITY, AS OF THE LAST BUSINESS DAY OF THE
REGISTRANT'S MOST RECENTLY COMPLETED SECOND FISCAL QUARTER.
APPROXIMATELY $731.51 MILLION ON JUNE 28, 2002.
NOTE.--IF A DETERMINATION AS TO WHETHER A PARTICULAR PERSON OR
ENTITY IS AN AFFILIATE CANNOT BE MADE WITHOUT INVOLVING UNREASONABLE
EFFORT AND EXPENSE, THE AGGREGATE MARKET VALUE OF THE COMMON STOCK HELD
BY NON-AFFILIATES MAY BE CALCULATED ON THE BASIS OF ASSUMPTIONS
REASONABLE UNDER THE CIRCUMSTANCES, PROVIDED THAT THE ASSUMPTIONS ARE
SET FORTH IN THIS FORM.
INDICATE THE NUMBER OF SHARES OUTSTANDING OF EACH OF THE
REGISTRANT'S CLASSES OF COMMON STOCK, AS OF THE LATEST PRACTICABLE DATE:
104,701,074 SHARES OF COMMON STOCK, $.01 PAR VALUE, OUTSTANDING AS OF
THE CLOSE OF BUSINESS ON FEBRUARY 24, 2003.
DOCUMENTS INCORPORATED BY REFERENCE
LIST HEREUNDER THE FOLLOWING DOCUMENTS IF INCORPORATED BY REFERENCE
AND THE PART OF THE FORM 10-K (E.G., PART I, PART II, ETC.) INTO WHICH
THE DOCUMENT IS INCORPORATED: (1) ANY ANNUAL REPORT TO SECURITY HOLDERS;
(2) ANY PROXY OR INFORMATION STATEMENT; AND (3) ANY PROSPECTUS FILED
PURSUANT TO RULE 424(b) OR (c) UNDER THE SECURITIES ACT OF 1933. THE
LISTED DOCUMENTS SHOULD BE CLEARLY DESCRIBED FOR IDENTIFICATION
PURPOSES: PORTIONS OF SOLUTIA INC.'S DEFINITIVE PROXY STATEMENT FOR ITS
2003 ANNUAL MEETING OF STOCKHOLDERS, TO BE FILED WITH THE SEC, ARE
INCORPORATED BY REFERENCE IN PART III OF THIS FORM 10-K.
- ------------------------------------------------------------------------
========================================================================
CAUTIONARY STATEMENT ABOUT FORWARD-LOOKING STATEMENTS
We make statements in this Annual Report on Form 10-K that are
considered forward-looking statements under the federal securities laws.
We consider all statements regarding anticipated or future matters,
including the following, to be forward-looking statements:
* our expected future financial position, liquidity, results of
operations, profitability and cash flows;
* dividends;
* financing plans;
* competitive position;
* business strategy;
* budgets;
* projected cost reductions;
* results of litigation;
* plans and objectives of management for future operations;
* contractual obligations;
* off-balance sheet arrangements;
* growth opportunities for existing products and services;
* price increases;
* benefits from new technology; and
* effect of changes in accounting due to recently issued accounting
standards.
These statements are not guarantees of our future performance. They
represent our estimates and assumptions only on the date we made them.
There are risks, uncertainties and other important factors that could
cause our actual performance or achievements to be materially different
from those we may project. These risks, uncertainties and factors
include:
* general economic, business and market conditions, which affect us
because some of our customers are in cyclical businesses;
* customer acceptance of new products;
* currency fluctuations;
* interest rate fluctuations;
* gain or loss of significant customers;
* price increases or shortages of raw materials and energy;
* disruption of operations;
* exposure to product liability and other litigation and cost of
environmental remediation;
* lower prices for our products or a decline in our market share due to
competition or price pressure by customers;
* ability to implement cost reduction initiatives in a timely manner;
* ability to divest existing businesses or acquire and integrate new
businesses;
* efficacy of new technology and facilities;
* changes in U.S. and foreign laws and regulations;
* geopolitical instability; and
* changes in pension assumptions.
PART I
ITEM 1. BUSINESS.
OVERVIEW
Solutia and its subsidiaries make and sell a variety of
high-performance chemical-based materials, which are used in a broad
range of consumer and industrial applications. For 2002, we are
reporting our business under two segments: Performance Products and
Services and Integrated Nylon.
Our Performance Products and Services segment comprises our
Performance Film product line and Specialties. Specialties consists of
Industrial Products and Pharmaceutical Services.
* Our Performance Films product line includes plastic interlayer for
laminated safety glass and custom-coated films for after-market
automotive and architectural applications. We market our plastic
interlayer under the SAFLEX(R) brand for use in automobile
windshields. In addition, our interlayer is used in Enhanced
Protective Glass and VANCEVA(TM) brand design systems for side and
rear windows of vehicles. We brand plastic interlayer under the
KEEPSAFE(R) and KEEPSAFE MAXIMUM(R) marks and use it in
VANCEVA(TM) brand design systems for architectural applications.
In addition, we produce custom-coated window films, branded
1
as LLUMAR(R) and VISTA(R), for professional after-market
automotive and architectural applications and as GILA(R) for the
do-it-yourself retail market.
* Our Industrial Products product line includes specialty chemicals
such as DEQUEST(R) water treatment chemicals, THERMINOL(R) heat
transfer fluids and SKYDROL(R) aviation hydraulic fluids.
* Our Pharmaceutical Services include an array of integrated
pharmaceutical development services ranging from process research
to manufacturing, clinical trial services and advisory services,
for leading pharmaceutical companies.
Our Integrated Nylon segment comprises an integrated family of nylon
products.
* Our chemical intermediates are used as feedstock for fiber and
resins production and are sold on the merchant market.
* Our VYDYNE(R) and ASCEND(R) nylon polymers are sold to the
engineered thermoplastic and apparel markets.
* Our fibers are sold under the WEAR-DATED(R) brand for use in
carpet and upholstery for customers, the ULTRON(R) brand for
commercial carpet and the ACRILAN(R) brand for knit apparel.
Solutia was incorporated in Delaware in April 1997 to hold most of
the chemical businesses of the former Monsanto Company, now known as
Pharmacia Corporation. On September 1, 1997, Monsanto distributed our
shares as a dividend to Monsanto's stockholders, and we became an
independent publicly held company.
RECENT DEVELOPMENTS
On December 2, 2002, we signed a definitive agreement to sell our
resins, additives and adhesives businesses to UCB S.A. for $500 million
in cash. In addition, UCB paid us $10 million up front for a short
period of exclusivity. The sale closed on January 31, 2003,
and resulted in a modest accounting gain.
In July 2002, we amended our bank credit facility. The amendment
extended the maturity of the facility until August 2004, reduced the
facility from $800 million to $600 million, and separated the facility
into a $300 million term loan and a $300 million revolving credit
facility. Net cash proceeds from the sale to UCB S.A. were used to repay
all of the borrowings outstanding under our bank credit facility, to
cash collateralize letters of credit and to purchase the co-generation
facility at our Pensacola, Florida plant.
Also in July 2002, we completed a private placement of 223,000 units
consisting of $223 million of senior secured 7-year notes and warrants
to purchase 5,533,522 shares of common stock. Part of the proceeds from
this offering was used to repay the principal and interest on
$150 million of 5-year notes that matured in October 2002.
SEGMENTS; PRINCIPAL PRODUCTS
In anticipation of the divestiture of our resins, additives and
adhesives businesses, we reorganized our management structure and
realigned our reportable segments during the fourth quarter of 2002. Our
new reportable segments are:
* Performance Products and Services; and
* Integrated Nylon.
The tabular and narrative information contained in Note 19 of "Notes
to Consolidated Financial Statements" appearing on pages 63 and 64 is
incorporated by reference into this section.
2
PERFORMANCE PRODUCTS AND SERVICES SEGMENT
Major End-Use
Major End-Use Products & Major Raw
Markets Major Products Applications Major Competitors Materials Major Plants
- ----------------------------------------------------------------------------------------------------------------------------------
CONSTRUCTION AND Polyvinyl butyral Products to increase DuPont; HT Troplast Butyraldehyde; Ghent, Belgium;
HOME FURNISHINGS for KEEPSAFE(R), the safety, ethanol; polyvinyl Springfield, MA;
SAFLEX INSIDE(R) security, sound alcohol; vinyl Trenton, MI
(used in Europe) and attenuation, energy acetate monomer
KEEPSAFE MAXIMUM(R) efficiency and
laminated window ultraviolet
glass; protection of
VANCEVA(TM) films; architectural glass
LLUMAR(R) and for residential and Bekaert;
VISTA(R) commercial Madico/Lintec; 3M Polyester film Martinsville, VA
professional window structures;
films and GILA(R) after-market films
retail window films for solar control,
security and safety
ASTROTURF(R) and Elecster; Fichet; Polyethylene St. Louis, MO;
CLEAN MACHINE(R) Entrance matting HBN-Teknik Ghent, Belgium
door mats
- ----------------------------------------------------------------------------------------------------------------------------------
VEHICLES SAFLEX(R) plastic Products to increase DuPont; Sekisui Butyraldehyde; Ghent, Belgium;
interlayer for the safety, ethanol; polyvinyl Springfield, MA;
windshields and for security, sound alcohol; vinyl Trenton, MI
side and rear attenuation and acetate monomer
windows of vehicles; ultraviolet
VANCEVA(TM) films; protection of
LLUMAR(R), automotive glass and
FORMULAONE give vehicles a Bekaert;
PERFORMANCE custom appearance Madico/Lintec; 3M Polyester film Martinsville, VA
AUTOMOTIVE FILMS(R)
and GILA(R) retail
window films
- ----------------------------------------------------------------------------------------------------------------------------------
INDUSTRIAL Metallized films; Window films; tapes; 3M; Toray; Polyester film; Martinsville, VA
APPLICATIONS sputtered films; automotive badging; Mitsubishi; ATI; glycol; n-methyl-
AND ELECTRONICS release liners and optical and colored Garware; Intellicoat 2-pyrrolidone; crude
deep-dyed films filters; shades; and dispersed dyes;
reprographics; aluminum wires and
packaging boats; uvinol
Performance films; Computer Bekaert; Southwall; Polyester film; Martinsville, VA;
conductive and touch-screens; OCLI Indium tin; precious Canogo Park, CA
anti-reflective electroluminescent metals
coated films displays for
hand-held
electronics and
watches; cathode ray
tube and LCD
monitors
Chlorobenzenes Herbicides Benzene; chlorine Anniston, AL;
Sauget, IL
- ----------------------------------------------------------------------------------------------------------------------------------
CAPITAL EQUIPMENT THERMINOL(R) heat Heat transfer Dow Chemical Co.; Benzene; phenol; Alvin, TX;
transfer fluids; fluids; water Nippon Steel phosphorus Anniston, AL;
DEQUEST(R) water treatment; oil field Chemical Co.; trichloride Newport, Wales
treatment chemicals chemicals Rhodia; Bayer (U.K.)
- ----------------------------------------------------------------------------------------------------------------------------------
AVIATION/ SKYDROL(R) aviation Hydraulic fluids for ExxonMobile Phosphorus St. Louis, MO
TRANSPORTATION hydraulic fluids; commercial aircraft; oxychloride;
SKYKLEEN(R) aviation environmentally methanol
solvents friendly solvents
for aviation
maintenance
- ----------------------------------------------------------------------------------------------------------------------------------
PHARMACEUTICALS Services for process New pharmaceuticals Rhodia ChiRex; Aarau, Bubendorf and
research and Albany Molecular Friborg, Switzerland
development, Research; Pharma-
scale-up Eco; Evotec
manufacturing and
small-volume
licensed production
- ---------------------------------------------------------------------------------------------------------------------------------
3
INTEGRATED NYLON SEGMENT
Major End-Use
Major End-Use Products & Major Raw
Markets Major Products Applications Major Competitors Materials Major Plants
- ---------------------------------------------------------------------------------------------------------------------------------
CONSTRUCTION AND Nylon carpet staple; WEAR-DATED(R) DuPont; Honeywell; Acrylonitrile; Pensacola, FL;
HOME FURNISHINGS nylon bulk residential and BASF ammonia; Greenwood, SC;
continuous filament; ULTRON(R) commercial cyclohexane; Decatur and
ACRILAN(R) acrylic carpet; propylene Foley, AL
fiber; ASCEND(R) WEAR-DATED(R)
nylon polymer upholstery fabrics;
blankets; non-woven
reinforcement and
linings
- ---------------------------------------------------------------------------------------------------------------------------------
PERSONAL PRODUCTS ACRILAN(R) acrylic Sweaters; knit Acordis; DuPont; Acrylonitrile; Pensacola, FL;
fiber; ASCEND(R) apparel; half-hose; Radici ammonia; Decatur, AL;
nylon polymer active wear; craft cyclohexane; Greenwood, SC
yarns; hand-knit propylene
yarns; apparel;
dental floss;
intimate apparel
- ---------------------------------------------------------------------------------------------------------------------------------
VEHICLES Nylon filament; Tires; brakes; Acordis; DuPont; Acrylonitrile; Pensacola, FL;
VYDYNE(R) nylon convertible tops; Rhodia; Asahi ammonia; Decatur, AL;
molding resins; automotive interior, Chemical; DUSA cyclohexane; Greenwood, SC
ASCEND(R) nylon exterior and propylene
polymer; ACRILAN(R) under-the-hood
acrylic fiber molded parts
- ---------------------------------------------------------------------------------------------------------------------------------
INDUSTRIAL ACRILAN(R) acrylic Conveyer belts; Acordis; DuPont; Acrylonitrile; Pensacola, FL;
APPLICATIONS fiber; ASCEND(R) awnings and outdoor Honeywell; BASF ammonia; Decatur, AL;
nylon polymer; furniture; nylon cyclohexane; Greenwood, SC
industrial nylon film cooking bags; propylene
fiber specialized food
packaging
- ---------------------------------------------------------------------------------------------------------------------------------
INTERMEDIATE Nylon salt; Nylon and acrylic DuPont; Rhodia; Natural gas; Decatur, AL;
CHEMICALS adipic acid; fiber; nylon and ABS BASF; Asahi Chemical propylene; Alvin, TX;
hexamethylenediamine; plastics; synthetic cyclohexane Greenwood, SC;
acrylonitrile resins; synthetic Pensacola, FL
lubricants; paper
chemicals;
plasticizers
- ---------------------------------------------------------------------------------------------------------------------------------
4
PRINCIPAL EQUITY AFFILIATES
We participate in several joint ventures in which we share
management control with other companies. Our equity earnings (loss)
from affiliates were $13 million in 2002, $(13) million in 2001 and
$35 million in 2000. Principal joint ventures include Flexsys, L.P. and
Astaris LLC.
Flexsys, headquartered in Belgium, is a leading supplier of process
chemicals to the rubber industry. Its product line includes a number of
branded accelerators (SANTOCURE(R), THIOFIDE(R) and THIOTAX(R)),
pre-vulcanization inhibitors (SANTOGARD(R)), antidegradants and
antioxidants (FLECTOL(R) and SANTOWHITE(R)) and insoluble sulphur
(CRYSTEX(R)). Flexsys is a 50/50 joint venture with Akzo Nobel N.V. For
additional information about Flexsys, see "Legal Proceedings--Other" on
page 11 below.
Astaris, headquartered in the United States, sells phosphorus and
phosphate salts. Its product line includes a number of branded products
such as LEVN-LITE(R), PAN-O-LITE(R) and LEVERAGE(R) phosphate, which are
sold into the bakery markets. The business also services the
pharmaceutical, meat and poultry and industrial marketplaces. Astaris is
a 50/50 joint venture with FMC Corporation. For additional information
about Astaris, see "Contingencies" on page 27 below.
SALE OF PRODUCTS
We sell our products directly to end users in various industries,
principally by using our own sales force, and, to a lesser extent, by
using distributors.
On May 1, 2002, we and Dow Plastics, a business unit of The Dow
Chemical Company, formally terminated the marketing alliance under which
Dow had marketed our VYDYNE(R) nylon 6,6 molding resins for injection
molding applications worldwide, and we resumed sole responsibility for
the business.
Our marketing and distribution practices do not result in unusual
working capital requirements on a consolidated basis. We maintain
inventories of finished goods, goods in process and raw materials to
meet customer requirements and our scheduled production. In general, we
do not manufacture our products against a backlog of firm orders; we
schedule production to meet the level of incoming orders and the
projections of future demand. We do not have material contracts with the
government of the United States or any state, local or foreign
government. We are not generally dependent on one or a group of
customers, and no single customer or customer group accounts for
10 percent or more of our net sales. However, sales to the carpet mill
industry and the European auto glass industry each represent a
significant portion of our net sales.
Our second and third quarters are typically stronger than our first
and fourth quarters because sales of carpet and window films are
stronger in the spring and fall.
COMPETITION
The global markets in which our chemical businesses operate are
highly competitive. We expect competition from other manufacturers of
the same products and from manufacturers of different products designed
for the same uses as ours to continue in both U.S. and ex-U.S. markets.
Depending on the product involved, we encounter various types of
competition, including price, delivery, service, performance, product
innovation, product recognition and quality. Overall, we regard our
principal product groups as competitive with many other products of
other producers and believe that we are an important producer of many of
these product groups. For additional information regarding competition
in specific markets, see the charts under "Segments; Principal Products"
above.
RAW MATERIALS AND ENERGY RESOURCES
We buy large amounts of commodity raw materials, including
propylene, cyclohexane, benzene and natural gas. We typically buy major
requirements for key raw materials pursuant to medium-term contracts. We
are not dependent on any one supplier for a material amount of our raw
materials or energy requirements, but we obtain certain important raw
materials from a few major suppliers. In general, in those cases where
we have limited sources of raw materials, we have developed contingency
plans to minimize the effect of any interruption or reduction in supply.
For information about specific raw materials, see the charts under
"Segments; Principal Products" above.
While temporary shortages of raw materials and energy may
occasionally occur, these items are generally sufficiently available to
cover our current and projected requirements. However, their continuing
availability and price may be affected by unscheduled plant
interruptions and domestic and world market conditions, political
conditions and governmental regulatory actions. We cannot accurately
predict the effect of any future raw material and energy prices or
shortages on our business as a whole or in specific world areas.
For additional information on raw materials and energy, see
"Economic Conditions and Outlook" on page 23 below.
5
PATENTS AND TRADEMARKS
We own a large number of patents that relate to a wide variety of
products and processes and have pending a substantial number of patent
applications. In addition, we are licensed under a small number of
patents owned by others. We own a considerable number of established
trademarks in many countries under which we market our products. These
patents and trademarks in the aggregate are of material importance to
our operations and to our Performance Products and Services and
Integrated Nylon segments.
RESEARCH AND DEVELOPMENT
Research and development constitute an important part of our
activities. Our expenses for research and development amounted to
approximately $39 million in 2002, $43 million in 2001 and $57 million
in 2000, or about 2 percent of sales on average. We focus our
expenditures for research and development on process improvements and
selected product development.
We continued to enhance and expand our Performance Films product
offerings for the automotive, architectural and specialty film markets
by introducing products with new colors, patterns, textures and heat
protection. We also introduced several new specialty films for the
electronic and decorative markets. We developed a new heat transfer
fluid for our Industrial Products portfolio to meet the growing demand
for ultra-low temperature processing in the pharmaceutical industry. We
continue to develop biodegradable chelates and scale inhibitors to meet
market needs for more environmentally friendly products. Our Integrated
Nylon segment focused on internal process improvements, resulting in
lower costs and higher quality in many of our key product families.
ENVIRONMENTAL MATTERS
The narrative information appearing under "Environmental Matters"
beginning on page 29 below is incorporated here by reference.
EMPLOYEE RELATIONS
On December 31, 2002, we had approximately 9,400 employees
worldwide. This number decreased to approximately 7,300 following the
sale of our resins, additives and adhesives businesses to UCB S.A. on
January 31, 2003. In general, satisfactory relations have prevailed
between our employees and us. We use self-directed work teams, incentive
programs and other initiatives to keep employees actively involved in
the success of the business. Approximately 16 percent of our workforce
is currently represented by various labor unions.
INTERNATIONAL OPERATIONS
Solutia and its subsidiaries are engaged in manufacturing, sales and
research and development in areas outside the United States.
Approximately 38% of our consolidated sales from continuing operations
in 2002 were made into markets outside the United States, including
Europe, Canada, Latin America and Asia. Our Performance Products and
Services segment is particularly dependent on its international
operations. Approximately 61% of the 2002 sales of the Performance
Products and Services segment were made into markets outside the United
States.
Operations outside the United States are potentially subject to a
number of risks and limitations that are not present in domestic
operations, including trade restrictions, investment regulations,
governmental instability and other potentially detrimental governmental
practices or policies affecting companies doing business abroad.
Operations outside the United States are also subject to
fluctuations in currency values. The functional currency of each of our
non-United States operations is the local currency. Exchange rates
between these currencies and U.S. dollars have fluctuated significantly
in recent years and may continue to do so. In addition, we generate
revenue from export sales and operations conducted outside the United
States that may be denominated in currencies other than the relevant
functional currency.
INTERNET ACCESS TO INFORMATION
Our Internet address is www.solutia.com. We make available free of
charge through our Internet website our annual report on Form 10-K, our
quarterly reports on Form 10-Q, current reports on Form 8-K, and any
amendments to these reports as soon as reasonably practicable after they
are electronically filed with, or furnished to, the Securities and
Exchange Commission.
ITEM 2. PROPERTIES.
Our general offices are located in a leased facility in St. Louis
County, Missouri. Our principal European offices are located in Louvain
La Neuve, Belgium, on land leased from the University of Louvain.
Information about our major manufacturing locations worldwide and
segments that used these locations on February 1, 2003, appears under
"Segments; Principal Products" in Item 1 of this report and is
incorporated here by reference.
6
Our principal plants are suitable and adequate for their use.
Utilization of these facilities varies with seasonal, economic and other
business conditions, but none of our principal plants is substantially
idle. Our facilities generally have sufficient capacity for existing
needs and expected near-term growth. We have plans for some incremental
capacity expansion at certain facilities in the next two to three years.
We own most of our principal plants. However, at Antwerp, Belgium
and Sao Jose dos Campos, Brazil, both of which are sites belonging to
Monsanto, we own certain buildings and production equipment and lease
the underlying land. In addition, we lease buildings for our
Pharmaceuticals Services Division, including the main production site in
Aarau, Switzerland.
Monsanto and Solutia have operating agreements with respect to each
of the two Monsanto facilities listed above and Solutia's Chocolate
Bayou facility in Alvin, Texas. Under these operating agreements, we are
the guest and Monsanto is the operator, except at the Chocolate Bayou
facility at which Monsanto is the guest and we are the operator. The
initial term of each of the operating agreements has 15 years remaining.
After the initial term, the operating agreements continue indefinitely
unless either party terminates on at least 24 months' prior written
notice. Each of the operating agreements also provides that, under
certain circumstances, either the operator or the guest may terminate
the operating agreement before the expiration of its initial term. We
operate several facilities for other third parties, principally within
the Alvin (Chocolate Bayou), Texas; Sauget, Illinois; Pensacola,
Florida; Trenton, Michigan; Newport Wales (U.K.) and Springfield,
Massachusetts sites under long-term lease and operating agreements.
Mortgages on our plants located in Decatur, Alabama; Springfield,
Massachusetts; Trenton, Michigan; Greenwood, South Carolina; Alvin
(Chocolate Bayou), Texas; Pensacola, Florida; and Martinsville, Virginia
constitute a portion of the collateral securing our amended credit
facility, our publicly issued debt, and our obligations under certain
other financing facilities. In addition, there is a mechanics' lien
filed by Fluor Daniel, a division of Fluor Enterprises, Inc., against
our Chocolate Bayou facility, currently in the amount of $10 million,
securing the remaining payments we have agreed to make to Fluor Daniel
over a three-year period in settlement of litigation arising out of the
construction of an acrylonitrile facility at the Chocolate Bayou plant.
ITEM 3. LEGAL PROCEEDINGS.
Because of the size and nature of our business, we are a party to
numerous legal proceedings. Most of these proceedings have arisen in the
ordinary course of business and involve claims for money damages. In
addition, at the time we became an independent company, we assumed
liabilities related to specified legal proceedings from the former
Monsanto Company, now known as Pharmacia Corporation ("Old Monsanto"),
under an agreement known as the Distribution Agreement. As a result,
although Old Monsanto remains the named defendant, we are required to
manage the litigation and indemnify Old Monsanto for costs, expenses and
judgments arising from the litigation. While the results of litigation
cannot be predicted with certainty, we do not believe, based on
currently available facts, that the ultimate resolution of any of these
preceding matters will have a material adverse effect on our financial
position or liquidity in any one year. However, resolution in those
cases described below involving the alleged discharge of polychlorinated
biphenyls ("PCBs") from the Anniston, Alabama plant site and the Penndot
case, also described below, may have a material adverse effect on our
net income in a given year, although it is impossible at this time to
estimate the range or amount of any such liability. In addition, there
cannot be any assurance that any final judgment against us in the
Anniston, Alabama cases, if upheld on appeal, will not have a material
adverse effect on our financial position and liquidity.
The following paragraphs describe several proceedings to which we
are a party or to which Old Monsanto is a party and for which we have
assumed any liabilities.
ANNISTON, ALABAMA CASES
In November 1993, Old Monsanto was named as a defendant in the first
of 41 lawsuits which have been filed in state or federal court in
Alabama in which plaintiffs claim to have sustained personal injuries or
property damage as a result of the alleged release of polychlorinated
biphenyls ("PCBs") and other materials from its Anniston, Alabama plant
site. To date 22 of those lawsuits, involving claims made by nearly
5,900 plaintiffs have been resolved for approximately $87 million.
Currently pending are the following matters:
(1) Abernathy v. Monsanto: Four consolidated cases, the first of
which was served on April 1, 1996, were originally filed in
Circuit Court for Calhoun County, Alabama on behalf of
3,516 plaintiffs who own or rent homes, own or operate businesses,
attend churches, or have otherwise resided in or visited
neighborhoods near the Anniston plant. Plaintiffs seek
compensatory and punitive damages in an unspecified amount or in
the amount of $3 million for each individual and injunctive
relief requiring the Company to remove alleged contamination.
The individual plaintiffs claim to have suffered permanent
adverse health effects and fear future disease. They assert the
need for medical monitoring, diminution in the value of their
properties in the case of residential and commercial property
owners and commercial losses in the case of business owners.
Because of significant pretrial publicity in Calhoun County,
venue in these cases was transferred to Circuit Court in Etowah
County. Sixteen individual plaintiffs and one business entity
were selected as plaintiffs for a Phase I trial that began on
January 7, 2002. On February 22, 2002, the jury returned a
verdict in favor of plaintiffs on six liability issues:
nuisance, trespass, negligence, wantonness, suppression of the
truth and outrage.
7
The trial court departed from its announced trial plan and did
not submit damage issues to the jury for the 17 Phase I trial
plaintiffs. Instead, the parties agreed on a streamlined format
for submission to the jury of property damage evidence for all
plaintiffs who are making a property damage claim. In total,
907 plaintiffs are asserting claims of property damage with respect
to 941 pieces of property. Hearings on plaintiffs' claims for
injunctive relief, which were not tried to a jury, began on
March 6, 2002, and concluded on April 12, 2002. The court then
referred the issue of injunctive relief and defendants' motions
to dismiss those claims to a Special Master for a
recommendation. On May 31, 2002, the Special Master issued a
report recommending that the court stay injunctive proceedings
in view of the filing by the United States Environmental
Protection Agency ("EPA") of a Partial Consent Decree, noted
below.
On March 29, 2002, we filed a motion to recuse the Abernathy trial
judge because of the appearance of bias or lack of impartiality
created by frequent ex parte interviews given to the media on
issues in the case, and because of improper actions at a
court-ordered settlement conference on March 12, 2002. On
November 8, 2002, following additional briefing and a hearing on
August 8, 2002, an Etowah County judge to whom the matter had
been referred, denied our recusal motion. On August 19, 2002,
the Alabama Supreme Court issued an order in response to our
request staying all proceedings in this case other than the
presentation of written evidence regarding property damage
claims pending further order by the Supreme Court on the recusal
issue. On February 26, 2003, the Alabama Supreme Court denied
our mandamus petition and upheld the ruling of the Etowah County
judge denying our recusal motion.
On July 1, 2002, Solutia, Pharmacia and the new Monsanto Company
("Monsanto") entered into an agreement pursuant to which
Pharmacia agreed to post an appeal bond in the Abernathy case if
needed, and if Solutia is unable to obtain such a bond. Pursuant
to the agreement, if Pharmacia is not required to provide
collateral in order to obtain an appeal bond, then Solutia,
Pharmacia and Monsanto will have shared control over any
decision to settle the Abernathy case. If Pharmacia is required
to provide collateral in order to obtain an appeal bond, then
Pharmacia will have control of any settlement decision but has
an obligation to consult with Solutia and Monsanto before
agreeing to any settlement.
(2) Tolbert v. Monsanto: Monsanto, Pharmacia and Solutia are
defendants in this action, served on June 4, 2001, and filed in
the United States District Court for the Northern District of
Alabama initially on behalf of 1,116 plaintiffs. On January 18,
2002, plaintiffs filed an amended complaint adding approximately
14,000 additional plaintiffs to the action. As a result of
further amendments, there are now 16,695 plaintiffs in this
case. Plaintiffs claim they were exposed to PCBs and suffer from
unspecified physical injuries and emotional distress. They seek
compensatory and punitive damages in unspecified amounts and
request medical testing, monitoring and treatment, as well as
unspecified injunctive relief. The court has ordered that trial
in this matter will proceed in phases. The parties have
designated eight plaintiffs for a Phase I trial, four of whom
claim liver disease and four of whom claim cancer. Trial is
currently scheduled to commence after July 31, 2003, the date of
the final pretrial conference. Our outside counsel in this
matter have been advised by counsel representing a group of
plaintiffs in the Tolbert case that those counsel represent
approximately 2,000 additional individuals who intend to file
suit. We are negotiating an acceptable tolling agreement that
will preserve the parties' respective rights and defenses
without the filing of an additional action.
(3) Payton v. Monsanto: This case was brought in Circuit Court in
Shelby County, Alabama on July 15, 1997, on behalf of a
purported class of all owners, lessees and licensees of
properties located on Lay Lake, which is downstream from Lake
Logan Martin on the Coosa River. Plaintiffs seek compensatory
and punitive damages in an unspecified amount for an alleged
increased risk of physical injury and illness, emotional
distress caused by fear of future injury or illness, medical
monitoring and diminishment in the value of their properties and
their riparian rights. On October 5, 1999, the trial court
granted Solutia's motion for summary judgment, and plaintiffs
appealed to the Supreme Court of Alabama. On May 4, 2001, the
Supreme Court issued an opinion affirming in part and reversing
in part the order of the trial court. The Supreme Court held
that summary judgment was properly granted with respect to
claims relating to the period up to the date of settlement of a
previous action which did not involve Monsanto, Pharmacia or us,
but which did seek compensation for the presence of PCBs on
plaintiffs' properties. However, the Supreme Court held that
plaintiffs were permitted to maintain their claims relating to
the period from the settlement of the prior action until the
filing of the instant action. The case has been remanded to the
trial court, where the parties currently await a decision by the
trial court on plaintiffs' motion for class certification.
(4) Other Anniston Cases: There are twelve other cases on behalf of
a total of 24 additional plaintiffs, four pending in Circuit
Court for Calhoun County, three pending in Circuit Court for
Jefferson County, one pending in Circuit Court for Dekalb County
and three pending in United States District Court for the
Northern District of Alabama. Plaintiffs in these actions own or
rent homes, own or operate businesses, attend churches, or have
otherwise resided or visited in neighborhoods near the Anniston
plant, or are commercial entities which own or have conducted
business on property near the Anniston plant. Two of these cases
are brought on behalf of purported classes of Alabama residents
exposed to PCBs from the Anniston plant. Plaintiffs seek
compensatory and punitive damages in unspecified amounts and
injunctive relief requiring the Company to remove alleged
contamination. The individual plaintiffs claim to have suffered
permanent adverse health effects and fear future disease. They
assert the need for
8
medical monitoring, diminution in the value of their properties
in the case of residential and commercial property owners and
commercial losses in the case of business owners.
Solutia believes that there are meritorious defenses to all these
matters, including lack of any imminent or substantial endangerment to
health or the environment caused by any activities at the Anniston
plant, lack of any physical injury or property damage to plaintiffs
caused by any activities at the Anniston plant, lack of any negligence
or improper conduct on Monsanto's or Solutia's part, and the
implementation of a remediation program under the oversight of the
United States Environmental Protection Agency and the Alabama Department
of Environmental Management. We are vigorously defending these actions.
Solutia has insurance coverage that is available to mitigate
potential damages in these cases. The applicable insurance coverage is
bound by a confidential claim administrative agreement that precludes
Solutia from disclosing the insurance carriers' names and limits of
coverage. The security of the insurers is better than A.M. Best's "A"
rated companies. Solutia is receiving contribution from these insurers
for defense costs, and there are currently no disputed coverage issues.
However, there is no assurance that our available insurance will cover
all claims, that our insurers will not challenge coverage for certain
claims or that the final damage awards will not exceed our available
insurance coverage.
ANNISTON PARTIAL CONSENT DECREE
In October 2000 Solutia entered into an Administrative Order on
Consent ("AOC") with the EPA providing for sampling of certain
residential properties and removal of soils found on those properties if
PCBs were found at a level of 10 parts per million (ppm) or above. That
order was amended in October 2001 to encompass additional areas for
sampling and possible soil removal. Following entry of the October 2000
AOC Solutia and the EPA commenced negotiations on a comprehensive
agreement that would address the steps leading to a final remedy. On
March 25, 2002, in an action captioned United States of America v.
Pharmacia Corporation (p/k/a Monsanto Company) and Solutia, the EPA
lodged a Partial Consent Decree with the United States District Court
for the Northern District of Alabama. Pursuant to that decree Solutia
and Pharmacia agreed to conduct a Remedial Investigation and Feasibility
Study to provide information for the selection by the EPA of a cleanup
remedy for the Anniston PCB site. The decree also provided for the
creation of an educational trust fund of $3.2 million to be funded over
a 12-year period to provide supplemental educational services for school
children in west Anniston. The Partial Consent Decree was submitted for
a public comment period, which closed on June 3, 2002. On October 23,
2002, the EPA filed a revised Partial Consent Decree with the court. The
revised decree contains a new provision, added in response to public
comment, for addressing cleanup of residential properties sooner than
would have been the case under the original proposed decree. The EPA has
asked the court to approve the revised Partial Consent Decree.
PENNDOT CASE
Old Monsanto is one of several defendants added on February 7, 1997,
to a case then pending in the Commonwealth Court of Pennsylvania. This
action was originally filed against United States Mineral Products
Company in 1990 by the Commonwealth, seeking damages caused by the
presence of asbestos fireproofing in the Transportation and Safety
Building ("T & S Building") in Harrisburg, Pennsylvania. In June 1994 a
fire broke out in the T & S Building. Testing following the fire
revealed the presence of low levels of PCBs at various locations in the
building. The Commonwealth claims that PCBs used in fluorescent light
ballasts, in adhesives in fiberglass ductboard that was part of the
heating and ventilation system and in caulking used on the exterior of
the building contaminated the building and necessitated its demolition.
The Commonwealth seeks recovery of costs it allegedly incurred in
testing, monitoring, cleanup, demolition and temporary relocation of
Commonwealth employees caused by the alleged contamination. In addition,
the Commonwealth seeks the cost of constructing a new building on the
site of the T & S Building. Trial of this action commenced with the
selection of a jury in April 1999. On August 23, 2000, the jury returned
a verdict of $90 million against Old Monsanto. The verdict was reduced
to $45 million by the trial court because the manufacturer of the
fiberglass ductboard reached a settlement with the Commonwealth during
trial. We filed extensive post-trial motions, seeking judgment
notwithstanding the jury's verdict or a new trial. The trial court
denied these motions in orders filed on October 16, 2002. On November
15, 2002, we filed an appeal as of right to the Supreme Court of
Pennsylvania.
On November 15, 2002, Solutia, Pharmacia and Monsanto entered into
an agreement (the "Penndot Protocol") pursuant to which Monsanto posted
an appeal bond and the collateral required to secure that bond. We
provided a $20 million letter of credit to secure a portion of
Monsanto's obligations with respect to the bond. In addition, we paid
all of Monsanto's out-of-pocket expenses incurred in obtaining the bond.
As a result of Monsanto's providing the collateral required to secure
the appeal bond, Monsanto assumed control of any settlement decision,
but agreed to consult with Solutia and Pharmacia before agreeing to any
settlement. The Penndot Protocol required us to release Monsanto from
its obligations with respect to the appeal bond, and to either secure a
replacement bond or settle the litigation within 15 business days
following an asset sale having an aggregate value of $100 million or
more (the "Release Conditions"). The Release Conditions were triggered
on January 31, 2003, when we closed the sale of our resins, additives
and adhesives businesses. On March 3, 2003, Solutia, Pharmacia and
Monsanto entered into an amendment to the Penndot Protocol pursuant to
which the appeal bond obtained by Monsanto will remain in effect and
Monsanto will extend the time frame for satisfying the Release
Conditions until November 30, 2003 (the
9
"Extension Period"). Under this amendment, Solutia will provide Monsanto
with an additional letter of credit in the amount of $39.9 million, and
Monsanto will return control of any settlement decision to Solutia
during the Extension Period (with Solutia agreeing to consult with
Monsanto and Pharmacia before entering into any settlement).
We believe that there are meritorious defenses, including lack of
any hazard or danger to occupants of or visitors to the T & S Building
caused by the presence of PCBs; a determination by the Pennsylvania
Department of Health that the building was safe for use and occupancy;
the failure of the Commonwealth to act prudently following the fire to
mitigate its alleged damages; the impropriety of using replacement cost
as a measure of damages; and the fact that most of plaintiffs' damages
would have been incurred during the removal of asbestos fireproofing and
the installation of fire suppression sprinklers required to comply with
the 1987 Harrisburg Fire Safety Code, and thus cannot be attributed to
the presence of PCBs. We are defending this matter vigorously.
Solutia has insurance coverage that is available to mitigate
potential damages in this case and is receiving contribution from its
insurers for defense costs.
OTHER PCB LITIGATION
Excluding the Anniston, Alabama cases and the Penndot case discussed
above, since 1971, Old Monsanto has been named as a defendant in
approximately 482 cases in which plaintiffs have made claims of personal
injuries or property damage resulting from alleged exposure to PCBs. Of
those cases 467 have been resolved, including the claims of
approximately 15,000 plaintiffs at a cost to Old Monsanto and Solutia of
approximately $32 million. These cases have usually involved
product-based claims in which plaintiffs have alleged that exposure to
PCBs occurred in the course of their employment or as a result of an
incident involving equipment which used PCBs as a dielectric, hydraulic
or heat transfer fluid. The fifteen pending cases that involve claims of
this nature are the following:
(1) Binghamton State Office Building Litigation: In January 1984,
Old Monsanto was served in the first of five cases brought in
state court in Broome County, New York, relating to claims of
injury allegedly resulting from exposure to PCBs during and
immediately after a fire which occurred on February 5, 1981, in
a State office building in Binghamton, N.Y. Plaintiffs are
43 emergency responders or individuals involved in clean up
activities immediately after the fire and their spouses, for a
total of 81 plaintiffs. PCBs, dibenzofurans and dibenzodioxins
were allegedly spread throughout the building when a
transformer, located in an equipment room in the basement of the
building, ruptured during the fire. The dielectric fluid in the
transformer was composed, in part, of PCBs. Plaintiffs claim to
have suffered various personal injuries, including in some cases
death, and allege fear of future disease and the need for
medical monitoring. They seek compensatory and punitive damages
in an unspecified amount. Plaintiffs have selected ten of their
number to participate in a "Phase I" trial. A trial date has not
yet been set by the court. Solutia is defending these actions
vigorously and believes that there are meritorious defenses,
including lack of proximate cause and lack of negligence or
other improper conduct on the part of Old Monsanto or Solutia.
(2) Crystal Springs, Mississippi Litigation: Old Monsanto is one of
many defendants named in a suit filed on May 14, 2001, on behalf
of one plaintiff in state court in Copiah County, Mississippi.
Three nearly identical suits, brought on behalf of an additional
168 plaintiffs in state court in Hinds County, Mississippi were
served on Old Monsanto on December 18, 2001. Plaintiffs are
present or former employees of Kuhlman Electric Company's
Crystal Springs, Mississippi transformer manufacturing facility.
As to Old Monsanto, plaintiffs claim exposure to PCBs, allegedly
resulting in unspecified physical injuries and emotional
distress. Plaintiffs claim to fear the development of disease in
the future and allege the need for medical monitoring. They seek
compensatory and punitive damages in an unspecified amount. All
four of these cases were removed to U.S. District Court for the
Southern District of Mississippi on April 10, 2002. Plaintiffs
filed motions to remand the cases to state court; those motions
await decision by the District Court. Old Monsanto and Solutia
were named as defendants in one additional action filed on
behalf of a single plaintiff in state court in Copiah County,
Mississippi on December 31, 2002. This case makes claims similar
to those previously filed, and has also been removed to U.S.
District Court for the Southern District of Mississippi. Solutia
is vigorously defending these actions and believes that there
are meritorious defenses, including lack of proximate cause and
lack of negligence or other improper conduct on the part of Old
Monsanto or Solutia.
(3) Other Pending PCB Cases: There are an additional five PCB cases
brought against Old Monsanto, one in state court in Louisiana
brought on behalf of ten plaintiffs, one in state court in West
Virginia brought on behalf of two plaintiffs, two in state
courts in New Jersey brought on behalf of a total of three
plaintiffs and one in federal court in Pennsylvania brought on
behalf of one plaintiff. These cases make a variety of
allegations, including personal injury or property damage
resulting from alleged exposure to PCBs, or seek recovery of
environmental remediation expenses resulting from the claimants'
improper disposal of PCBs. Plaintiffs seek compensatory and, in
some cases, punitive damages in unspecified amounts. Solutia is
vigorously defending all these actions and believes that there
are meritorious defenses, including lack of proximate cause and
lack of negligence or other improper conduct on the part of Old
Monsanto or Solutia.
10
Solutia has insurance coverage that is available to mitigate
potential damages in cases alleging personal injury or property damage,
and is either receiving contribution from its insurers for defense
costs, or expects to receive such contribution once self-insured
retentions are exhausted. Cases which seek recovery of environmental
remediation costs are not insured.
PREMISES BASED ASBESTOS LITIGATION
Like a great number of other companies that used high temperature
manufacturing processes, Old Monsanto historically used asbestos
insulating materials in piping and other equipment at its chemicals
plants. As a result, Old Monsanto and Solutia have been named as
defendants along with numerous other premises owners in actions brought
by employees of contractors who claim that they were exposed to asbestos
at our facilities and at the facilities of these other owners. Solutia
has no product-based asbestos litigation. Historically, we have resolved
these premises-related actions without a material effect on our results
of operation, liquidity or financial position. Settlements in cases
resolved in 2002 totaled approximately $6 million, a portion of which we
expect to recover from our insurers. Although we have recently
experienced an increase in the number of asbestos-related premises
liability claims, we do not expect them to have a material effect. We
now have pending approximately 450 such actions in Texas, West Virginia,
Illinois, Missouri, Michigan and Florida involving an estimated 2,500 to
3,500 plaintiffs. More than 80% of these plaintiffs do not suffer from
any manifest illness but may exhibit non-symptomatic pleural or
pulmonary changes on x-ray screening, and, if not dismissed, such claims
are typically settled for nominal amounts. Solutia believes that there
are meritorious defenses, including the lack of injury or proximate
causation and the responsible actions taken by Old Monsanto and Solutia
to prevent asbestos exposures in the workplace, and is vigorously
defending these actions.
ROCK SPRINGS CASE
On December 4, 1998, the EPA issued a notice of violation to
Solutia, Old Monsanto and P4 Production, L.L.C., alleging violations of
the Wyoming Environmental Quality Act, the Wyoming Air Quality Standards
& Regulations and a permit issued in 1994 by the Wyoming Department of
Environmental Quality to Sweetwater Resources, Inc., a former subsidiary
of Old Monsanto, for a coal coking facility in Rock Springs, Wyoming.
This facility is currently owned by P4 Production, a joint venture which
the new Monsanto Company now both operates and controls. We remain a
party to this litigation despite the sale of substantially all of our
interest in this joint venture. On November 22, 1999, the United States,
on behalf of the EPA, demanded $2.5 million from the parties as well as
injunctive relief ensuring compliance with the permit requirements. On
August 9, 2002, the United States filed a motion for summary judgment on
the issue of liability. The motion is pending while the parties attempt
to resolve the amount of the penalty through mediation.
OTHER
Authorities in the United States, Europe and Canada are
investigating past commercial practices in the rubber chemicals
industry. Flexsys, our 50/50 joint venture with Akzo Nobel N.V., has
been fully cooperating with the authorities and will continue to do so.
In addition, Solutia is aware of 20 purported class actions that have
been filed against Flexsys and other producers of rubber chemicals in
various state courts in the United States. Each seeks actual and treble
damages under the law of the state in which it was filed on behalf of
all retail purchasers of tires in that state since 1994.
For information about certain environmental proceedings involving
Solutia, see "Environmental Matters" on page 29.
RISK MANAGEMENT
We have evaluated risk retention and insurance levels for product
liability, property damage and other potential areas of risk. We will
continue to devote significant effort to maintaining and improving
safety and internal control programs, which reduce our exposure to
certain risks. We actively participate in the safety and health
Voluntary Protection Program ("VPP") administered by the Occupational
Safety and Health Administration ("OSHA") for sites in the United
States, and implemented by Solutia for sites outside the United States.
Currently, ten of our U.S. sites have received the OSHA VPP "Star"
designation, a rating signifying full compliance. Three of our ex-U.S.
sites, two in Europe and one in Canada, have achieved the Solutia "Star"
designation, which is an internal equivalent to the OSHA designation.
Our management determines the amount of insurance coverage to buy
from unaffiliated companies and the appropriate amount of risk to retain
and/or co-insure based on the cost and availability of insurance and the
likelihood of a loss. Management believes that the levels of risk that
Solutia has retained are consistent with those of other companies in the
chemical industry. There can be no assurance that we will not incur
losses beyond the limits, or outside the coverage, of our insurance. For
additional information, see "Self-Insurance" on page 30.
ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
We did not submit any matters to our security holders during the
fourth quarter of 2002.
11
PART II
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER
MATTERS.
Our stock is traded principally on the New York Stock Exchange under
the Symbol "SOI."
The following table shows the high and low sales prices for each
quarter during 2002 and 2001 as reported in the New York Stock Exchange
Composite Transactions.
2002 High Low 2001 High Low
- --------------------------------- ------ ----- ------------------------------------ ------ ------
First Quarter.................... $13.20 $6.12 First Quarter....................... $14.85 $12.06
Second Quarter................... 8.92 7.10 Second Quarter...................... 15.07 12.03
Third Quarter.................... 7.10 4.51 Third Quarter....................... 14.14 11.25
Fourth Quarter................... 5.95 2.81 Fourth Quarter...................... 14.28 11.71
On February 24, 2003, we had 32,878 registered shareholders.
The declaration and payment of dividends is made at the discretion
of our board of directors. The board's current policy is to pay cash
dividends on an annual basis in December. The annual dividend paid in
2002 and 2001 was $0.04 per share. Our credit facility and our senior
secured notes restrict our ability to increase our dividend. We
anticipate that the current four-cent annual dividend will remain
unchanged for the foreseeable future.
12
ITEM 6. SELECTED FINANCIAL DATA.
FINANCIAL SUMMARY
(Dollars in millions, except per share amounts)
2002 2001 2000 1999 1998
------- ------- ------- ------- -------
OPERATING RESULTS FROM CONTINUING OPERATIONS:
NET SALES................................................ $ 2,241 $ 2,268 $ 2,617 $ 2,705 $ 2,714
GROSS PROFIT............................................. 363 310 348 620 725
As percent of net sales.............................. 16% 14% 13% 23% 27%
MARKETING, ADMINISTRATIVE, AND TECHNOLOGICAL EXPENSES.... 322 334 352 328 340
As percent of net sales.............................. 14% 15% 13% 12% 13%
AMORTIZATION EXPENSE..................................... 3 12 11 3 --
OPERATING INCOME (LOSS)(1)............................... 38 (36) (15) 289 385
As percent of net sales.............................. 2% (2)% (1)% 11% 14%
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME
TAXES AND CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING
PRINCIPLE(2),(3)....................................... (19) (124) 30 298 377
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE
CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING
PRINCIPLE(2),(3)....................................... (8) (81) 36 203 250
As percent of net sales.............................. -- (4)% 1% 8% 9%
CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING PRINCIPLE...... (167) -- -- -- --
SHARE DATA FROM CONTINUING OPERATIONS:
BASIC EARNINGS (LOSS) PER SHARE FROM CONTINUING
OPERATIONS(3).......................................... $ (0.08) $ (0.78) $ 0.34 $ 1.83 $ 2.16
DILUTED EARNINGS (LOSS) PER SHARE FROM CONTINUING
OPERATIONS............................................. (0.08) (0.78) 0.34 1.77 2.04
DIVIDENDS PER SHARE...................................... 0.04 0.04 0.04 0.04 0.04
TOTAL ASSETS............................................. 2,706 2,667 2,755 2,902 2,694
LONG-TERM DEBT........................................... 839 626 783 801 597
COMMON STOCK PRICE:
HIGH................................................. 13.20 15.07 17.19 26.31 32.00
LOW.................................................. 2.81 11.25 10.38 13.50 18.69
CLOSE................................................ 3.63 14.02 12.00 15.44 22.38
PRICE/EARNINGS RATIO ON YEAR-END STOCK PRICE............. (45) (18) 35 9 11
NUMBER OF REGISTERED SHAREHOLDERS........................ 32,878 34,668 36,703 39,171 41,864
YEAR-END SHARES OUTSTANDING (IN MILLIONS)................ 104.7 104.5 102.9 109.5 112.8
SHARES REPURCHASED (IN MILLIONS)......................... -- -- 7.7 3.8 6.2
AVERAGE DAILY TRADING VOLUME
(IN THOUSANDS)......................................... 649 358 518 458 401
OTHER DATA FROM CONTINUING OPERATIONS:
INTEREST EXPENSE......................................... $ 84 $ 70 $ 55 $ 39 $ 43
INCOME TAXES (BENEFIT)................................... (11) (43) (6) 95 127
DEPRECIATION AND AMORTIZATION............................ 134 143 152 147 143
CAPITAL EXPENDITURES..................................... 59 83 211 255 156
EMPLOYEES (YEAR-END)..................................... 7,300 7,100 8,100 8,500 6,600
- --------
(1) Operating income (loss) includes restructuring charges and other items of $22 million in 2002, $78 million in
2001, $158 million in 2000, $61 million in 1999 and $1 million in 1998.
(2) Income (loss) from continuing operations before cumulative effect of change in accounting principle includes
restructuring charges and other items of $15 million, or $0.14 per share in 2002, $96 million, or $0.92 per
share in 2001, $81 million, or $0.75 per share in 2000, $38 million, or $0.33 per share in 1999 and
$1 million, or $0.01 per share in 1998.
(3) Income (loss) from continuing operations includes amortization expense which, under the provisions of
Statement of Financial Accounting Standard No. 142, adopted on January 1, 2002, is no longer recognized of
$12 million, or $0.12 per share net of tax, and $10 million, or $0.09 per share net of tax, in 2001 and 2000,
respectively.
See Management's Discussion and Analysis of Financial Condition and
Results of Operations and Financial Condition and Liquidity under Item 7
for more information.
13
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS.
The following discussion and analysis should be read in conjunction
with the consolidated financial statements and related notes thereto
included in Item 8 of this Form 10-K.
OVERVIEW
On December 2, 2002, Solutia signed a definitive agreement to sell
its resins, additives and adhesives businesses to UCB S.A. for
$500 million in cash, plus an upfront payment of $10 million for a
period of exclusivity. The sale closed on January 31, 2003. The resins,
additives and adhesives businesses had net assets, including goodwill
and identified intangible assets from the Vianova Resins acquisition, of
approximately $471 million at December 31, 2002, and $554 million at
December 31, 2001. The resins, additives and adhesives businesses had
net sales of approximately $559 million in 2002, $549 million in 2001
and $568 million in 2000.
The resins, additives and adhesives businesses are presented as
discontinued operations in the consolidated financial statements and
related notes. As such, management's discussion and analysis excludes
discontinued operations and focuses on the results of the Company's
continuing operations. See Note 2 to the Consolidated Financial
Statements for further information on the discontinued operations. In
anticipation of the divestiture, Solutia reorganized its management
structure and realigned its reportable segments during the fourth
quarter of 2002. Solutia's new reportable segments and their major
products are as follows:
PERFORMANCE PRODUCTS AND SERVICES INTEGRATED NYLON
- ------------------------------------------------------------ ------------------------------------------------------------
SAFLEX(R) plastic interlayer Nylon intermediate "building block" chemicals
Polyvinyl butyral for KEEPSAFE(R), SAFLEX INSIDE(R) (in Merchant polymer and nylon extrusion polymers, including
Europe only) and KEEPSAFE MAXIMUM(R) laminated window VYDYNE(R) and ASCEND(R)
glass
LLUMAR(R), VISTA(R) and GILA(R) professional and retail Carpet fibers, including the WEAR-DATED(R) and ULTRON(R)
window films brands
VANCEVA(TM) films Industrial nylon fibers
Conductive and anti-reflective coated films and deep-dyed ACRILAN(R) acrylic fibers for apparel, upholstery fabrics,
films craft yarns and other applications
Industrial products, including THERMINOL(R) heat transfer
fluids, DEQUEST(R) water treatment chemicals, SKYDROL(R)
aviation hydraulic fluids, SKYKLEEN(R) aviation solvents,
and chlorobenzenes
Services for process research and development, scale-up
manufacturing and small volume licensed production for the
pharmaceutical industry
Solutia evaluates the performance of its operating segments based on
segment earnings before interest expense and income taxes (EBIT), which
includes marketing, administrative, technological and amortization
expenses and other income and expense items that can be directly
attributable to the segment profit/(loss). Certain expenses and other
items that are managed outside of the segments are excluded. These
unallocated items consist primarily of corporate expenses, equity
earnings (loss) from affiliates, interest expense, other income--net and
expense items, gains and losses from asset dispositions and
restructuring charges that are not directly attributable to the
operating segment. See Note 19 to the Consolidated Financial Statements
for further information.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions in certain
circumstances that affect amounts reported in the accompanying
consolidated financial statements and related footnotes. In preparing
these financial statements, the Company has made its best estimates of
certain amounts included in these financial statements. However,
application of these accounting policies involves the exercise of
judgment and use of assumptions as to future uncertainties and, as a
result, actual results could differ materially from these estimates.
Management has discussed the development, selection and disclosure of
these critical accounting policies and estimates with the Audit and
Finance Committee of Solutia's board of directors.
14
The Company believes that the estimates, assumptions and judgments
involved in the accounting policies described below have the greatest
potential impact on our financial statements and require assumptions
that can be highly uncertain at the time the estimate is made. The
Company considers the following items to be its critical accounting
policies:
* Environmental Remediation
* Self-Insurance
* Income Taxes
* Impairment of Long-Lived Assets
* Pension and Other Postretirement Benefits
The Company also has other significant accounting policies. The
Company believes that, compared to the critical accounting policies
listed above, the other policies either do not generally require
estimates and judgments that are as difficult or as subjective, or are
less likely to have a material impact on the reported results of
operations for a given period.
ENVIRONMENTAL REMEDIATION
With respect to environmental remediation obligations, the Company's
policy is to accrue costs for remediation of contaminated sites in the
accounting period in which the obligation becomes probable and the cost
is reasonably estimable. The Company's estimates of the environmental
remediation reserve requirements fall within a range. If the Company
believes no best estimate exists on a project-by-project basis within a
range of possible outcomes, in accordance with accounting guidance, the
minimum loss is accrued. Environmental liabilities are not discounted,
and they have not been reduced for any claims for recoveries from
insurance or third parties. In those cases where insurance carriers or
third-party indemnitors have agreed to pay any amount and the Company
believes that collectability of such amount is probable, the amounts are
reflected as receivables in the consolidated financial statements.
These estimates are critical because the Company must forecast
remediation activity into the future which is highly uncertain and
requires a large degree of judgment. Therefore, the environmental
reserves may materially differ from ultimate actual liabilities if the
Company's estimates prove to be inaccurate, which could materially
affect net income in a period. Uncertainties related to recorded
environmental liabilities include changing governmental policy and
regulations, judicial proceedings, the method and extent of remediation
and future changes in technology. Because of these uncertainties, the
range of possible outcomes could exceed the amounts reserved by an
additional $30 million and could be below the amounts reserved by
approximately $10 million. The estimate for environmental liabilities is
a critical accounting estimate for both reportable segments.
SELF-INSURANCE
Solutia maintains self-insurance reserves to cover its estimated
future legal costs, settlements and judgments related to workers'
compensation, product, general, auto and operations liability claims
that are less than policy deductible amounts or not covered by
insurance. Self-insured losses are accrued based upon estimates of the
aggregate liability for uninsured claims incurred using certain
actuarial assumptions followed in the insurance industry and the
Company's historical experience. In those cases where insurance carriers
or third-party indemnitors have committed to pay, the amounts are
reflected as receivables in the consolidated financial statements. These
estimates are critical because changes to the actuarial assumptions used
in the development of these reserves can materially affect net income in
a given period and the Company must forecast loss activity into the
distant future which is highly uncertain and requires a large degree of
judgment. The estimate for self-insurance reserves is a critical
accounting estimate for both reportable segments.
Actuarial reserve indications are projections of the remaining
future payments for workers' compensation, product, general, auto and
operations liability claims for which Solutia is legally responsible.
These projections are made in the context of an uncertain future where
variations between estimated and actual amounts are caused by many
factors, including changes in operations, changes in judicial
environments, shifts in the types or timing of the reporting of claims,
changes in the frequency or severity of losses and random chance. The
actuarial estimates of the reserve requirements fall within a range. The
actuary's best estimate of the liability is near the middle of the
actuary's range; accordingly, the Company has recorded the liability at
this level. Solutia estimates that the high end of the range of possible
outcomes exceeds the amounts reserved by approximately $15 million.
INCOME TAXES
Solutia accounts for income taxes using the asset and liability
method. Under this method, deferred tax assets and liabilities are
recognized for the future tax consequences of temporary differences
between the carrying amounts and tax bases of assets and liabilities at
enacted rates. The Company bases its estimate of deferred tax assets and
liabilities on current tax laws and rates and, in certain cases,
business plans and other expectations about future outcomes. Solutia
records a valuation allowance to reduce its deferred tax assets to the
15
amount that is more likely than not to be realized. While Solutia has
considered future taxable income and ongoing prudent and feasible tax
planning strategies in assessing the need for the valuation allowance,
in the event Solutia were to determine that it would be able to realize
its deferred tax assets in the future in excess of its net recorded
amount, an adjustment to the deferred tax asset would increase income in
the period such determination was made. Likewise, should Solutia
determine that it would not be able to realize all or part of its net
deferred tax asset in the future, an adjustment to the deferred tax
asset would be charged to income in the period such determination was
made.
Changes in existing regulatory tax laws, rates and future business
results may affect the amount of deferred tax liabilities or the
valuation of deferred tax assets over time. The Company's accounting for
deferred tax consequences represents management's best estimate of
future events that can be appropriately reflected in the accounting
estimates.
IMPAIRMENT OF LONG-LIVED ASSETS
Impairment tests of long-lived assets are made when conditions
indicate a possible loss. Impairment tests are based on a comparison of
undiscounted cash flows to the recorded value of the asset. The
Company's estimate of the cash flows is based on information available
at that time including these and other factors: sales forecasts,
customer trends, operating rates, raw material and energy prices and
other global economic indicators and factors. If an impairment is
indicated, the asset value is written down to its fair value based upon
market prices or, if not available, upon discounted cash value, at an
appropriate discount rate determined by the Company to be commensurate
with the risk inherent in the business model. These estimates are
critical because changes to the Company's assumptions used in the
development of the impairments analyses can materially affect net income
in a given period and the Company must forecast cash flows into the
future which is highly uncertain and requires a large degree of
judgment. The assumptions used in the cash flow projections approximate
the market conditions experienced at the time an impairment becomes
known.
PENSION AND OTHER POSTRETIREMENT BENEFITS
Under the provisions of SFAS No. 87, "Employers' Accounting for
Pensions" and SFAS No. 106, "Employers' Accounting for Postretirement
Benefits Other Than Pension," measurement of the obligations under the
defined benefit pension plans and the other post-employment benefit
(OPEB) plans are subject to several significant estimates. These
estimates include the rate of return on plan assets, health care cost
trend rates and the rate at which the future obligations are discounted
to value the liability.
The Company estimates its assumed long-term rate of return based on
its historical rate of return experienced by the plan assets, adjusted
for assumed asset allocation and forecasted capital market returns. A
25 basis point change in the assumed long-term rate of return would result
in a $3 million change in pension expense.
The Company's annual measurement date is December 31 for the pension
and OPEB plans. Historically, the Company has based its discount rate on
a review of long-term bonds that receive one of the two highest ratings
given by a recognized rating agency. A 25 basis point change in the
discount rate results in a $27 million change in the pension projected
benefit obligation and $1 million change in pension expense. A 25 basis
point change in the discount rate results in a $9 million change in the
accumulated benefit obligation for the OPEB plans and an immaterial
change to OPEB expense.
The Company estimates the assumed trend rate for healthcare costs
and the ultimate trend rate for healthcare costs based on actual
experience.
RESULTS OF OPERATIONS
2002 2001 2000
------ ------ ------
(dollars in millions)
Net Sales................................................... $2,241 $2,268 $2,617
====== ====== ======
Net Sales from Polymer Modifiers and Phosphorus
Derivatives businesses included in Net Sales.......... $ -- $ -- $ 176
====== ====== ======
Operating Income/(Loss)..................................... $ 38 $ (36) $ (15)
====== ====== ======
Operating Income from Polymer Modifiers and Phosphorus
Derivatives businesses included in Operating
Income/(Loss)......................................... $ -- $ -- $ 29
====== ====== ======
Charges included in Operating Income/(Loss)............. $ (22) $ (78) $ (158)
====== ====== ======
Solutia's net sales for 2002 were $2,241 million compared with net
sales of $2,268 million in 2001. The net sales decrease reflected lower
average selling prices of approximately 2 percent, partially offset by
favorable currency exchange rate fluctuations of 1 percent. Sales
volumes were essentially flat year over year. The lower average selling
prices were driven by unfavorable global economic conditions experienced
during 2002. Net sales of $2,268 million in 2001 decreased 13 percent
from 2000 net sales of $2,617 million. Two events affect the
16
comparability of 2001 net sales with those in 2000. These events include
the contribution of the Company's Phosphorus Derivatives business to the
Astaris joint venture in April 2000 and the sale of its Polymer
Modifiers business in August 2000. Excluding the sales associated with
these businesses, net sales for 2001 decreased 7 percent from net sales
in 2000. The decrease reflected lower average selling prices of
approximately 4 percent, lower volumes of 3 percent and slightly
unfavorable currency exchange rate fluctuations.
Operating income for the year ended December 31, 2002, was
$38 million compared to an operating loss of $36 million in 2001. As
indicated in the preceding table, operating results for each year were
affected by various charges, which are described in greater detail in
the following sections. Excluding the effects of the charges from 2002
and 2001, operating income increased $18 million or 43 percent over 2001
because of lower raw material and energy costs and lower personnel costs
resulting from restructuring activities carried out during 2001. The
operating loss for the year ended December 31, 2001, was $36 million
compared to an operating loss of $15 million in 2000. Excluding the
effects of the charges from 2001 and 2000 and the operating income
associated with the Phosphorus Derivatives and Polymer Modifiers
businesses, operating income decreased $72 million or 63 percent in 2001
versus 2000 because of lower net sales and higher incentive expense,
partially offset by lower raw material and energy costs and lower
administrative and technological expenses.
PERFORMANCE PRODUCTS AND SERVICES
2002 2001 2000
---- ---- ------
(dollars in millions)
Net Sales................................................... $945 $960 $1,128
==== ==== ======
Net Sales from Polymer Modifiers and Phosphorus
Derivatives businesses included in Net Sales.......... $ -- $ -- $ 176
==== ==== ======
Segment Profit.............................................. $ 78 $ 77 $ 111
==== ==== ======
Segment Profit from Polymer Modifiers and Phosphorus
Derivatives businesses included in Segment Profit..... $ -- $ -- $ 29
==== ==== ======
Charges included in Segment Profit...................... $ -- $ (3) $ (15)
==== ==== ======
Net sales for Performance Products and Services were $945 million in
2002 compared with $960 million in 2001. The decrease in 2002 net sales
versus 2001 resulted from lower average selling prices of approximately
3 percent partially offset by favorable currency exchange rate
fluctuations of approximately 2 percent. Lower average selling prices in
2002 versus 2001 reflected competitive pricing pressures in SAFLEX(R)
plastic interlayer products and chlorobenzenes. Net sales were
positively affected by the strengthening euro and Australian dollar in
relation to the U.S. dollar. Sales volumes were essentially flat year
over year as increased SAFLEX(R) plastic interlayer products sales
volumes in the Asia Pacific markets were offset by significantly lower
sales to a large Saflex customer during 2002. Additionally, higher sales
volumes of CPFilms window film and precision coated products and
DEQUEST(R) water treatment chemicals were offset by lower sales volumes
of chlorobenzenes.
The Performance Products and Services segment's net sales for 2001
of $960 million decreased 15 percent from 2000 net sales of
$1,128 million because of the sale of the Polymer Modifiers business and
the contribution of the Phosphorus Derivatives business to the Astaris
joint venture. Excluding net sales from these businesses, net sales for
2001 increased 1 percent over the comparable prior year period. Higher
sales volumes of approximately 3 percent primarily resulting from a full
year of net sales from Pharmaceutical Services were partially offset by
unfavorable currency exchange rate fluctuations of approximately
1 percent due to the devaluation of the euro and Japanese yen in relation
to the U.S. dollar and lower average selling prices of approximately
1 percent due to competitive pricing pressures.
Segment profit was $78 million in 2002 versus $77 million in 2001.
Segment profit for 2001 included a fourth quarter charge of $3 million
associated with the termination of the employment of a former owner of a
component of Pharmaceutical Services. Excluding this charge, segment
profit decreased $2 million or 3 percent in 2002 versus 2001 because of
lower net sales partially offset by lower raw material costs, lower
amortization expense due to adoption of SFAS No. 142 and lower personnel
expense associated with restructuring activities carried out during
2001. The impact of significantly lower sales volumes to a large Saflex
customer on segment profitability was mostly offset by higher sales of
SAFLEX(R) plastic interlayer products to other glass laminators,
improved product mix and cost reductions. Chlorobenzenes negatively
impacted segment profitability by $8 million in 2002 compared to 2001.
Segment profit was $77 million in 2001 compared to $111 million in 2000.
Segment profit for 2000 included an impairment charge of $15 million to
write down chlorobenzenes' production equipment. Excluding charges from
both 2001 and 2000 and the impact of the loss of income associated with
the sale of the Polymer Modifiers business and the contribution of the
Phosphorus Derivatives business to the Astaris joint venture, segment
profit in 2001 decreased $17 million or 18 percent versus 2000 primarily
because of higher incentive expense, unfavorable product mix and higher
manufacturing costs primarily associated with production cutbacks to
control inventory in SAFLEX(R) plastic interlayer products.
17
INTEGRATED NYLON
2002 2001 2000
------ ------ ------
(dollars in millions)
Net Sales.................................................... $1,296 $1,308 $1,490
====== ====== ======
Segment Profit/(Loss)....................................... $ 24 $ 6 $ (33)
====== ====== ======
Charges included in Segment Profit/(Loss)............... $ (5) $ (12) $ (105)
====== ====== ======
Solutia's Integrated Nylon segment had net sales of $1,296 million
in 2002 compared with $1,308 million in 2001. The 1 percent decrease in
2002 net sales primarily resulted from a decline in average selling
prices in almost all businesses in this segment of approximately
2 percent partially offset by sales volume improvements of less than
1 percent. The effects of a weak U.S. economy continued to unfavorably
impact average selling prices in 2002. Increased sales volumes in nylon,
plastics and polymers and intermediate chemicals were mostly offset by
decreased volumes in nylon industrial products and carpet fiber. Sales
volumes in nylon, plastics and polymers improved following Solutia's
successful reintegration of the marketing responsibilities for the nylon
molding resins business previously performed under a marketing alliance
with Dow Plastics, a business unit of Dow Chemical. In addition, the
fiber's businesses experienced unfavorable product mix.
Solutia's Integrated Nylon segment had net sales in 2001 of
$1,308 million compared with $1,490 million in 2000. The 12 percent decrease
in 2001 sales resulted from a decline in volumes of approximately 6 percent
and a decline in average selling prices of approximately 6 percent. The
effects of a weak U.S. economy had an unfavorable impact on the
Integrated Nylon segment. With the exception of intermediate chemicals,
significant volume declines occurred in all of the segment's businesses.
Carpet fiber sales volumes decreased as carpet mills continued to manage
inventory levels in response to lower retail demand. Decreased sales
volumes of nylon plastics and polymers resulted from lower shipments of
VYDYNE(R) nylon molding resins to Dow Plastics under a marketing
alliance because of the slowdown in the U.S. automotive industry, and
lower global demand for textile polymers. Sales volumes for nylon
industrial products decreased because of the slowdown in the U.S.
automotive industry. Sales volumes for acrylic fibers decreased in the
U.S. because of the slowing U.S. economy. The effects of lower segment
sales were partially offset by higher sales volumes of merchant
acrylonitrile sales to Asian and European customers. Price decreases in
intermediate chemicals were primarily attributable to contract business
with formula pricing tied to raw material costs that decreased year over
year. Price decreases in the remaining businesses were due to
competitive pricing pressures.
The Integrated Nylon segment's profit was $24 million in 2002
compared to $6 million in 2001. Excluding charges of $5 million incurred
during the third quarter of 2002 resulting from the resolution of a
construction dispute with the contractor of an acrylonitrile plant in
Alvin, Texas, and $12 million incurred during 2001 to write down certain
notes and accounts receivables primarily from insolvent textile fiber
customers, segment profit increased $11 million or 61 percent. Lower raw
material and energy prices offset the effects of lower net sales in the
segment on a year over year basis. Lower personnel expense associated
with restructuring activities carried out during 2001 significantly
contributed to the increase in segment profit, partially offset by
unscheduled outages at the Chocolate Bayou Intermediates facility during
the second and third quarters of 2002. During the fourth quarter of
2002, raw material and energy prices significantly increased. The
Company expects raw material and energy prices to remain at elevated
levels for at least the first half of 2003, which could have a
significant negative impact on segment profitability.
The Integrated Nylon segment's profit was $6 million in 2001,
compared to a loss of $33 million in 2000. Segment profitability in 2001
was negatively impacted by the aforementioned charge. Segment
profitability in 2000 was negatively affected by charges of $14 million
to write down certain Asian investments based upon indicators that the
loss in their values was permanent and $5 million to accrue for debt
payments under certain loan guarantees associated with one of the
investments; impairment charges of $76 million to write down certain
non-performing and non-strategic fiber spinning, drawing and packaging
equipment and a charge of $10 million primarily to reserve for advances
and working capital loans to an Asian equity affiliate. Excluding these
items, 2001 segment profit decreased $54 million or 75 percent versus
2000. The decline resulted primarily from lower net sales, higher energy
prices and unfavorable manufacturing variances associated with lower
capacity utilization rates. Partially offsetting the decline in segment
profit were lower raw material costs and lower personnel expense
associated with restructuring activities. In addition to increased
energy costs and decreased sales volumes, segment profitability was also
negatively affected by the temporary shutdown of the Chocolate Bayou
Intermediates facility in February 2001 as a result of a power outage.
18
CORPORATE EXPENSES
2002 2001 2000
---- ----- -----
(dollars in millions)
Corporate Expenses.......................................... $(61) $(121) $(115)
==== ===== =====
Charges included in Corporate Expenses.................. $(17) $ (66) $ (67)
==== ===== =====
Corporate expenses were $61 million in 2002 compared to $121 million
in 2001. However, as indicated in the preceding table, corporate
expenses for each year were affected by various charges. During 2002,
Solutia recorded a $17 million charge for a non-cash pension settlement
loss because of the significant amount of lump sum distributions from
the pension plan during 2002. During the fourth quarter of 2001, Solutia
reached agreements with various state and federal agencies having
enforcement authority on the nature, timing and extent of certain
environmental remediation obligations. As a result, the 2001 corporate
expenses included a fourth quarter charge of $34 million to increase
environmental reserves. Actual costs to terminate certain European and
North American management employees and certain employee benefit costs
for involuntary terminations in 2001 were higher than the original
estimates. As a result, Solutia recorded an additional restructuring
charge of $9 million to cover these higher costs. In addition, Solutia
modified its estimates of the aggregate liability for uninsured product
liability claims based upon certain actuarial assumptions and historical
experience. As a result, the Company recorded a fourth quarter of 2001
charge of $20 million to increase self-insurance reserves. Solutia also
recorded a loss contingency during the fourth quarter of 2001 of
$3 million in corporate expenses due to certain unoccupied leased office
space. Excluding these items, corporate expenses in 2002 declined
$11 million or 20 percent from 2001 because of lower personnel expense
associated with restructuring activities carried out during 2001,
partially offset by higher legal expenses due to protracted litigation
in Anniston, Alabama.
Corporate expenses were $121 million in 2001 compared to
$115 million in 2000. Corporate expenses in 2000 included restructuring
charges of $53 million associated with workforce reductions and the
closure of certain non-strategic facilities, a restructuring charge of
$8 million related to exiting operations at the Port Plastics site in
Addyston, Ohio, and charges of $6 million related to the formation and
startup of the Astaris joint venture. Excluding these charges, corporate
expenses in 2001 increased $7 million or 15 percent from 2000 primarily
because of higher incentive expense and increased pension and
postretirement costs.
OPERATING INCOME (LOSS)
2002 2001 2000
---- ----- -----
(dollars in millions)
Performance Products and Services Segment Profit............ $ 78 $ 77 $ 111
Integrated Nylon Segment Profit/(Loss)...................... $ 24 $ 6 $ (33)
Less: Corporate Expenses................................ $(61) $(121) $(115)
Less: Equity (Earnings) Loss from Affiliates and Other
(Income) Expense items included in Segment
Profit/(Loss)..................................... $ (3) $ 2 $ 22
---- ----- -----
Operating Income/(Loss)..................................... $ 38 $ (36) $ (15)
==== ===== =====
Charges included in Operating Income/(Loss)............. $(22) $ (78) $(158)
==== ===== =====
Solutia had operating income of $38 million in 2002 compared to an
operating loss of $36 million in 2001. However, when the charges
described above are excluded from the results in each year, operating
income improved $18 million. Excluding $10 million of amortization
expense from operating results for 2001 associated with the adoption of
SFAS No. 142 (see Note 6), operating income for 2002 improved
$8 million from 2001. The increase in operating income was primarily
driven by lower raw material and energy costs, favorable currency
exchange rate fluctuations and lower personnel costs resulting from
restructuring activities carried out during 2001, partially offset by
manufacturing outages at the Chocolate Bayou Intermediates facility.
Operating income in 2001 declined $21 million from 2000 levels.
However, when the charges described above are excluded from the results
in each year, operating income declined $101 million. This decline was
caused primarily by the impact of lower net sales and higher incentive
expense, partially offset by lower raw material and energy costs and lower
administrative and technological expenses. The decrease in administrative
and technological expenses can be attributed principally to lower personnel
costs resulting from restructuring activities during 2001.
19
EQUITY EARNINGS (LOSS) FROM AFFILIATES
2002 2001 2000
---- ---- ----
(dollars in millions)
Flexsys Equity Earnings..................................... $ 11 $ 12 $ 12
Astaris Equity Earnings/(Loss).............................. $ 1 $(36) $ 5
Advanced Elastomer Systems Equity Earnings.................. $ 2 $ 11 $ 20
Other Equity Earnings/(Loss) from Affiliates included in
Reportable Segment Profit................................. $ (1) $ -- $ (2)
---- ---- ----
Equity Earnings/(Loss) from Affiliates...................... $ 13 $(13) $ 35
==== ==== ====
Charges included in Equity Earnings/(Loss) from
Affiliates............................................ $ (4) $(41) $(15)
==== ==== ====
Solutia records the equity earnings (loss) from affiliates net of
income taxes. Equity earnings from affiliates were $13 million for 2002
compared to an equity loss from affiliates of $13 million in 2001.
Equity earnings (loss) from affiliates were affected by various items in
each year. During the first quarter of 2002, the Company sold its
50 percent interest in the Advanced Elastomer Systems joint venture to
ExxonMobil Chemical Company, a subsidiary of Exxon Mobil Corporation.
During the fourth quarter of 2002, the Flexsys joint venture recorded
charges to write-down certain production assets to fair market value.
Solutia's share of these charges was $4 million. During 2001, the
Astaris joint venture recorded charges associated with the closure of
its elemental phosphorus production facility in Pocatello, Idaho.
Solutia's share of these charges was approximately $37 million. Also in
2001, Flexsys recorded charges associated with the closure of its 4NDPA
facility in Newport, Wales. Solutia's share of these charges was
approximately $4 million. Excluding these charges and the loss of income
from the sale of Solutia's 50 percent interest in Advanced Elastomer
Systems, equity earnings (loss) from affiliates in 2002 decreased
$2 million versus 2001 largely due to lower earnings from Flexsys. Lower
earnings from Flexsys in 2002 resulted from competitive pricing
pressures. Astaris' 2002 earnings, while essentially flat with 2001,
benefited from higher year over year earnings under a multi-year
electricity sales contract, offset by lower sales volumes, lower average
selling prices and higher manufacturing cost variances. Astaris'
earnings in 2003 are expected to be lower than 2002 due to the loss of
the aforementioned electricity sales contract which expires in early
2003 and continued sales price compression from increased competitive
activity, partially offset by expected improved manufacturing
performance.
Equity loss from affiliates of $13 million in 2001 compared to
equity earnings from affiliates of $35 million in 2000. During 2000,
Flexsys recorded charges associated with the closure and impairment of
certain manufacturing operations in the United Kingdom. Solutia's share
of these charges was $13 million. In addition, Astaris recorded charges
in 2000 related to the closure of certain of its production facilities.
Solutia's share of these charges was approximately $2 million. Excluding
charges in both years, equity earnings (loss) from affiliates decreased
$22 million in 2001 versus 2000 because of higher raw material costs at
Astaris and lower sales volumes at Advanced Elastomer Systems and
Flexsys.
SALE OF POLYMER MODIFIERS BUSINESS
In August 2000, Solutia completed the sale of its Polymer Modifiers
business and related manufacturing facilities to Ferro Corporation for
approximately $130 million. As a result of this transaction, Solutia
recognized a $73 million pretax gain. Solutia's results of operations
included net sales of approximately $90 million in 2000 and operating
income of approximately $16 million in 2000 from the Polymer Modifiers
business.
OTHER INCOME (EXPENSE)--NET
2002 2001 2000
---- ---- ----
(dollars in millions)
Other Income (Expense)--Net................................. $14 $(5) $ (8)
=== === ====
Other Income (Expense)--Net included in Reportable
Segment Profit........................................ $ 4 $(2) $(20)
=== === ====
Net (Charges)/Gains included in Other Income
(Expense)--Net........................................ $ 5 $(8) $(22)
=== === ====
Other income in 2002 was $14 million compared to other expense in
2001 of $5 million. However, each year was affected by various gains and
charges. During the first quarter of 2002, Solutia sold its 50 percent
interest in the Advanced Elastomer Systems joint venture resulting in a
gain of $5 million. During 2001, Solutia recorded charges of $5 million
to write down an e-commerce investment to its fair value based upon
indicators that the loss in its value was permanent and $3 million in
the Integrated Nylon segment to write off certain non-performing assets.
Excluding these gains and charges, other income for 2002 increased
$6 million versus 2001. The increase primarily resulted from currency
gains.
20
Other expense in 2001 was $5 million compared to other expense of
$8 million in 2000. During 2000, Solutia recorded in the Integrated Nylon
segment a charge of $10 million to reserve for advances and working
capital loans to an Asian equity affiliate. During 2000, Solutia
recorded in the Integrated Nylon segment charges of $14 million to write
down Asian investments based upon indicators that the loss in their
values was permanent, $5 million to accrue for debt payments under
certain loan guarantees associated with one of the Asian equity
investments, $8 million associated with the startup and formation of the
Astaris joint venture and a $15 million gain resulting from the sale of
substantially all of Solutia's 40 percent interest in P4 Production
L.L.C., a phosphorus manufacturing venture. Excluding these gains and
charges, other income for 2001 decreased $11 million versus 2000. The
decrease primarily resulted from higher miscellaneous asset sales from
the Integrated Nylon segment during 2000.
INCOME TAX (BENEFIT)
Solutia's effective income tax (benefit) rates were (58) percent in
2002 compared to (35) percent in 2001. Items reducing Solutia's overall
effective tax rate in 2002 compared to 2001 include a greater percentage
of after-tax equity earnings from affiliates and effective tax planning
strategies in pretax operating income.
Solutia's effective income tax (benefit) rates were (35) percent in
2001 compared to (20) percent in 2000. Items reducing Solutia's overall
effective tax rate in 2001 compared to 2000 include lower valuation
allowances, a greater percentage of after-tax equity earnings from
affiliates and effective tax planning strategies in pretax operating
income.
CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING PRINCIPLE
Effective January 1, 2002, Solutia adopted SFAS No. 142, "Goodwill
and Other Intangible Assets." In accordance with SFAS No. 142, Solutia
discontinued the amortization of goodwill and identifiable intangible
assets that have indefinite useful lives. Intangible assets that have
finite useful lives will continue to be amortized over their useful
lives. Goodwill will be assessed annually for impairment. This statement
also required certain intangible assets that did not meet the criteria
for recognition apart from goodwill, to be subsumed into goodwill.
During the quarter ended March 31, 2002, Solutia subsumed into goodwill
$1 million of intangible assets net of related deferred tax liabilities
representing assembled workforce that did not meet the separability
criteria under SFAS No. 141, "Business Combinations."
Fair value measurements of the reporting units were estimated by a
third-party specialist utilizing both an income and market multiple
approach. Based on this analysis, Solutia recorded an impairment loss of
$167 million during the first quarter of 2002 for the resins and
additives business (which is presented as discontinued operations) due
to declining estimates of future results given current economic and
market conditions. The goodwill impairment charge is non-deductible for
tax purposes and is reflected as the cumulative effect of change in
accounting principle in the accompanying statement of consolidated
income (loss).
21
SUMMARY OF EVENTS AFFECTING COMPARABILITY
Charges and gains recorded in 2002, 2001 and 2000 and other events
affecting comparability have been summarized in the tables below
(dollars in millions, except per share amounts).
2002
--------------------------------------------------------------
Performance
Products
and Integrated Corporate/ Consoli-
Increase/(Decrease) Services Nylon Other dated
------------------- ----------- ---------- ---------- ----------
IMPACT ON:
Cost of goods sold......................................... $5 $ 5 (a)
12 12 (b)
-- -- --- ----
Total cost of goods sold................................... -- 5 12 17
Marketing, administrative, technological and amortization
expenses................................................. 5 5 (b)
-- -- --- ----
OPERATING INCOME (LOSS) IMPACT............................. -- (5) (17) (22)
Equity earnings (loss) from affiliates..................... (4) (4) (c)
Other income (expense)..................................... 5 5 (d)
-- -- --- ----
PRETAX INCOME STATEMENT IMPACT............................. -- (5) (16) (21)
== == ===
Income tax benefit......................................... (6)
----
AFTERTAX INCOME STATEMENT IMPACT........................... $(15)
====
- ---------
2002 CHARGES, GAINS AND OTHER EVENTS
(a) Charges recorded in the Integrated Nylon segment related to the resolution of a construction dispute with the
contractor of the acrylonitrile plant in Alvin (Chocolate Bayou), Texas ($5 million pretax, $3 million
aftertax, or $0.03 per share).
(b) As required by SFAS No. 88, "Employers' Accounting for Settlements and Curtailments of Defined Benefit
Pension Plans and for Termination Benefits," the Company recorded a non-cash pension settlement loss because
of the significant amount of lump sum distributions from the pension plan during 2002 ($17 million pretax,
$11 million aftertax, or $0.11 per share).
(c) Charges for the Flexsys joint venture related to the write-down of production assets to fair value
($4 million aftertax, or $0.04 per share).
(d) Gain resulting from the sale of the Company's 50 percent interest in the Advanced Elastomer Systems joint
venture ($5 million pretax, $3 million aftertax, or $0.03 per share).
2001
---------------------------------------------------------------
Performance
Products
and Integrated Corporate/ Consoli-
Increase/(Decrease) Services Nylon Other dated
------------------- ----------- ---------- ---------- -----------
IMPACT ON:
Cost of goods sold........................................ $ 2 $ 2 (e)
54 54 (g)
9 9 (h)
--- --- ---- -----
Total cost of goods sold.................................. 2 -- 63 65
Marketing, administrative, technological and amortization
expenses................................................ 1 1 (e)
9 9 (f)
3 3 (i)
--- --- ---- -----
OPERATING INCOME (LOSS) IMPACT............................ (3) (9) (66) (78)
Equity earnings (loss) from affiliates.................... (37) (37) (j)
(4) (4) (k)
Other income (expense).................................... (3) (3) (f)
(5) (5) (l)
--- --- ---- -----
PRETAX INCOME STATEMENT IMPACT............................ (3) (12) (112) (127)
=== === ====
Income tax benefit........................................ (31)
-----
AFTERTAX INCOME STATEMENT IMPACT.......................... $ (96)
=====
- ---------
2001 CHARGES AND OTHER EVENTS
(e) Charges recorded in the Performance Products and Services segment related to the termination of a former
Pharmaceutical Services owner ($3 million pretax, $2 million aftertax, or $0.02 per share).
22
(f) Charges recorded in the Integrated Nylon segment to write down certain notes, primarily from textile fiber
customers, and to write down certain non-performing assets ($12 million pretax, $8 million aftertax, or
$0.07 per share).
(g) Charges to increase environmental and self-insurance reserves ($54 million pretax, $34 million aftertax, or
$0.33 per share).
(h) Additional severance charges recorded to cover cost overruns associated with the 2001 restructuring program
($9 million pretax, $6 million aftertax, or $0.06 per share).
(i) A loss contingency due to certain unoccupied leased office space ($3 million pretax, $2 million aftertax, or
$0.02 per share).
(j) Charges for the closure of Astaris' elemental phosphorus production facility in Pocatello, Idaho ($37 million
pretax, $37 million aftertax, or $0.35 per share).
(k) Charges for the closure of Flexsys' 4NDPA manufacturing facility in the Newport, Wales ($4 million pretax,
$4 million aftertax, or $0.04 per share).
(l) A charge to write down the value of an e-commerce investment based upon indicators that the loss in its value
was permanent ($5 million pretax, $3 million aftertax, or $0.03 per share).
2000
---------------------------------------------------------------
Performance
Products
and Integrated Corporate/ Consoli-
Increase/(Decrease) Services Nylon Other dated
------------------- ----------- ---------- ---------- -----------
IMPACT ON:
Cost of goods sold........................................ $ 15 $ 15 (m)
8 8 (v)
76 76 (n)
53 53 (q)
---- ----- --- -----
Total cost of goods sold.................................. 15 76 61 152
Marketing, administrative, technological and amortization
expenses................................................ 6 6 (r)
---- ----- --- -----
OPERATING INCOME (LOSS) IMPACT............................ (15) (76) (67) (158)
Equity earnings (loss) from affiliates.................... (2) (2) (r)
(13) (13) (s)
Gain on sale of Polymer Modifiers business................ 73 73 (t)
Other income (expense).................................... (8) (8) (r)
15 15 (u)
(14) (14) (o)
(5) (5) (o)
(10) (10) (p)
---- ----- --- -----
PRETAX INCOME STATEMENT IMPACT............................ (15) (105) (2) (122)
==== ===== ===
Income tax benefit........................................ (41)
-----
AFTERTAX INCOME STATEMENT IMPACT.......................... $ (81)
=====
- ---------
2000 CHARGES, GAINS AND OTHER EVENTS
(m) Impairment charges recorded in the Performance Products and Services segment to write down chlorobenzenes'
production assets ($15 million pretax, $10 million aftertax, or $0.09 per share).
(n) Impairment charges recorded in the Integrated Nylon segment to write down certain non-performing and
non-strategic production assets ($76 million pretax, $47 million aftertax, or $0.44 per share).
(o) Charges recorded in the Integrated Nylon segment to write down certain investments in Asia based upon
indicators that the loss in their values was permanent ($14 million pretax, $8 million aftertax, or $0.07 per
share) and to accrue for payment of debt obligations associated with one of the investments ($5 million
pretax, $3 million aftertax, or $0.03 per share).
(p) Charges recorded in the Integrated Nylon segment to primarily reserve for advances and working capital loans
to an Asian equity affiliate ($10 million pretax, $6 million aftertax, or $0.06 per share).
(q) Restructuring charges for workforce reductions of approximately 700 people across all world areas and
functions of the Company and the closure of certain non-strategic facilities ($53 million pretax, $33 million
aftertax, or $0.31 per share).
(r) Charges related to the formation and startup of the Astaris joint venture ($16 million pretax, $11 million
aftertax, or $0.10 per share).
(s) Charges associated with the impairment and closure of certain manufacturing operations in the United Kingdom
for the Flexsys joint venture ($13 million pretax, $13 million aftertax, or $0.12 per share).
(t) A gain on the sale of the Polymer Modifiers business and related manufacturing facilities ($73 million
pretax, $46 million aftertax, or $0.43 per share).
(u) A gain on the sale of P4 Production L.L.C., a phosphorus manufacturing venture ($15 million pretax,
$9 million aftertax, or $0.08 per share).
(v) Restructuring charges related to exiting operations at the Port Plastics site in Addyston, Ohio ($8 million
pretax, $5 million aftertax, or $0.05 per share).
ECONOMIC CONDITIONS AND OUTLOOK
Solutia is affected by economic conditions, particularly those
in the domestic housing industry and global automotive and textile
industries. Each of these industries is cyclical. A general weakening of
the major global economies impacted consumer demand in these
23
marketplaces, which negatively affected Solutia's sales volumes and selling
prices starting in the latter half of 2000 and continuing through 2002.
During the first three quarters of 2002, Solutia experienced lower
feedstock raw material and energy costs in comparison to 2001. This
decrease was mostly offset by continued weakness in consumer demand. As
a result of the weak demand and significant available capacity in the
markets the Company serves, selling prices eroded and Solutia was unable
to capture the full benefit of declining raw material and energy costs.
In the fourth quarter of 2002, significant increases in raw material and
energy costs were experienced due to the impact of geopolitical factors
on these markets. In 2003, Solutia expects raw material and energy costs
to remain above their five-year historical averages, mitigated by a
modest increase in demand, continued reductions in employee and
contractor expenses due to cost management, disciplined capital and
growth spending and improved manufacturing operating rates. If, however,
raw material and energy costs rise dramatically above historical
averages, the Company does not expect to be able to fully offset with
price increases or further cost containment activities, potentially
resulting in a significant negative impact on profitability,
particularly within the Integrated Nylon segment.
FINANCIAL CONDITION
On December 2, 2002, Solutia signed a definitive agreement to sell
its resins, additives and adhesives businesses to UCB S.A. for
$500 million in cash, plus an upfront payment of $10 million for a
period of exclusivity. On January 31, 2003, the sale was completed.
Proceeds from the divestiture were used to pay down all of the
borrowings under the amended credit facility, provide $39 million cash
collateral for certain outstanding letters of credit and purchase the
co-generation facility at Pensacola, Florida for $32 million in
accordance with bank agreements. The Company retained certain tax
liabilities related to the divested businesses and expects to pay
approximately $30 million in 2003 related to these liabilities.
Solutia's financial condition improved in 2002 with the successful
refinancing of the $150 million, 6.5 percent notes and the revolving
credit facility, both of which came due in the second half of 2002.
Operating cash flow, divestiture proceeds and borrowings from the
revolving credit facility provided the primary sources of funds to
finance operating needs and capital expenditures during the year. Free
cash flow from continuing operations, defined as cash from operations
less capital expenditures, was $68 million for 2002, compared to
negative free cash flow of $57 million for 2001. This increase is
indicative of the heightened emphasis on cash generation and working
capital management the Company has placed on all of its operating units.
In 2002, cash generated from continuing operations was $127 million,
up $101 million from $26 million in 2001. The improvement was primarily
attributable to higher income tax refunds, lower working capital,
stronger operating earnings and lower severance payments. Cash generated
from continuing operations in 2001 decreased from $177 million in 2000
because of lower net earnings associated with recession-like economic
conditions experienced in the U.S. during 2001.
Capital spending efficiency has been a focus area for the Company.
Spending decreased $24 million to $59 million in 2002, compared to
$83 million in 2001 and $211 million in 2000. These expenditures were used
to fund various cost reduction, maintenance and revenue growth expansion
projects. The Company expects that its capital requirements in 2003 will
be approximately $80 million, including approximately $32 million for
the purchase of the co-generation facility in Pensacola, Florida,
currently under an operating lease arrangement. The majority of the
remainder of capital expenditures in 2003 will be for maintenance and
cost reduction projects. Approximately $7 million of estimated capital
requirements were committed at December 31, 2002.
Net cash used for acquisitions completed during 2002 totaled
approximately $5 million for the purchase of Axio Research Corporation,
a contract research organization providing clinical trial design and
data management. This compares to no acquisitions in 2001 and
approximately $118 million in 2000, which included the CarboGen Holdings
AG and AMCIS AG acquisitions. Solutia used approximately $30 million in
2002 and $31 million in 2001 for investment payments to keep the Astaris
joint venture in compliance with its financial covenants.
The Company continues to divest certain non-strategic businesses in
order to focus resources on core businesses. The proceeds from these and
other asset sales generated $109 million in 2002, compared to $9 million
in 2001 and $220 million in 2000. Proceeds generated in the current year
primarily included the sale of the Company's 50 percent interest in the
Advanced Elastomer Systems joint venture to ExxonMobil Chemical Company,
a subsidiary of Exxon Mobil Corporation for approximately $102 million.
Total debt decreased by $112 million to $1,197 million compared to
$1,309 million at the end of 2001 and consisted of borrowings under the
amended credit facility, notes, indenture and debentures. The decrease
was primarily driven by divestiture proceeds, income tax refunds and
lower working capital requirements.
Solutia's working capital from continuing operations increased by
$299 million to negative $270 million in 2002 compared to negative
$569 million in 2001. The increase in the working capital position
primarily resulted from lower short-term debt. Short-term debt decreased
24
because of the maturity of the Company's $150 million of 6.5 percent notes
due in October of 2002, divestiture proceeds, income tax refunds and lower
working capital.
Solutia had a shareholders' deficit of $249 million at December 31,
2002 compared to $113 million at December 31, 2001. The $136 million
decline was principally caused by lower 2002 earnings, which included a
goodwill impairment loss of $167 million during the first quarter of
2002 for the resins and additives business, which is presented as
discontinued operations. Favorable currency translation adjustments,
principally related to the increase in value of the euro, were offset by
a charge to accumulated other comprehensive loss for a minimum pension
liability.
During 2000, Solutia repurchased 7.7 million shares of its common
stock at a cost of $106 million. On April 26, 2000, the board of
directors authorized the repurchase of up to 15 million additional
shares of Solutia common stock. Under this authorization, Solutia has
the authority to repurchase an additional 12.1 million shares of its
common stock. Solutia has currently suspended this program and has not
repurchased any shares since October 2000 and is barred from further
purchases under the terms of the revolving credit facility.
LIQUIDITY
The Company's primary sources of liquidity have been and will
continue to be cash from operations, divestiture proceeds, borrowings
from its revolving credit facility and other external financing sources.
At December 31, 2002, after consideration of $78 million of letters of
credit outstanding under the credit facility, the Company had capacity
to borrow up to $140 million.
AMENDED CREDIT FACILITY
On July 25, 2002, Solutia and its bank syndicate amended Solutia's
revolving credit facility. The amendment extended the maturity of the
facility until August 2004. It also reduced the facility from
$800 million to $600 million and separated the facility into a $300 million
term loan and a $300 million revolving credit facility. The term loan
was paid with proceeds from the sale of the resins, additives and
adhesives businesses on January 31, 2003. The amended credit facility
required the Company to cash collateralize certain outstanding letters
of credit. Fees, expenses and other costs associated with the amended
credit facility and cash collateralization of letters of credit totaled
$33 million. The amended credit facility is available for working
capital and other general corporate purposes.
In September 2002, Solutia negotiated an amendment to its revolving
credit facility which reduced the amount of debt outstanding as defined
in the credit agreement for purposes of the leverage covenant ratio.
Solutia deposited approximately $155 million from the proceeds of the
Senior Secured Notes offering which occurred in July 2002 with the
trustee for the $150 million of 6.5 percent notes due October 15, 2002,
to pay the principal and interest at maturity. However, the principal
amount of the 6.5 percent notes due October 15, 2002, was still
considered outstanding debt under the amended credit facility. The
amendment eliminated the $150 million of 6.5 percent notes due
October 15, 2002, from consideration in the leverage covenant ratio.
Without the amendment, Solutia would not have been in compliance with
the leverage coverage ratio at September 30, 2002.
In order to facilitate the sale of the resins, additives and
adhesives businesses to UCB S.A. and to be in compliance with the
interest coverage ratio at December 31, 2002, the Company was required
to obtain amendments to its revolving credit facility. Effective
December 24, 2002, the facility was amended to modify certain financial
covenants, release any collateral that is subject to the divestiture and
release all liens on the property of the European subsidiary borrowers
upon the repayment in full of the principal and interest of all amounts
outstanding in connection with the divestiture. Without the amendment,
Solutia would not have been able to sell its resins, additives and
adhesives businesses or been in compliance with the interest coverage
ratio at December 31, 2002.
Guarantees
Solutia's obligations and the obligations of its subsidiary
borrowers under the amended credit facility are guaranteed by CPFilms
Inc., Monchem International, Inc., Monchem, Inc., Solutia Systems, Inc.
(the "Subsidiary Guarantors") and each of Solutia's subsequently
acquired or organized domestic subsidiaries, subject to certain
exceptions. In addition, Solutia Inc. guarantees the payment of amounts
due from subsidiary borrowers under the amended credit facility.
Collateral
Borrowings under the amended credit facility as well as the
beneficiaries of the Astaris support agreement, the lessee under the co-
generation facility at Pensacola, Florida and holders of certain
designated letters of credit are secured by a majority of the Company's
assets. Specifically, the Company has pledged the following: (1) liens
on all of Solutia Inc.'s inventory and receivables and those of the
Subsidiary Guarantors, (2) pledges of 100 percent of the stock of
Monchem, Inc. and Solutia Systems, Inc. and 65 percent of the voting
stock and 100 percent of all other stock of Monchem International, Inc.,
(3) liens on intercompany debt of and held by Monchem, Inc., Monchem
International, Inc. and Solutia Systems, Inc., (4) pledges of 65 percent
of the voting stock (and 100 percent of all other stock) of Solutia
Europe, S.A./N.V. and Solutia U. K. Holdings Limited, (5) a lien on
certain principal properties, (6) a lien on certain intellectual
property; and (7) liens on property, plant and equipment, inventory,
receivables and certain intellectual property of four European
subsidiaries. The
25
aggregate amount of Solutia's obligations entitled to the benefit of the
lien on principal properties is limited to 15 percent of its consolidated
net tangible assets, as determined at the date that the lien was granted.
On January 31, 2003, item (7) liens were released because of the paydown
of the credit facility with the proceeds from the sale of resins,
additives and adhesives businesses.
In addition, borrowings under the amended credit facility are
secured by liens shared equally and ratably with the holders of
Solutia's outstanding publicly traded notes and senior secured notes
described below. These include a lien on (1) certain other principal
properties, (2) 100 percent of the stock of CPFilms Inc., and
(3) pledges of intercompany debt of CPFilms Inc; and a second-priority
lien shared equally and ratably on the principal properties on which
the banks have a first priority lien. The amended credit facility also
contains customary representations and warranties and affirmative and
negative covenants.
Interest
Borrowings under the amended credit facility bear interest at a
floating rate based on LIBOR, plus an applicable margin. The margin for
LIBOR loans is 5.75 percent and will increase by 50 basis points in July
2003 and an additional 50 basis points in January 2004. A premium in the
amount of 2 percent of the principal repaid on the term loan will apply
until July 25, 2003, and a premium of 1 percent will apply to such
principal payments thereafter.
Covenants
The amended credit facility requires Solutia to meet certain
financial tests, including, but not limited to, maximum leverage and
minimum interest coverage ratios. In addition, the amended credit
facility contains certain covenants which, among other things, limit the
incurrence of additional debt, aggregate capital expenditures,
guarantees, liens, investments, asset sales, dividends, restricted
payments, acquisitions, mergers and consolidations, change of business,
transactions with affiliates, prepayments of debt, repurchases of stock
and redemptions of certain other indebtedness and other matters
customarily restricted in such agreements.
SENIOR SECURED NOTES
On July 9, 2002, Solutia completed a private placement of
223,000 units consisting of $223 million of senior secured 7-year notes
and warrants to purchase 5,533,522 shares of common stock at an exercise
price of $7.59 per share. The 7-year notes were issued by SOI Funding
Corp., a special purpose entity, and the offering resulted in cash
proceeds, net of estimated fees, of $193 million, which were placed in
escrow pending amendment of Solutia's credit facility, as described
under "Amended Credit Facility" above and assumption of SOI Funding
Corp.'s obligations under the notes. Both of these events occurred on
July 25, 2002, at which time the net offering proceeds were released
from escrow. Solutia deposited approximately $155 million of the
proceeds with the trustee for the $150 million of 6.5 percent notes due
October 15, 2002, to pay the principal and interest at maturity. The
remaining proceeds were used to pay fees, expenses and other costs
related to the amended credit facility, cash collateralize existing
letters of credit and repay a portion of borrowings under Solutia's
amended credit facility. The discount associated with this offering,
which includes the value given to the warrants, will be non-deductible
for income tax purposes.
Guarantees
All of the subsidiaries that guarantee the obligations under
Solutia's amended credit facility fully and unconditionally guarantee
the notes on a joint and several basis. Certain of Solutia's future
domestic subsidiaries will be required to execute similar guarantees.
The subsidiary guarantees will each rank in right of payment equal to
each subsidiary guarantor's existing and future senior debt.
Collateral
The notes and guarantees are secured by a first-priority lien
(shared with (A) holders of our bank obligations, (B) the beneficiaries
of the Astaris support agreement, (C) the lessee under the co-generation
facility at Pensacola, Florida and (D) holders of certain designated
letters of credit) on the following assets: (1) certain principal
properties, (2) pledges of 100 percent of the stock of CPFilms Inc., and
(3) intercompany debt of CPFilms Inc.; and a second-priority lien on the
following assets: (1) 65 percent of the voting stock (100 percent of all
other stock) of Monchem International, Inc. and 100 percent of the stock
of the remaining Subsidiary Guarantors, Monchem, Inc. and Solutia
Systems, Inc., (2) intercompany debt of and held by the Subsidiary
Guarantors (other than CPFilms Inc.), (3) substantially all of Solutia's
and the Subsidiary Guarantors' accounts receivable and inventory and
certain intellectual property, (4) 65 percent of the voting stock (and
100 percent of all other stock) of two foreign subsidiaries, and
(5) certain of the principal properties.
INTEREST EXPENSE
The weighted average interest rate on Solutia's total debt
outstanding at December 31, 2002, was approximately 7.8 percent and
6.1 percent at December 31, 2001. Interest expense, giving effect to the
new facilities and the divestiture of the resins, additives and
adhesives businesses, was $84 million in 2002 compared to $70 million in
2001. The increase resulted from the new credit facilities entered
into during 2002, which carried higher interest rates. Interest expense
is expected to be approximately $90 million for 2003, an increase over
26
2002 levels because of the full year's impact of the senior secured
notes. Included in the 2003 estimate for interest expense is
approximately $15 million of amortization of debt discount and issuance
costs primarily for the amended credit facility and the senior secured
notes.
OFF-BALANCE SHEET ARRANGEMENTS
In 1993, a co-generation facility was constructed at the Pensacola,
Florida manufacturing site to provide the plant with electricity and
steam. Solutia financed the construction by placing the co-generation
facility in a trust that was funded by a syndicate of commercial banks.
This arrangement enabled the Company to lease the facility rather than
acquire it. Solutia makes operating lease payments of approximately
$2 million annually and the lease term is co-terminous with the amended
credit facility. As required by the amended credit facility, Solutia
used a portion of the proceeds from the sale of the resins, additives
and adhesives businesses to purchase the co-generation facility from the
trust for approximately $32 million during the first quarter of 2003.
In 1999, the Company's corporate headquarters office building was
constructed in St. Louis, Missouri. Solutia financed the construction of
the building by placing the facility in a trust that was funded by a
syndicate of financial institutions. This arrangement enabled the
Company to lease the facility rather than acquire it. Solutia makes
operating lease payments of approximately $3 million annually. The lease
term expires in August 2007, at which time the Company has the option to
refinance the building through a similar lease arrangement, purchase the
building from the trust for the lease balance of approximately
$43 million or sell the building on behalf of the trust and deliver the
proceeds to the trust. Solutia has provided the trust a residual value
guaranty of approximately $35 million in the event that the building is
sold for less than the lease balance or cannot be sold. Although current
commercial real estate values in the St. Louis, Missouri metropolitan
area have declined recently because of the general weakening of the
economy in the U.S., the Company estimates that the fair value of the
building exceeds the residual value guaranty and will continue to do so
in the foreseeable future. As a result, the Company does not expect this
guarantee to have a financial statement impact. The Company intends to
refinance the building with a similar leasing arrangement when the
current lease expires. As further discussed in Recently Issued
Accounting Standards, the Company is currently evaluating the effects of
the newly issued Interpretation No. 46 "Consolidation of Variable
Interest Entities" (FIN 46). Based on the terms of the lease agreements
and the residual value guarantee Solutia provides to the trust, the
Company expects to be the primary beneficiary as defined by FIN 46. As a
result, Solutia would be required to consolidate the assets and
liabilities held by the trust in the third quarter of 2003.
CONTINGENCIES
In connection with the completion of the external financing
agreement for Astaris, which expires in September of 2005, Solutia and
its equal partner in the venture, FMC Corporation, contractually agreed
to provide Astaris with funding in the event the joint venture fails to
meet certain financial benchmarks. The financial benchmarks were based
on forecasted earnings that were developed when the joint venture was
formed in April 2000. Astaris' earnings have fallen short of the
forecast underlying its external financing agreement due to numerous
factors including significantly less than planned utilization of its
purified wet acid technology, lower sales volumes and lower average
selling prices due to the prolonged weak U.S. economy. As a result of
these earnings shortfalls versus the original expectations developed at
the time the venture was formed, Solutia has been required to make
additional investments of $30 million in 2002 and $31 million in 2001 to
the joint venture. These payments have largely been used to reduce debt
outstanding within the venture. At December 31, 2002, net debt (total
debt less cash) for Astaris totaled $160 million, $59 million lower than
net debt at the end of the prior year. Solutia and its partner FMC are
evaluating other financing alternatives for the joint venture. However,
if no new financing arrangements are in place for 2003, Solutia
anticipates required contributions of approximately $50 million for
2003. Contributions are recorded in the Investments in Affiliates line
on the Statement of Consolidated Financial Position.
Because of the size and nature of its business, Solutia is a party
to numerous legal proceedings. Most of these proceedings have arisen in
the ordinary course of business and involve claims for money damages. In
addition, at the time we became an independent company, we assumed
liabilities related to specified legal proceedings from the former
Monsanto Company (now known as Pharmacia Corporation), under an
agreement known as the Distribution Agreement. As a result, although
Monsanto remains the named defendant, the Company is required to manage
the litigation and indemnify Monsanto for costs, expenses and judgments
arising from the litigation. While the results of litigation cannot be
predicted with certainty, the Company does not believe, based on
currently available facts, that the ultimate resolution of any of these
preceding matters will have a material adverse effect on our financial
position or liquidity in any one year. However, resolution in those
cases involving the alleged discharge of polychlorinated biphenyls
("PCBs") from the Anniston, Alabama plant site and the Penndot case, may
have a material adverse effect on net income in a given year, although
it is impossible at this time to estimate the range or amount of any
such liability. In addition, there cannot be any assurance that any
final judgment against the Company in the Anniston, Alabama cases, if
upheld on appeal, will not have a material adverse effect on financial
position and liquidity.
COMMITMENTS
Solutia has entered into agreements with certain customers to supply
a guaranteed quantity of certain products annually at prices specified
in the agreements. In return, the customers have advanced funds to
Solutia to cover the costs of expanding capacity to provide the
27
guaranteed supply. Solutia has recorded the advances as deferred credits
and amortizes the amounts to income as the customers purchase the
products. The unamortized deferred credits were approximately
$161 million at December 31, 2002, and approximately $175 million at
December 31, 2001.
Solutia's obligations and the obligations of its subsidiary
borrowers under the amended credit facility are guaranteed by CPFilms
Inc., Monchem International, Inc., Monchem, Inc., Solutia Systems, Inc.
(the "Subsidiary Guarantors") and each of Solutia's subsequently
acquired or organized domestic subsidiaries, subject to certain
exceptions. In addition, Solutia Inc. guarantees the payment of amounts
due from subsidiary borrowers under the amended credit facility. All of
the subsidiaries that guarantee the obligations under Solutia's amended
credit facility fully and unconditionally guarantee the senior secured
notes on a joint and several basis. Certain of Solutia's future domestic
subsidiaries will be required to execute similar guarantees. The
subsidiary guarantees will each rank in right of payment equal to each
subsidiary guarantor's existing and future senior debt.
The following tables summarize Solutia's contractual obligations and
commercial commitments as of December 31, 2002 (dollars in millions).
Payments Due by Period
------------------------------------------------------- 2008 and
Contractual Obligations Total 2003 2004 2005 2006-2007 thereafter
----------------------- ------ ---- ---- ---- --------- ----------
Credit Facility.................................. $ 357 $357 $ -- $ -- $ -- $ --
Long-Term Debt................................... 881 -- 150 208 -- 523
Capital Lease Obligations........................ 4 2 1 1 -- --
Operating Leases................................. 133 20 19 13 58 23
Unconditional Purchase Obligations............... 67 3 6 5 10 43
Standby Letters of Credit(a)..................... 157 157 -- -- -- --
Environmental Liabilities........................ 146 38 27 19 22 40
Unfunded Pension Obligations(b).................. 587 -- -- 178 306 103
Unfunded Other Postretirement Obligations(c)..... 803 78 74 68 99 484
Other Commercial Commitments(d).................. 243 95 12 13 24 99
------ ---- ---- ---- ---- ------
Total Contractual Cash Obligations............... $3,378 $750 $289 $505 $519 $1,315
====== ==== ==== ==== ==== ======
- --------
(a) Includes a $40 million letter of credit Solutia will provide to Monsanto associated with the Penndot Protocol
agreement signed on March 3, 2003, as discussed in Item 3 to this report.
(b) Represents estimated contributions required to be made by the Company into the Pension trust based on current
actuarial assumptions. However, the Company may elect to make voluntary contributions to the Pension trust in
2003 and 2004 which could change the scheduled payments provided above.
(c) Payments are net of participant contributions.
(d) Other commercial commitments in 2003 represent estimates of anticipated cash contributions to the Astaris
joint venture, exercise of the purchase option for the co-generation facility at Pensacola, Florida, and
agreements with customers to supply a guaranteed quantity of certain products annually at prices specified in
the agreements. For 2004 and thereafter, other commercial commitments represent agreements with customers to
supply a guaranteed quantity of certain products annually at prices specified in the agreements.
Solutia believes that it has sufficient liquidity to finance its
needs for the next 12 months.
LEGAL MATTERS
As discussed in Item 3 to this report, because of the size and
nature of its business, Solutia is a party to numerous legal
proceedings. Most of these proceedings have arisen in the ordinary
course of business and involve claims for money damages. In addition, at
the time we became an independent company, we assumed liabilities
related to specified legal proceedings from the former Monsanto Company
(now known as Pharmacia Corporation), under an agreement known as the
Distribution Agreement. As a result, although Monsanto remains the named
defendant, the Company is required to manage the litigation and
indemnify Monsanto for costs, expenses and judgments arising from the
litigation. While the results of litigation cannot be predicted with
certainty, the Company does not believe, based on currently available
facts, that the ultimate resolution of any of these preceding matters
will have a material adverse effect on our financial position or
liquidity in any one year. However, resolution in those cases involving
the alleged discharge of polychlorinated biphenyls ("PCBs") from the
Anniston, Alabama plant site and the Penndot case, may have a material
adverse effect on net income in a given year, although it is impossible
at this time to estimate the range or amount of any such liability. In
addition, there cannot be any assurance that any final judgment against
the Company in the Anniston, Alabama cases, if upheld on appeal, will not
have a material adverse effect on financial position and liquidity.
28
ENVIRONMENTAL MATTERS
Solutia continues its strong commitment to comply with laws and
government regulations concerning environmental matters and employee
safety and health in the United States and other countries. U.S.
environmental legislation that has a particular impact on the Company
includes the Toxic Substances Control Act; the Resource Conservation and
Recovery Act; the Clean Air Act; the Clean Water Act; the Safe Drinking
Water Act; and the Comprehensive Environmental Response, Compensation
and Liability Act (commonly known as Superfund). The Company is also
subject to the Occupational Safety and Health Act and regulations of the
Occupational Safety and Health Administration ("OSHA") concerning
employee safety and health matters. The U.S. Environmental Protection
Agency, OSHA and other federal agencies have the authority to promulgate
regulations that have an impact on the Company's operations. In addition
to these federal activities, various states have been delegated certain
authority under several of these federal statutes. Many state and local
governments have adopted environmental and employee safety and health
laws and regulations, many of which meet federal requirements for
delegation of federal mandates to state entities. State or federal
agencies having lead enforcement authority may seek fines and penalties
for violation of these laws and regulations.
Solutia is dedicated to long-term environmental protection and
compliance programs that reduce and monitor emissions of hazardous
materials into the environment as well as to the remediation of
identified existing environmental concerns. Solutia is among the leaders
in Responsible Care, the chemical industry's performance-enhancement
program.
Expenditures in 2002 were approximately $5 million for environmental
capital projects and approximately $88 million for the management of
environmental programs. Included in environmental program management is
the operation and maintenance of facilities for environmental control,
which is expensed in the period incurred, and $26 million for
remediation activity, which was charged against recorded environmental
liabilities. Solutia estimates that a total of approximately $6 million
will be spent during 2003 on additional capital projects for
environmental protection and that expenses for the management of
environmental programs in 2003 will increase from the 2002 levels.
Recoveries from third parties were $5 million in 2002, and no recoveries
in 2001 and 2000. Recoveries in 2003 are expected to approximate 2002
recoveries. In addition, Solutia expects to incur expenditures in the
range of $30 million to $40 million annually for remediation activities,
inclusive of the Company's proposed accelerated remediation activities
in Anniston, Alabama, for the foreseeable future.
At the time of the spinoff, Solutia assumed liabilities related to
specified Superfund proceedings from the former Monsanto Company (now
Pharmacia Corporation), under the Distribution Agreement between
Monsanto and Solutia. As a result, while Monsanto remains the named
potentially responsible party or defendant for actions that occurred
before September 1, 1997, Solutia manages these proceedings and
litigation against Monsanto and indemnify it for any costs, expenses and
judgments arising from these proceedings.
Solutia's estimates of its liabilities for Superfund sites are based
on evaluations of currently available facts with respect to each
individual site and take into consideration factors such as existing
technology, laws and agency policy and prior experience in remediation
of contaminated sites. As assessments and remediation activities
progress at individual sites, these liabilities are reviewed
periodically and adjusted to reflect additional technical, engineering
and legal information that becomes available. Solutia had an accrued
liability of $24 million as of December 31, 2002, for Superfund sites.
Major Superfund sites in this category include the noncompany-owned
sites at Brio and MOTCO in Texas, and Fike/Artel in West Virginia, which
account for $16 million of the accrued amount. Solutia spent
approximately $5 million in 2002 for remediation of Superfund sites.
Solutia had an accrued liability of $63 million as of December 31,
2002, for plants no longer in operation and third-party sites for which
it assumed responsibility under the Distribution Agreement entered into
with Monsanto. Solutia's estimate of its liability related to these
sites is based on evaluations of currently available facts with respect
to each individual site. The estimate takes into consideration factors
such as existing technology, laws and agency policy, and prior
experience in remediation of contaminated sites. The Company spent
$11 million in 2002 for remediation of these sites. In addition, the
Company has proposed accelerated remediation activities in Anniston,
Alabama, and if the necessary regulatory and judicial approvals are
obtained, the Company expects to incur a charge of approximately
$30 million in 2003.
Solutia had an accrued liability of $59 million as of December 31,
2002, for solid and hazardous waste remediation, and for post-closure
costs at the Company's operating locations. Solutia recognizes certain
post-closure costs over the estimated remaining useful life of the
related facilities. Solutia spent $10 million in 2002 for remediation of
these facilities.
Uncertainties related to all of Solutia's environmental liabilities
include changing governmental policy and regulations, discovery of
unknown conditions, judicial proceedings, the method and extent of
remediation and future changes in technology. The Company believes
that these matters, when ultimately resolved, which may be over an
extended period of time, will not have a material adverse effect on the
consolidated financial position or liquidity, but could have a material
adverse effect on net income in any given period.
29
SELF-INSURANCE
Solutia has purchased commercial insurance in order to reduce its
exposure to future legal costs, settlements and judgments related to
workers' compensation, product, general, auto and operations liability
claims from continuing operations. Because some of these claims are for
amounts lower than the policy deductible amounts or are not covered by
insurance, Solutia maintains self-insurance reserves to reflect its
estimates of such future uninsured costs. The majority of Solutia's
self-insurance reserves and a portion of its commercial liability
insurance policies are associated with estimated product liabilities
that Solutia inherited in the spinoff from Monsanto Company in 1997 and
for products that are no longer produced.
Solutia had an accrued liability of $102 million as of December 31,
2002 and $109 million as of December 31, 2001 for self-insurance
liabilities. Self-insurance expense was $25 million in 2002, $40 million
in 2001 and $13 million in 2000. Solutia recorded a charge in 2001 of
$20 million to cost of goods sold to increase its self-insurance
reserves. This charge was necessary to bring the aggregate
self-insurance liability to an appropriate balance based upon recent
loss experience and updated actuarial assumptions. Gross payments
related to this liability were $47 million in 2002, $34 million in 2001
and $54 million in 2000. Recoveries from third parties were $16 million
in 2002, $10 million in 2001 and $4 million in 2000. Based upon recent
history, insurance policies and current actuarial assumptions, it is
expected that annual gross payments related to this liability will be in
the range of $40 million to $45 million for 2003 and recoveries in 2003
are expected to approximate 2002 recoveries.
EMPLOYEE BENEFITS
Employee benefits include noncontributory defined benefit pension
plans and other postemployment programs that provide certain health care
and life insurance benefits (OPEB). The Company also has stock option
plans covering officers and employees and a non-employee director
compensation plan for non-employee members of Solutia's board of
directors.
Under the provisions of SFAS No. 87, "Employers' Accounting for
Pension and SFAS No. 106, "Employers' Accounting for Postretirement
Benefits Other Than Pension," measurement of the obligations under the
defined benefit pension plans and the OPEB plans are subject to a number
of assumptions. These include the rate of return on pension plan assets,
health care cost trend rates and the rate at which the future
obligations are discounted to value the liability at December 31st of
each year presented in the Statement of Consolidated Financial Position.
The assumed long-term rate of return on pension plan assets was
9.25% in 2002 and is expected to be 9.00% in 2003. The Company estimated
its assumed long-term rate of return based on its historical rate of
return experienced by the plan assets adjusted for assumed asset
allocation and forecasted capital market returns. The plan asset
allocation for 2002 was approximately 65% equity instruments, 30% fixed
income instruments and 5% other. The assumed plan asset allocation for
2003 will be similar to 2002. Pension expense was $40 million in 2002,
$19 million in 2001 and $10 million in 2000. Pension expense is expected
to be $35 million to $40 million for 2003, which will include
amortization of approximately $10 million of unrealized losses. The
25 basis point change in the assumed long-term rate of return will
result in a $3 million increase to pension expense.
The Company's annual measurement date is December 31 for the pension
and OPEB plans. The discount rate used to remeasure the obligations was
6.75% in 2002 and 7.00% in 2001. Historically, the Company has based its
discount rate on a review of long-term bonds that receive one of the two
highest ratings given by a recognized rating agency. A 25 basis point
change in the discount rate results in a $27 million change in the
pension projected benefit obligation and $1 million change in pension
expense. A 25 basis point change in the discount rate results in a
$9 million change in the accumulated benefit obligation for the OPEB
plans and an immaterial change to OPEB expense.
The Company estimated the five-year assumed trend rate for
healthcare costs to be 10% and the ultimate trend rate for healthcare
costs to be 5% for 2003. This represents a change from the Company's
2002 estimate of assumed and ultimate trend rates for healthcare costs
of 5.25%. Five year trend rate assumption was adjusted in 2002 to
reflect recent experience. The rate is assumed to decrease to 5.0% by
2008 and remain at that level thereafter. This change in estimate will
result in an increase of approximately $2 million to OPEB expense in
2003.
Under SFAS No. 123, "Accounting for Stock-Based Compensation," the
Company has elected to account for stock options under APB Opinion
No. 25, "Accounting for Stock Issued to Employees," based on their intrinsic
value at the date of grant. Because options are granted at market value,
there is no intrinsic value and resultant compensation expense. If the
Company had accounted for options based on the method proscribed by SFAS
No. 123, pro forma earnings (loss) would have been $(158) million in
2002, $(67) million in 2001 and $42 million in 2000 and diluted earnings
(loss) per share would have been $(1.51) in 2002, $(0.64) in 2001 and
$0.39 in 2000. That methodology yields an estimate of fair value based on
a measurement method that contains a number of management estimates,
including estimated option life and future volatility. Changes in these
assumptions could significantly impact the estimated fair value of the
options.
30
PENSION PLAN FUNDED STATUS
The majority of Solutia's employees are covered under
noncontributory defined benefit pension plans. The pension plans are
funded in accordance with Solutia's long-range projections of the plan's
financial conditions. These projections take into account benefits
earned and expected to be earned, anticipated returns on pension plan
assets and income tax and other regulations.
During 2002, Solutia recorded a $17 million non-cash pension
settlement loss as required by SFAS No. 88, "Employers' Accounting for
Settlements and Curtailments of Defined Benefit Pension Plans and for
Termination Benefits," because of the significant amount of lump sum
distributions from the pension plans in 2002.
As a result of the decline in the fair value of plan assets, and, to
a lesser extent, higher benefit obligations resulting from a lower discount
rate, the amount of pension plan underfunding in the pension plans increased
to $587 million as of December 31, 2002. As a result of the underfunded
status of the pension plans and in accordance with SFAS No. 87, "Employers'
Accounting for Pensions," Solutia recorded a non-cash minimum pension
liability of $262 million, an intangible asset of $68 million, an aftertax
charge to shareholders' deficit of $122 million and a related deferred tax
asset of $72 million as of December 31, 2002.
The Company is actively managing the funding of the pension plan in
order to meet the requirements of the IRS and the Pension Benefits
Guarantee Corporation (a U.S. federal agency). In the third quarter of
2002, Solutia made discretionary contributions of $17 million to reduce
the probability of larger contribution requirements in the future and to
utilize available tax benefits. According to IRS funding rules, Solutia
does not expect to be required to make a pension contribution in 2003.
However, future discretionary contributions will be considered based on
actual market returns, pension cost projections and tax and other
financial considerations.
DERIVATIVE FINANCIAL INSTRUMENTS
Solutia's business operations give rise to market risk exposures
that result from changes in currency exchange rates, interest rates and
certain commodity prices. To manage the volatility relating to these
exposures, Solutia enters into various hedging transactions that enable
it to alleviate the adverse effects of financial market risk. Solutia's
hedging transactions are carried out under policies and procedures
approved by the Audit and Finance Committee of the board of directors,
which do not permit the purchase or holding of any derivative financial
instruments for trading purposes. Note 7 to the Consolidated Financial
Statements includes a discussion of the Company's accounting policies
for financial instruments.
FOREIGN CURRENCY EXCHANGE RATE RISK
Solutia manufactures and sells its products in a number of countries
throughout the world and, as a result, is exposed to movements in
foreign currency exchange rates. Solutia uses foreign currency hedging
instruments to manage the volatility associated with foreign currency
purchases of materials and other assets and liabilities created in the
normal course of business. Solutia primarily uses forward exchange
contracts and purchased options to hedge these risks with maturities of
less than 18 months. Solutia also enters into certain foreign currency
derivative instruments primarily to protect against exposure related to
intercompany financing transactions. Corporate policy prescribes the
range of allowable hedging activity and the instruments that are
permitted for use. Because the counterparties to these contracts are
major international financing institutions, credit risk arising from
these contracts is not significant, and Solutia does not anticipate any
counterparty losses.
At December 31, 2002, Solutia had currency forward contracts to
purchase and sell $413 million of currencies, principally the U.S.
dollar, euro, Swiss Franc and United Kingdom Pound-Sterling, with
average maturities of six months.
Based on the Company's overall currency rate exposure at
December 31, 2002, including derivative and other foreign currency sensitive
instruments, a near-term change in currency rates, within a 95 percent
confidence level based on historical currency rate movements, would not
materially affect Solutia's financial statements.
INTEREST RATE RISK
Interest rate risk is primarily related to the changes in fair value
of fixed-rate long-term debt and short-term, floating rate debt. Solutia
believes its current debt structure appropriately protects the Company
from changes in interest rates and is not actively using any contracts
to manage interest rate risk. Based on the Company's overall interest
rate exposure at December 31, 2002, a near-term change in interest
rates, within a 95 percent confidence level based on historical interest
rate movements, would not materially affect Solutia's financial
statements. This is consistent with the overall interest rate exposure
at December 31, 2001. A 1 percent increase in the LIBOR rate would have
increased interest expense by approximately $4 million during 2002,
assuming the debt composition at December 31, 2002, was consistent
throughout the year.
31
COMMODITY PRICE RISK
Certain raw materials and energy sources used by Solutia are subject
to price volatility caused by weather, crude oil prices, supply
conditions, political and economic variables and other unpredictable
factors. Solutia routinely uses forward and option contracts to manage a
portion of the volatility related to anticipated energy purchases.
RESTRUCTURING ACTIVITIES
During 2000, Solutia recorded restructuring charges of $53 million
to cost of goods sold for costs associated with workforce reductions and
the closure of certain non-strategic facilities. The restructuring was
part of an enterprise-wide cost reduction initiative that was targeted
to achieve $100 million in annual savings. The closure of non-strategic
facilities is not anticipated to have a significant impact on future
operations.
During 2001, Solutia reduced its workforce by approximately
700 positions and eliminated more than 750 contractor positions. While
savings from the restructuring program are difficult to estimate, given
the nature of the activities, the corollary benefits achieved and the
timing of the actions taken, the best estimate of the savings realized
during 2001 from Solutia's restructuring actions was approximately
$60 million in continuing operations. These savings were primarily
reflected in cost of goods sold. Solutia received approximately
$94 million in cumulative savings in continuing operations during 2002
as compared with 2000, primarily reflected in cost of goods sold, from
reduced employee and contractor expenses. Cash outlays associated with
the restructuring actions were funded from operations. Approximately
90 percent of the workforce reductions affected North American business
and manufacturing operations, and approximately 10 percent affected
European, Asian and Latin American operations and sales offices.
Management positions represented approximately one-third of the
workforce reductions. During 2001, Solutia determined that the original
provision taken for its 2001 restructuring program was insufficient to
cover its total costs. Actual costs to terminate certain European and
North American management employees and certain employee benefit costs
for involuntary terminations were higher than the original estimates. As
a result, Solutia recorded additional restructuring charges of
$9 million to cost of goods sold to cover these higher costs. The
restructuring actions contemplated by this reserve were completed by the
end of 2001. Certain severance payments owed to individuals terminated
late in the fourth quarter of 2001 were included in accrued liabilities
at December 31, 2001, and were paid during the first quarter of 2002.
ASSET IMPAIRMENTS
During 2000, Solutia recorded to cost of goods sold impairment
charges of $76 million, primarily to write down certain non-performing
and non-strategic fiber spinning, drawing and packaging equipment which
supports several of Integrated Nylon's product lines. Solutia also
recorded an impairment charge to cost of goods sold in the Performance
Products and Services segment of $15 million for the write down of
chlorobenzenes' production equipment. The impairments were indicated by
current period operating losses and projections of continued losses
primarily because of the noncompetitive cost positions these businesses
have and the competitive market conditions that they face. The carrying
values of the assets were written down as determined by discounting
expected future cash flows, using an appropriate discount rate. The
assumptions used in the cash flow projections approximated market
conditions experienced in 2000. These conditions are not expected to
improve significantly in the foreseeable future. The cash flow
assumptions included declining demand and market share combined with
decreased operating margins. Lower operating margins reflect the
non-competitive cost position of these businesses and the impact of
lower selling prices associated with an extremely competitive operating
environment. Annual depreciation charges associated with these assets of
approximately $10 million will no longer be reflected in cost of goods
sold. Solutia will continue to operate these assets as they contribute
to the recovery of fixed costs. Also during 2000, the Company recorded
an impairment charge of $6 million to administrative expenses for the
write down of capitalized software costs related to the formation of the
Astaris joint venture.
See Notes 4 and 5 to the Consolidated Financial Statements for
additional information regarding Solutia's restructuring activities and
asset impairments.
RECENTLY ISSUED ACCOUNTING STANDARDS
Effective January 1, 2003, Solutia adopted SFAS No. 143, "Accounting
for Asset Retirement Obligations." The statement addresses accounting
and reporting requirements for obligations associated with the
retirement of tangible long-lived assets and the associated asset
retirement obligations. The adoption of SFAS No. 143 did not have a
material effect on the consolidated financial statements.
Effective January 1, 2003, Solutia adopted SFAS No. 145, "Rescission
of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement
No. 13, and Technical Corrections." The statement addresses the financial
accounting and reporting for a number of areas, including gains and
losses derived from the extinguishment of debt and the treatment of
sale-leaseback transactions. The adoption of SFAS No. 145 did not have a
material effect on the consolidated financial statements.
32
Effective January 1, 2003, Solutia adopted SFAS No. 146, "Accounting
for Costs Associated with Exit or Disposal Activities." The statement
addresses financial accounting and reporting for costs associated with
exit or disposal activities and supercedes Emerging Issues Task Force
(EITF) Issue 94-3, Liability Recognition for Certain Employee
Termination Benefits and Other Costs to Exit an Activity (including
Certain Costs Incurred in a Restructuring). SFAS No. 146 requires that a
liability for a cost associated with an exit or disposal activity be
recognized when the liability is incurred. SFAS No. 146 also establishes
that the liability should initially be measured and recorded at fair
value. The adoption of SFAS No. 146 did not have a material effect on
the consolidated financial statements.
Effective January 1, 2003, Solutia adopted SFAS No. 148, "Accounting
for Stock-Based Compensation--Transition and Disclosure." The statement
amends SFAS No. 123, "Accounting for Stock-Based Compensation," to
provide alternative methods of transition for a voluntary change to the
fair value based method of accounting for stock-based employee
compensation. In addition, this statement amends the disclosure
requirements of Statement 123 to require prominent disclosures in both
annual and interim financial statements about the method of accounting
for stock-based employee compensation and the effect of the method used
on reported results. The Company accounts for stock options under APB
Opinion No. 25, "Accounting for Stock Issued to Employees," based on
their intrinsic value at the date of grant. As such, Solutia has adopted
the additional disclosure requirements applicable under this standard
for accounting for stock based compensation using the intrinsic value
method.
Effective January 1, 2003, Solutia adopted FASB Interpretation
No. 45, "Guarantor's Accounting and Disclosure Requirements for Guarantees,
Including Indirect Guarantees of Indebtedness of Others." This
Interpretation elaborates on the disclosures to be made by a guarantor
in its interim and annual financial statements about its obligations
under certain guarantees that it has issued. It also clarifies that a
guarantor is required to recognize, at the inception of a guarantee, a
liability for the fair value of the obligation undertaken in issuing the
guarantee. This Interpretation also incorporates, without change, the
guidance in FASB Interpretation No. 34, "Disclosure of Indirect
Guarantees of Indebtedness of Others," which is being superseded. The
adoption of this Interpretation did not have a material effect on the
consolidated financial statements.
In January 2003, the FASB issued Interpretation No. 46,
"Consolidation of Variable Interest Entities." This Interpretation
provides guidance related to identifying variable interest entities and
determining whether such entities should be consolidated. This
Interpretation also provides guidance related to the initial and
subsequent measurement of assets, liabilities, and noncontrolling
interests of newly consolidated variable interest entities and requires
disclosures for both the primary beneficiary of a variable interest
entity and other beneficiaries of the entity. In addition, this
Interpretation requires certain disclosures if it is reasonably possible
that a company will consolidate or disclose information about a variable
interest entity when it initially applies the guidance in this
Interpretation. This Interpretation must be applied immediately to
(a) variable interest entities created, or (b) interests in variable
interest entities obtained, after January 31, 2003. For those variable
interest entities created, or interests in variable interest entities
obtained, on or before January 31, 2003, the guidance in this
Interpretation must be applied in the first fiscal year or interim
period beginning after June 15, 2003. Solutia is evaluating this
Interpretation to determine the impact on its consolidated financial
statements. However, the Company currently expects to consolidate the
assets and liabilities associated with the leasing of the Company's
corporate headquarters in the third quarter of 2003.
33
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.
FINANCIAL SECTION--TABLE OF CONTENTS
Page
Number
------
Management Report........................................... 35
Report of Independent Auditors.............................. 35
Statement of Consolidated Income (Loss)..................... 36
Statement of Consolidated Comprehensive Loss................ 36
Statement of Consolidated Financial Position................ 37
Statement of Consolidated Cash Flows........................ 38
Statement of Consolidated Shareholders' Deficit............. 39
Notes to Consolidated Financial Statements.................. 40
34
MANAGEMENT REPORT
Management is responsible for the integrity, objectivity and
preparation of Solutia Inc.'s consolidated financial statements and all
of the related information appearing in this annual report. The
statements have been prepared in accordance with accounting principles
generally accepted in the United States of America. Where necessary,
this information reflects estimates that are based upon currently
available information and management's judgments.
Management is also responsible for maintaining a system of internal
accounting controls designed to provide reasonable assurance that
Solutia's assets are safeguarded against material loss from unauthorized
use or disposition and that authorized transactions are properly
recorded to permit the preparation of accurate financial information.
Cost/benefit judgments are an important consideration in this regard.
The effectiveness of internal controls is maintained by careful
personnel selection and thorough training, division of responsibilities,
establishment and communication of policies and ongoing internal review
programs and audits.
Management believes that Solutia's system of internal accounting
controls as of and for the period ended December 31, 2002, was effective
and adequate to accomplish the objectives described above.
/s/ JOHN C. HUNTER III /s/ ROBERT A. CLAUSEN
John C. Hunter III Robert A. Clausen
Chairman, President and Vice Chairman,
Chief Executive Officer Chief Financial Officer and
Chief Administrative Officer
February 28, 2003
REPORT OF INDEPENDENT AUDITORS
To the Shareholders of Solutia Inc.:
We have audited the accompanying statements of consolidated
financial position of Solutia Inc. and subsidiaries (the Company) as of
December 31, 2002 and 2001, and the related statements of consolidated
income (loss), comprehensive loss, cash flows, and shareholders' deficit
for each of the three years in the period ended December 31, 2002. Our
audits also included the financial statement schedule in the Index at
Item 15. These financial statements and the financial statement schedule
are the responsibility of the Company's management. Our responsibility
is to express an opinion on these financial statements and the financial
statement schedule based on our audits.
We conducted our audits in accordance with auditing standards
generally accepted in the United States of America. Those standards
require that we plan and perform the audit to obtain reasonable
assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An
audit also includes assessing the accounting principles used and
significant estimates made by management, as well as evaluating the
overall financial statement presentation. We believe that our audits
provide a reasonable basis for our opinion.
In our opinion, such consolidated financial statements present
fairly, in all material respects, the financial position of the Company
as of December 31, 2002 and 2001, and the results of its operations and
its cash flows for each of the three years in the period ended
December 31, 2002, in conformity with accounting principles generally
accepted in the United States of America. Also, in our opinion, such
financial statement schedule, when considered in relation to the basic
consolidated financial statements taken as a whole, presents fairly in
all material respects the information set forth therein.
As discussed in the notes to the consolidated financial statements,
the Company adopted Statement of Financial Accounting Standards (SFAS)
No. 142, "Goodwill and Other Intangible Assets" and SFAS No. 133
"Accounting for Derivative Instruments and Hedging Activities" effective
January 1, 2002 and January 1, 2001, respectively.
/s/ DELOITTE & TOUCHE LLP
Deloitte & Touche LLP
St. Louis, Missouri
February 28, 2003
35
SOLUTIA INC.
STATEMENT OF CONSOLIDATED INCOME (LOSS)
(DOLLARS IN MILLIONS, EXCEPT PER SHARE AMOUNTS)
Year Ended December 31,
--------------------------------
2002 2001 2000
------ ------ ------
NET SALES................................................... $2,241 $2,268 $2,617
Cost of goods sold.......................................... 1,878 1,958 2,269
------ ------ ------
GROSS PROFIT................................................ 363 310 348
Marketing expenses.......................................... 147 142 134
Administrative expenses..................................... 128 142 151
Technological expenses...................................... 47 50 67
Amortization expense........................................ 3 12 11
------ ------ ------
OPERATING INCOME (LOSS)..................................... 38 (36) (15)
Equity earnings (loss) from affiliates--net of tax.......... 13 (13) 35
Interest expense............................................ (84) (70) (55)
Gain on sale of Polymer Modifiers business.................. -- -- 73
Other income (expense)--net................................. 14 (5) (8)
------ ------ ------
INCOME (LOSS) BEFORE INCOME TAXES........................... (19) (124) 30
Income taxes (benefit)...................................... (11) (43) (6)
------ ------ ------
INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE DISCONTINUED
OPERATIONS AND CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING
PRINCIPLE................................................. (8) (81) 36
Income from Discontinued Operations, net of tax............. 24 22 13
Cumulative Effect of Change in Accounting Principle......... (167) -- --
------ ------ ------
NET INCOME (LOSS)........................................... $ (151) $ (59) $ 49
====== ====== ======
BASIC EARNINGS (LOSS) PER SHARE:
Income (Loss) from Continuing Operations Before Discontinued
Operations and Cumulative Effect of Change in Accounting
Principle................................................. $(0.08) $(0.78) $ 0.34
Net Income (Loss)........................................... $(1.44) $(0.57) $ 0.46
DILUTED EARNINGS (LOSS) PER SHARE:
Income from Continuing Operations Before Discontinued
Operations and Cumulative Effect of Change in Accounting
Principle................................................. $(0.08) $(0.78) $ 0.34
Diluted Earnings (Loss) per Share........................... $(1.44) $(0.57) $ 0.46
WEIGHTED AVERAGE EQUIVALENT SHARES (IN MILLIONS):
Basic................................................... 104.7 103.9 105.9
Effect of dilutive securities:
Common share equivalents--common shares issuable
upon exercise of outstanding stock options and
warrants.......................................... -- -- 1.6
------ ------ ------
Diluted................................................. 104.7 103.9 107.5
====== ====== ======
STATEMENT OF CONSOLIDATED COMPREHENSIVE LOSS
(DOLLARS IN MILLIONS)
Year Ended December 31,
--------------------------------
2002 2001 2000
----- ---- ----
NET INCOME (LOSS)........................................... $(151) $(59) $ 49
OTHER COMPREHENSIVE INCOME (LOSS):
Currency translation adjustments............................ 119 (37) (86)
Cumulative effect of accounting change, net of tax of $(1).. -- 2 --
Net realized loss on derivative instruments, net of tax
of $(1)................................................... 1 -- --
Net unrealized loss on derivative instruments, net of tax
of $2..................................................... -- (3) --
Minimum pension liability adjustments, net of tax of $72 in
2002, $(2) in 2001, and $(4) in 2000...................... (122) 2 7
----- ---- ----
COMPREHENSIVE LOSS.......................................... $(153) $(95) $(30)
===== ==== ====
See accompanying Notes to Consolidated Financial Statements.
36
SOLUTIA INC.
STATEMENT OF CONSOLIDATED FINANCIAL POSITION
(DOLLARS IN MILLIONS, EXCEPT PER SHARE AMOUNTS)
As of December 31,
-------------------
2002 2001
------ ------
ASSETS
CURRENT ASSETS:
Cash and cash equivalents................................... $ 17 $ 23
Trade receivables, net of allowances of $16 in 2002 and
$20 in 2001............................................... 270 264
Miscellaneous receivables................................... 97 100
Prepaid expenses............................................ 17 15
Deferred income tax benefit................................. 108 123
Inventories................................................. 262 242
Assets of Discontinued Operations........................... 636 154
------ ------
TOTAL CURRENT ASSETS........................................ 1,407 921
PROPERTY, PLANT AND EQUIPMENT:
Land........................................................ 19 18
Buildings................................................... 375 362
Machinery and equipment..................................... 2,946 2,846
Construction in progress.................................... 26 47
------ ------
Total property, plant and equipment......................... 3,366 3,273
Less accumulated depreciation............................... 2,436 2,313
------ ------
NET PROPERTY, PLANT AND EQUIPMENT........................... 930 960
INVESTMENTS IN AFFILIATES................................... 232 313
GOODWILL, net............................................... 144 126
IDENTIFIED INTANGIBLE ASSETS, net........................... 66 64
LONG-TERM DEFERRED INCOME TAX BENEFIT....................... 290 251
LONG-TERM ASSETS--DISCONTINUED OPERATIONS................... -- 587
OTHER ASSETS................................................ 273 186
------ ------
TOTAL ASSETS................................................ $3,342 $3,408
====== ======
LIABILITIES AND SHAREHOLDERS' DEFICIT
CURRENT LIABILITIES:
Accounts payable............................................ $ 234 $ 195
Wages and benefits.......................................... 42 43
Postretirement liabilities.................................. 93 82
Miscellaneous accruals...................................... 314 333
Short-term debt............................................. 358 683
Liabilities of Discontinued Operations...................... 165 80
------ ------
TOTAL CURRENT LIABILITIES................................... 1,206 1,416
LONG-TERM DEBT.............................................. 839 626
POSTRETIREMENT LIABILITIES.................................. 1,164 929
LONG-TERM LIABILITIES--DISCONTINUED OPERATIONS.............. -- 107
OTHER LIABILITIES........................................... 382 443
SHAREHOLDERS' DEFICIT:
Common stock (authorized, 600,000,000 shares, par value
$0.01)
Issued: 118,400,635 shares in 2002 and 2001............. 1 1
Additional contributed capital.......................... 19 --
Treasury stock, at cost (13,659,351 and 13,921,604
shares in 2002 and 2001, respectively)................ (251) (257)
Net deficiency of assets at spinoff......................... (113) (113)
Unearned ESOP shares........................................ -- (1)
Accumulated other comprehensive loss........................ (146) (144)
Reinvested earnings......................................... 241 401
------ ------
TOTAL SHAREHOLDERS' DEFICIT................................. (249) (113)
------ ------
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT................. $3,342 $3,408
====== ======
See accompanying Notes to Consolidated Financial Statements.
37
SOLUTIA INC.
STATEMENT OF CONSOLIDATED CASH FLOWS
(DOLLARS IN MILLIONS)
Year Ended December 31,
-----------------------------
2002 2001 2000
----- ----- -----
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
OPERATING ACTIVITIES:
Net income (loss)........................................... $(151) $ (59) $ 49
Adjustments to reconcile to Cash From Operations:
Cumulative effect of change in accounting principle..... 167 -- --
Depreciation and amortization........................... 134 143 152
Income from discontinued operations, net of tax......... (24) (22) (13)
Amortization of deferred credits........................ (14) (14) (12)
Amortization of deferred debt issuance costs and debt
discount.............................................. 11 2 1
Restructuring expenses and other unusual items.......... 23 127 195
Net pretax gains from asset disposals................... (6) (2) (79)
Changes in assets and liabilities:
Income and deferred taxes........................... 54 (57) (10)
Trade receivables................................... (6) 37 65
Inventories......................................... (20) 52 (24)
Accounts payable.................................... 41 (105) 38
Other assets and liabilities........................ (82) (76) (185)
----- ----- -----
CASH PROVIDED BY OPERATIONS--CONTINUING OPERATIONS.......... 127 26 177
CASH PROVIDED BY OPERATIONS--DISCONTINUED OPERATIONS........ 44 18 67
----- ----- -----
CASH PROVIDED BY OPERATIONS................................. 171 44 244
----- ----- -----
INVESTING ACTIVITIES:
Property, plant and equipment purchases..................... (59) (83) (211)
Acquisition and investment payments, net of cash acquired... (37) (33) (110)
Property disposals and investment proceeds.................. 109 9 220
----- ----- -----
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES--CONTINUING
OPERATIONS................................................ 13 (107) (101)
CASH PROVIDED BY (USED IN) INVESTING
ACTIVITIES--DISCONTINUED OPERATIONS....................... -- 21 (10)
----- ----- -----
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES............. 13 (86) (111)
----- ----- -----
FINANCING ACTIVITIES:
Net change in short-term debt obligations................... (327) 41 (22)
Proceeds from issuance of long-term debt obligations........ 182 -- --
Reduction in long-term debt obligations..................... -- -- (13)
Issuance of stock warrants.................................. 19 -- --
Treasury stock purchases.................................... -- -- (106)
Dividend payments........................................... (4) (4) (4)
Common stock issued under employee stock plans.............. 2 13 4
Deferred debt issuance costs................................ (29) (4) (1)
Other financing activities.................................. (13) -- --
----- ----- -----
CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES--CONTINUING
OPERATIONS................................................ (170) 46 (142)
CASH USED IN FINANCING ACTIVITIES--DISCONTINUED
OPERATIONS................................................ (20) -- --
----- ----- -----
CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES............. (190) 46 (142)
----- ----- -----
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS............ (6) 4 (9)
CASH AND CASH EQUIVALENTS:
BEGINNING OF YEAR........................................... 23 19 28
----- ----- -----
END OF YEAR................................................. $ 17 $ 23 $ 19
===== ===== =====
See accompanying Notes to Consolidated Financial Statements.
The effect of exchange rate changes on cash and cash equivalents was
not material. Cash payments for interest (net of amounts capitalized)
were $84 million in 2002, $90 million in 2001 and $88 million in 2000.
Cash refunds, net of payments for income taxes were $37 million in 2002.
Cash payments for income taxes were $24 million in 2001 and $17 million
in 2000. Cash payments for the management of environmental programs
which were charged against recorded environmental liabilities were
$26 million in 2002, $40 million in 2001 and $29 million in 2000.
38
SOLUTIA INC.
STATEMENT OF CONSOLIDATED SHAREHOLDERS' DEFICIT
(DOLLARS IN MILLIONS)
Year Ended December 31,
-----------------------------
2002 2001 2000
----- ----- -----
COMMON STOCK:
BALANCE, JANUARY 1.......................................... $ 1 $ 1 $ 1
----- ----- -----
BALANCE, DECEMBER 31........................................ $ 1 $ 1 $ 1
----- ----- -----
ADDITIONAL CONTRIBUTED CAPITAL:
BALANCE, JANUARY 1.......................................... $ -- $ -- $ --
Issuance of 5,533,522 warrants in 2002.................. 19 -- --
----- ----- -----
BALANCE, DECEMBER 31........................................ $ 19 $ -- $ --
----- ----- -----
NET DEFICIENCY OF ASSETS AT SPINOFF:
BALANCE, JANUARY 1.......................................... $(113) $(113) $(113)
----- ----- -----
BALANCE, DECEMBER 31........................................ $(113) $(113) $(113)
----- ----- -----
TREASURY STOCK:
BALANCE, JANUARY 1.......................................... $(257) $(296) $(209)
Shares purchased (0 shares in 2002, 2001 and
7,717,300 shares in 2000)............................. -- -- (106)
Net shares issued under employee stock plans
(262,253 shares in 2002, 1,562,590 shares in 2001
and 1,092,870 shares in 2000)......................... 6 39 19
----- ----- -----
BALANCE, DECEMBER 31........................................ $(251) $(257) $(296)
----- ----- -----
UNEARNED ESOP SHARES:
BALANCE, JANUARY 1.......................................... $ (1) $ (9) $ (18)
Amortization of ESOP balance............................ 1 8 9
----- ----- -----
BALANCE, DECEMBER 31........................................ $ -- $ (1) $ (9)
----- ----- -----
ACCUMULATED OTHER COMPREHENSIVE LOSS:
ACCUMULATED CURRENCY ADJUSTMENT:
BALANCE, JANUARY 1.................................. (138) (101) (15)
Currency translation adjustments.................... 119 (37) (86)
----- ----- -----
BALANCE, DECEMBER 31................................ (19) (138) (101)
----- ----- -----
MINIMUM PENSION LIABILITY:
BALANCE, JANUARY 1.................................. (5) (7) (14)
Minimum pension liability adjustments............... (122) 2 7
----- ----- -----
BALANCE, DECEMBER 31................................ (127) (5) (7)
----- ----- -----
DERIVATIVE INSTRUMENTS:
BALANCE, JANUARY 1.................................. (1) -- --
Cumulative effect of accounting change.............. -- 2 --
Net losses on derivative instruments................ 1 (3) --
----- ----- -----
BALANCE, DECEMBER 31................................ -- (1) --
----- ----- -----
BALANCE, DECEMBER 31........................................ $(146) $(144) $(108)
----- ----- -----
REINVESTED EARNINGS:
BALANCE, JANUARY 1.......................................... $ 401 $ 491 $ 450
Net income (loss)....................................... (151) (59) 49
Employee stock plans.................................... (5) (27) (4)
Dividends............................................... (4) (4) (4)
----- ----- -----
BALANCE, DECEMBER 31........................................ $ 241 $ 401 $ 491
----- ----- -----
TOTAL SHAREHOLDERS' DEFICIT................................. $(249) $(113) $ (34)
===== ===== =====
See accompanying Notes to Consolidated Financial Statements.
39
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(DOLLARS IN MILLIONS, EXCEPT PER SHARE AMOUNTS)
1. SIGNIFICANT ACCOUNTING POLICIES
Nature of Operations
Solutia Inc. and its subsidiaries make and sell a variety of
high-performance chemical-based materials. Solutia is a world leader in
performance films for laminated safety glass and after-market applications;
process development and scale-up services for pharmaceutical fine chemicals;
specialties such as water treatment chemicals, heat transfer fluids and
aviation hydraulic fluid and an integrated family of nylon products
including high-performance polymers and fibers.
Prior to September 1, 1997, Solutia was a wholly-owned subsidiary of
the former Monsanto Company (now known as Pharmacia Corporation). On
September 1, 1997, Monsanto distributed all of the outstanding shares of
common stock of the Company as a dividend to Monsanto stockholders (the
spinoff). As a result of the spinoff, on September 1, 1997, Solutia
became an independent publicly-held company listed on the New York Stock
Exchange and its operations ceased to be owned by Monsanto. Net
deficiency of assets of $113 million resulted from the spinoff.
Basis of Consolidation
The consolidated financial statements include the accounts of
Solutia and its majority-owned subsidiaries. Other companies in which
Solutia has a significant interest (20 to 50 percent) are included in
"Investments in Affiliates" in the Statement of Consolidated Financial
Position. Solutia's share of these companies' net earnings or losses is
reflected in "Equity Earnings (Loss) from Affiliates" in the Statement
of Consolidated Income (Loss).
Use of Estimates
The preparation of financial statements in conformity with
accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent
assets and liabilities at the date of the financial statements and that
affect revenues and expenses during the period reported. Estimates are
adjusted when necessary to reflect actual experience. Significant
estimates were used to account for restructuring reserves, environmental
reserves, self-insurance reserves, employee benefit plans, asset
impairments and contingencies.
Cash and Cash Equivalents
Cash and cash equivalents consist of cash and temporary investments
with maturities of three months or less when purchased.
Inventory Valuation
Inventories are stated at cost or market, whichever is less. Actual
cost is used to value raw materials and supplies. Standard cost, which
approximates actual cost, is used to value finished goods and goods in
process. Standard cost includes direct labor and raw materials, and
manufacturing overhead based on practical capacity. The cost of certain
inventories (67 percent as of December 31, 2002) is determined by the
last-in, first-out (LIFO) method, which generally reflects the effects
of inflation or deflation on cost of goods sold sooner than other
inventory cost methods. The cost of other inventories generally is
determined by the first-in, first-out (FIFO) method.
Property, Plant and Equipment
Property, plant and equipment are recorded at cost. The cost of
plant and equipment is depreciated over weighted average periods of
20 years for buildings and 12 years for machinery and equipment, by the
straight-line method.
Intangible Assets
Solutia discontinued the amortization of goodwill and identifiable
intangible assets that have indefinite useful lives in accordance with
SFAS No. 142. Intangible assets that have finite useful lives are
amortized on a straight-line basis over their useful lives, generally
periods ranging from 5 to 20 years. Goodwill is assessed annually for
impairment. Fair value measurements of the reporting units are estimated
by a third-party specialist utilizing both an income and market multiple
approach.
Impairment of Long-Lived Assets
Impairment tests of long-lived assets are made when conditions
indicate a possible loss. Impairment tests are based on a comparison of
undiscounted cash flows to the recorded value of the asset. If an
impairment is indicated, the asset value is written down to its fair
value based upon market prices or, if not available, upon discounted
cash value, at an appropriate discount rate.
40
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Environmental Remediation
Costs for remediation of waste disposal sites are accrued in the
accounting period in which the obligation is probable and when the cost
is reasonably estimable. Postclosure costs for hazardous and other waste
facilities at certain U.S. operating locations are accrued over the
estimated life of the facility as part of its anticipated closure cost.
Environmental liabilities are not discounted, and they have not been
reduced for any claims for recoveries from insurance or third parties.
In those cases where insurance carriers or third-party indemnitors have
agreed to pay any amounts and management believes that collectability of
such amounts is probable, the amounts are reflected as receivables in
the consolidated financial statements.
Self-Insurance
Solutia has purchased commercial insurance in order to reduce its
exposure to future legal costs, settlements and judgments related to
workers' compensation, product, general, auto and operations liability
claims from continuing operations. Because some of these claims are for
amounts lower than policy deductible amounts or are not covered by
insurance, Solutia maintains self-insurance reserves to reflect its
estimates of such future uninsured costs. Self-insured losses are
accrued based upon estimates of the aggregate liability for uninsured
claims incurred using certain actuarial assumptions followed in the
insurance industry and the Company's historical experience.
Revenue Recognition
The Company's primary revenue-earning activities involve delivering
or producing goods, and revenues are considered to be earned when the
Company has completed the process by which it is entitled to such revenues.
The following criteria are used for revenue recognition: persuasive
evidence of an arrangement exists, delivery has occurred, selling price
is fixed or determinable and collection is reasonably assured.
Derivative Financial Instruments
Currency forward contracts are used to manage currency exposures for
financial instruments denominated in currencies other than the entity's
functional currency. Natural gas contracts are used to manage some of
the exposure for the cost of natural gas. Gains and losses on contracts
that are designated and effective as hedges are included in net income
(loss) and offset the exchange gain or loss of the transaction being
hedged.
Major currencies affecting the Company's business are the U.S.
dollar, the British pound sterling, the euro, the Canadian dollar, the
Australian dollar and the Brazilian real. Currency restrictions are not
expected to have a significant effect on Solutia's cash flow, liquidity
or capital resources.
Income Taxes
Solutia accounts for income taxes using the asset and liability
method. Under this method, deferred tax assets and liabilities are
recognized for the future tax consequences of temporary differences
between the carrying amounts and tax bases of assets and liabilities at
enacted rates.
Currency Translation
The local currency has been used as the functional currency for
nearly all worldwide locations. The financial statements for most of
Solutia's ex-U.S. operations are translated into U.S. dollars at current
or average exchange rates. Unrealized currency translation adjustments
in the Statement of Consolidated Financial Position are accumulated as a
component of Shareholders' Deficit.
Earnings (Loss) per Share
Basic earnings (loss) per share is a measure of operating
performance that assumes no dilution from securities or contracts to
issue common stock. Diluted earnings (loss) per share is a measure of
operating performance by giving effect to the dilution that would occur
if securities or contracts to issue common stock were exercised or
converted.
New Accounting Pronouncements
Effective January 1, 2003, Solutia adopted SFAS No. 143, "Accounting
for Asset Retirement Obligations." The statement addresses accounting
and reporting requirements for obligations associated with the
retirement of tangible long-lived assets and the associated asset
retirement obligations. The adoption of SFAS No. 143 did not have a
material effect on the consolidated financial statements.
Effective January 1, 2003, Solutia adopted SFAS No. 145, "Rescission
of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement
No. 13, and Technical Corrections." The statement addresses the financial
accounting and reporting for a number of areas,
41
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
including gains and losses derived from the extinguishment of debt and the
treatment of sale-leaseback transactions. The adoption of SFAS No. 145 did
not have a material effect on the consolidated financial statements.
Effective January 1, 2003, Solutia adopted SFAS No. 146, "Accounting
for Costs Associated with Exit or Disposal Activities." The statement
addresses financial accounting and reporting for costs associated with
exit or disposal activities and supercedes Emerging Issues Task Force
(EITF) Issue 94-3, Liability Recognition for Certain Employee
Termination Benefits and Other Costs to Exit an Activity (including
Certain Costs Incurred in a Restructuring). SFAS No. 146 requires that a
liability for a cost associated with an exit or disposal activity be
recognized when the liability is incurred. SFAS No. 146 also establishes
that the liability should initially be measured and recorded at fair
value. The adoption of SFAS No. 146 did not have a material effect on
the consolidated financial statements.
Effective January 1, 2003, Solutia adopted SFAS No. 148, "Accounting
for Stock-Based Compensation--Transition and Disclosure." The statement
amends SFAS No. 123, "Accounting for Stock-Based Compensation," to
provide alternative methods of transition for a voluntary change to the
fair value based method of accounting for stock-based employee
compensation. In addition, this statement amends the disclosure
requirements of Statement 123 to require prominent disclosures in both
annual and interim financial statements about the method of accounting
for stock-based employee compensation and the effect of the method used
on reported results. The Company accounts for stock options under APB
Opinion No. 25, "Accounting for Stock Issued to Employees," based on
their intrinsic value at the date of grant. As such, Solutia has adopted
the additional disclosure requirements applicable under this standard
for accounting for stock based compensation using the intrinsic value
method.
Effective January 1, 2003, Solutia adopted FASB Interpretation
No. 45, "Guarantor's Accounting and Disclosure Requirements for Guarantees,
Including Indirect Guarantees of Indebtedness of Others." This
Interpretation elaborates on the disclosures to be made by a guarantor
in its interim and annual financial statements about its obligations
under certain guarantees that it has issued. It also clarifies that a
guarantor is required to recognize, at the inception of a guarantee, a
liability for the fair value of the obligation undertaken in issuing the
guarantee. This Interpretation also incorporates, without change, the
guidance in FASB Interpretation No. 34, "Disclosure of Indirect
Guarantees of Indebtedness of Others," which is being superseded. The
adoption of this Interpretation did not have a material effect on the
consolidated financial statements.
In January 2003, the FASB issued Interpretation No. 46,
"Consolidation of Variable Interest Entities." This Interpretation
provides guidance related to identifying variable interest entities and
determining whether such entities should be consolidated. This
Interpretation also provides guidance related to the initial and
subsequent measurement of assets, liabilities, and noncontrolling
interests of newly consolidated variable interest entities and requires
disclosures for both the primary beneficiary of a variable interest
entity and other beneficiaries of the entity. In addition, this
Interpretation requires certain disclosures if it is reasonably possible
that a company will consolidate or disclose information about a variable
interest entity when it initially applies the guidance in this
Interpretation. This Interpretation must be applied immediately to
(a) variable interest entities created, or (b) interests in variable
interest entities obtained, after January 31, 2003. For those variable
interest entities created, or interests in variable interest entities
obtained, on or before January 31, 2003, the guidance in this
Interpretation must be applied in the first fiscal year or interim
period beginning after June 15, 2003. Solutia is evaluating this
Interpretation to determine the impact on its consolidated financial
statements. However, as further discussed in Note 17, the Company
expects to consolidate the assets and liabilities associated with
leasing of the Company's corporate headquarters in the third quarter
of 2003.
Reclassifications
Certain reclassifications to prior years' financial information have
been made to conform to the 2002 presentation. These reclassifications
include amounts related to resins, additives and adhesives businesses
which have been presented as discontinued operations.
2. ACQUISITIONS AND DIVESTITURES
Discontinued Operations
On December 2, 2002, Solutia signed a definitive agreement to sell
its resins, additives and adhesives businesses to UCB S.A. for
$500 million in cash, plus an upfront payment of $10 million for a
period of exclusivity. On January 31, 2003, the sale was completed
resulting in a modest gain; accordingly, the assets and liabilities of
the discontinued operations have been classified as current in the
Statement of Consolidated Financial Position at December 31, 2002. In
addition, as further described in Note 11, proceeds from this
divestiture were used to pay down borrowings under the amended credit
facility in accordance with bank agreements. As a result, all borrowings
under this facility have been classified as short-term at December 31,
2002. The Company retained certain tax liabilities of approximately
$40 million related
42
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
to the divested businesses and has excluded them from the liabilities
identified below. The carrying amounts of assets and liabilities from
discontinued operations at December 31, 2002, consisted of the
following:
Year Ended December 31,
-----------------------
2002 2001
------ ------
ASSETS:
Receivables and prepaids.................................... $100 $ 93
Inventories................................................. 68 61
Other current assets........................................ 36 --
---- ----
Total Current Assets.................................... 204 154
---- ----
Property, plant and equipment, net.......................... 199 183
Intangible assets........................................... 205 390
Other long-term assets...................................... 28 14
---- ----
Total Assets............................................ $636 $741
==== ====
LIABILITIES:
Accounts payable............................................ $ 42 $ 38
Miscellaneous accruals...................................... 51 42
---- ----
Total Current Liabilities............................... 93 80
---- ----
Postretirement liabilities.................................. 21 18
Non-current deferred tax liability.......................... 33 73
Other long-term liabilities................................. 18 16
---- ----
Total Liabilities....................................... $165 $187
==== ====
The operating results of the resins, additives and adhesives
businesses have been reported separately as discontinued operations in
the Consolidated Financial Statements for each year presented. The
operating results exclude certain corporate expenses of $10 million in
2002, $12 million in 2001, and $11 million in 2000, which had previously
been allocated to the resins, additives and adhesives businesses. In
addition, interest expense of $26 million in 2002, $20 million in 2001,
and $28 million in 2000, associated with debt that was repaid with the
sales proceeds was allocated to discontinued operations. Net sales and
income from discontinued operations are as follows:
Year Ended December 31,
--------------------------
2002 2001 2000
---- ---- ----
Net sales.................................................. $559 $549 $568
Income before income tax expense........................... 34 47 11
Income tax (expense) benefit............................... (10) (25) 2
---- ---- ----
Income from discontinued operations........................ $ 24 $ 22 $ 13
==== ==== ====
Other Acquisitions and Divestitures
On May 31, 2002, Solutia acquired Axio Research Corporation (Axio)
for approximately $5 million, which was financed with cash from
operations. Axio is a contract research organization providing clinical
trial design and data management to a wide range of clients including
pharmaceutical, biotechnology and medical device companies as well as
academic and government research groups. Axio will complement the
Pharmaceutical service offering within the Performance Products and
Services segment. The allocation of the purchase price to assets and
liabilities acquired resulted in current assets of $1 million,
non-current assets of $1 million, goodwill of $4 million and current
liabilities of $1 million. Axio's results of operations were included in
Solutia's results of operations from the acquisition date and were not
material to Solutia's consolidated results of operations for the year
ended December 31, 2002.
During the first quarter of 2002, Solutia sold its 50 percent
interest in the Advanced Elastomer Systems joint venture to ExxonMobil
Chemical Company, a division of Exxon Mobil Corporation and Exxon
Chemical Asset Management Partnership, a subsidiary of Exxon Mobil
Corporation for approximately $102 million. The sale resulted in a gain
of $5 million.
During 2000, Solutia completed the sale of its Polymer Modifiers
business and related manufacturing facilities to Ferro Corporation for
approximately $130 million. As a result of this transaction, Solutia
recognized a $73 million pretax gain. Solutia's continuing operations
43
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
results included net sales of approximately $90 million in 2000 and
operating income of approximately $16 million in 2000 from the Polymer
Modifiers business.
During 2000, Solutia recognized a $15 million pretax gain on the
sale of substantially all of its minority interest in P4 Production
L.L.C., a phosphorus manufacturing venture. The results of operations
from Solutia's minority interest in P4 Production L.L.C. were not
material to Solutia's consolidated results of operations.
During 2000, Solutia completed two acquisitions in the Performance
Products and Services segment, which provide custom process and
technology services to the global pharmaceutical industry. In the first
acquisition, which closed on February 10, Solutia acquired CarboGen
Holdings AG. CarboGen is a leading process research and development
firm. In the second acquisition, which closed on March 24, Solutia
purchased AMCIS AG. AMCIS serves the global pharmaceutical industry by
developing production processes and by manufacturing active ingredients
for clinical trials and small-volume commercial drugs. The combined
purchase price for these acquisitions was approximately $118 million,
which was financed with commercial paper and the assumption of debt.
Both of the acquisitions have been accounted for using the purchase
method. The allocations of the purchase price to the assets and
liabilities acquired resulted in current assets of $17 million, non-
current assets of $27 million, goodwill of $57 million, other intangible
assets of $41 million, current liabilities of $21 million and
non-current liabilities of $3 million. Other intangible assets are being
amortized over their estimated useful lives, which average 18 years.
Results of operations for CarboGen and AMCIS were included in Solutia's
results of operations from the acquisition dates. The results of
operations for the acquired businesses were not material to Solutia's
consolidated results of operations for 2000.
3. EARNINGS (LOSS) PER SHARE
Year Ended December 31,
--------------------------------
2002 2001 2000
------ ------ ------
Income (Loss) from Continuing Operations Before Discontinued
Operations and Cumulative Effect of Change in Accounting
Principle................................................. $ (8) $ (81) $ 36
Income from Discontinued Operations, net of tax............. 24 22 13
Cumulative Effect of Change in Accounting Principle......... (167) -- --
------ ------ ------
Net Income (Loss)........................................... $ (151) $ (59) $ 49
====== ====== ======
Basic Earnings (Loss) per Share:
Income (Loss) from Continuing Operations Before Discontinued
Operations and Cumulative Effect of Change in Accounting
Principle................................................. $(0.08) $(0.78) $ 0.34
Income from Discontinued Operations, net of tax............. 0.23 0.21 0.12
Cumulative Effect of Change in Accounting Principle......... (1.59) -- --
------ ------ ------
Basic Earnings (Loss) per Share............................. $(1.44) $(0.57) $ 0.46
------ ------ ------
Diluted Earnings (Loss) per Share:
Income from Continuing Operations Before Discontinued
Operations and Cumulative Effect of Change in Accounting
Principle................................................. $(0.08) $(0.78) $ 0.34
Income from Discontinued Operations, net of tax............. 0.23 0.21 0.12
Cumulative Effect of Change in Accounting Principle......... (1.59) -- --
------ ------ ------
Diluted Earnings (Loss) per Share........................... $(1.44) $(0.57) $ 0.46
------ ------ ------
Weighted average equivalent shares (in millions):
Basic................................................... 104.7 103.9 105.9
Effect of dilutive securities:
Common share equivalents--common shares issuable upon
exercise of outstanding stock options and warrants.... -- -- 1.6
------ ------ ------
Diluted................................................. 104.7 103.9 107.5
------ ------ ------
At December 31, 2002 and 2001, 0.2 million and 1.2 million common
share equivalents, respectively, were excluded because the effect would
be antidilutive.
44
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
4. RESTRUCTURING RESERVES
During 2000, Solutia recorded restructuring charges of $53 million
to cost of goods sold for costs associated with work force reductions
and closure of certain non-strategic facilities. During 2001, Solutia
reduced its workforce by approximately 700 positions. Additionally,
Solutia eliminated more than 750 contractor positions during 2001.
Approximately 90 percent of the workforce reductions affected North
American business and manufacturing operations, and approximately
10 percent affected European, Asian and Latin American operations and sales
offices. Management positions represented approximately one-third of the
workforce reductions. During the fourth quarter of 2001, Solutia
determined that the original provision taken for its 2001 restructuring
program was insufficient to cover its total costs. Actual costs to
terminate certain European and North American management employees and
certain employee benefit costs for involuntary terminations were higher
than the original estimates. As a result, Solutia recorded additional
restructuring charges of $9 million to cost of goods sold to cover these
higher costs. The restructuring actions contemplated by this reserve
were completed by the end of 2001. Certain severance payments owed to
individuals terminated late in the fourth quarter of 2001 were included
in accrued liabilities at December 31, 2001, and were paid during the
first quarter of 2002. The closure of non-strategic facilities is not
anticipated to have a significant impact on future operations.
The following table summarizes the 2000 restructuring charge and
amounts utilized to carry out those plans:
Employment Shutdown of
Reductions Facilities Total
---------- ----------- -----
Balance at January 1, 2000........................ $ -- $-- $ --
Charges taken................................ 50 3 53
Amounts utilized............................. -- (3) (3)
---- --- ----
Balance at December 31, 2000...................... $ 50 $-- $ 50
---- --- ----
Charges taken................................. 9 -- 9
Amounts utilized.............................. (59) -- (59)
---- --- ----
Balance at December 31, 2001...................... $ -- $-- $ --
==== === ====
During 2000, Solutia identified excess production capacity for
certain Solutia resins products that allowed for consolidation of
production facilities. As a result, Solutia exited its operations at the
Port Plastics site in Addyston, Ohio. An $8 million charge to cost of
goods sold was recorded to carry out the exit plan. The charge included
$2 million to write down plant assets to their fair value of
approximately $1 million, $2 million of dismantling costs and $4 million
of estimated costs for which Solutia was contractually obligated under
an operating agreement. Fair value was determined by discounting future
cash flows using an appropriate discount rate based on the Company's
cost of capital. Under the operating agreement, Solutia is required to
provide 24 months notice of intent to exit and is required to pay
contractually obligated costs for an additional 18 months thereafter to
a third-party operator. Solutia provided notice of intent to exit on
June 30, 2000, and exited the site in June of 2002. The contractually
obligated costs represent direct manufacturing, overhead, utilities and
severance. The financial impact was not material to Solutia as
production will be shifted to other production facilities.
The following table summarizes the restructuring charge, amounts
utilized to carry out those plans and amount remaining at
December 31, 2002:
Shutdown of Asset Write- Other
Facilities downs Costs Total
----------- ------------ ----- -----
Balance at January 1, 2000................. $-- $-- $-- $--
Charges taken......................... 2 2 4 8
Amounts utilized...................... -- (2) -- (2)
--- --- --- ---
Balance at December 31, 2000............... $ 2 $-- $ 4 $ 6
Amounts utilized....................... -- -- -- --
--- --- --- ---
Balance at December 31, 2001............... $ 2 $-- $ 4 $ 6
Amounts utilized....................... (2) -- -- (2)
--- --- --- ---
BALANCE AT DECEMBER 31, 2002............... $-- $-- $ 4 $ 4
=== === === ===
45
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
5. ASSET IMPAIRMENTS
During 2000, Solutia recorded a $76 million impairment charge to
cost of goods sold primarily to write down certain non-performing and
non-strategic fiber spinning, drawing and packaging equipment which
supports several of Integrated Nylon's product lines. Solutia also
recorded an impairment charge to cost of goods sold of $15 million to
write down chlorobenzenes' production equipment in the Performance
Products and Services segment. The impairments were indicated by 2000
operating losses and projections of continued losses primarily because
of the noncompetitive cost positions these businesses have and the
competitive market conditions that they face. The carrying values of the
assets were written down as determined by discounting expected future
cash flows, using an appropriate discount rate. The assumptions used in
the cash flow projections approximated the market conditions experienced
in 2000. These conditions are not expected to improve significantly in
the foreseeable future. The cash flow assumptions included a declining
demand and market share combined with decreased operating margins. Lower
operating margins reflect the non-competitive cost position of these
businesses and the impact of lower selling prices associated with an
extremely competitive operating environment.
During 2000, Solutia recorded a $6 million impairment charge to
administrative expenses for the write down of capitalized software costs
related to the formation of the Astaris joint venture. The software had
previously been fully dedicated to Solutia's Phosphorus Derivatives
business. Impairment was indicated by a significant change in the extent
and manner in which Astaris was expected to utilize the asset under a
transition services agreement. The carrying value of the asset was
written down to its estimated fair value, as determined by discounting
expected future cash flows, using an appropriate discount rate.
6. GOODWILL AND OTHER INTANGIBLE ASSETS
Effective January 1, 2002, Solutia adopted SFAS No. 142, "Goodwill
and Other Intangible Assets." In accordance with SFAS No. 142, Solutia
discontinued the amortization of goodwill and identifiable intangible
assets that have indefinite useful lives. This statement also required
certain intangible assets that did not meet the criteria for recognition
apart from goodwill, to be subsumed into goodwill. During the quarter
ended March 31, 2002, Solutia subsumed into goodwill $1 million of
intangible assets net of related deferred tax liabilities representing
assembled workforce that did not meet the separability criteria under
SFAS No. 141, "Business Combinations."
In connection with the adoption of this standard, fair value
measurements of the reporting units were estimated by a third-party
specialist utilizing both an income and market multiple approach. Based
on this analysis, Solutia recorded an impairment loss of $167 million
during the first quarter of 2002 for the resins and additives
businesses, which is presented as discontinued operations, due to
declining estimates of future results given current economic and market
conditions. The goodwill impairment charge is non-deductible for tax
purposes and is reflected as the cumulative effect of change in
accounting principle in the accompanying statement of consolidated
income (loss).
46
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Net income (loss) and earnings (loss) per share, excluding
discontinued operations, for the years ended December 31, 2002, 2001 and
2000, adjusted to exclude the non-amortization provisions of SFAS No. 142,
net of tax, are as follows:
2002 2001 2000
------ ------ -----
Net income (loss):
Income (loss) from continuing operations before
cumulative effect of change in accounting
principle........................................ $ (8) $ (81) $ 36
Goodwill amortization............................... -- 8 6
Equity method goodwill amortization................. -- 2 1
Trademark amortization.............................. -- 2 3
Cumulative effect of change in accounting
principle......................................... (167) -- --
------ ------ -----
ADJUSTED NET INCOME (LOSS).............................. $ (175) $ (69) $ 46
====== ====== =====
2002 2001 2000
------ ------ -----
Basic earnings (loss) per share:
Income (loss) from continuing operations before
cumulative effect of change in accounting
principle......................................... $(0.08) $(0.78) $0.34
Goodwill amortization............................... -- 0.08 0.05
Equity method goodwill amortization................. -- 0.02 0.01
Trademark amortization.............................. -- 0.02 0.03
Cumulative effect of change in accounting
principle......................................... (1.59) -- --
------ ------ -----
ADJUSTED BASIC EARNINGS (LOSS) PER SHARE................ $(1.67) $(0.66) $0.43
====== ====== =====
2002 2001 2000
------ ------ -----
Diluted earnings (loss) per share:
Income (loss) from continuing operations before
cumulative effect of change in accounting
principle......................................... $(0.08) $(0.78) $0.34
Goodwill amortization............................... -- 0.08 0.05
Equity method goodwill amortization................. -- 0.02 0.01
Trademark amortization.............................. -- 0.02 0.03
Cumulative effect of change in accounting
principle......................................... (1.59) -- --
------ ------ -----
ADJUSTED DILUTED EARNINGS (LOSS) PER SHARE.............. $(1.67) $(0.66) $0.43
====== ====== =====
47
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Identified intangible assets are as follows:
December 31, 2002
----------------------------------------------------
Gross Carrying Accumulated Net Carrying
Value Amortization Value
-------------- ------------ ------------
Amortized intangible assets:
Contractual customer relationships..... $23 $ (5) $18
Employment agreements.................. 5 (3) 2
Other.................................. 8 (5) 4
Translation............................ 6 -- 6
--- ---- ---
TOTAL AMORTIZED INTANGIBLE ASSETS........... $42 $(13) $29
=== ==== ===
Unamortized intangible assets:
Trademarks.............................. 39 (4) 35
Translation............................. 2 -- 2
--- ---- ---
TOTAL UNAMORTIZED INTANGIBLE ASSETS......... $41 $ (4) $37
--- ---- ---
TOTAL IDENTIFIED INTANGIBLE ASSETS.......... $83 $(17) $66
=== ==== ===
December 31, 2001
----------------------------------------------------
Gross Carrying Accumulated Net Carrying
Value Amortization Value
-------------- ------------ ------------
Intangible assets:
Contractual customer relationships...... $23 $ (3) $20
Trademarks.............................. 39 (4) 35
Assembled workforce..................... 3 (1) 2
Employment agreements................... 5 (1) 4
Other................................... 7 (4) 3
--- ---- ---
TOTAL INTANGIBLE ASSETS..................... $77 $(13) $64
=== ==== ===
The Company's second quarter acquisition of Axio (see Note 2),
resulted in goodwill of approximately $4 million. As a result of
adoption of SFAS No. 142, there have been no changes to amortizable
lives or methods, except for trademarks, which have indefinite lives as
defined under the new standard. Trademarks are associated with products
and tradenames of the Company and are expected to provide benefits
beyond the foreseeable future. Amortization expense for the net carrying
amount of intangible assets is $3 million in 2003, $3 million in 2004,
$3 million in 2005, $3 million in 2006 and $3 million in 2007.
Goodwill as allocated by reportable segment is as follows:
Performance
Products
and Integrated
Services Nylon Total
----------- ---------- -----
Gross goodwill, December 31, 2001................... $142 $-- $142
Accumulated amortization............................ (16) -- (16)
---- --- ----
Net goodwill, December 31, 2001..................... $126 $-- $126
Goodwill acquired................................... 4 -- 4
Intangible assets and related accounts subsumed:
Assembled workforce............................. 2 -- 2
Deferred tax liabilities........................ (1) -- (1)
Translation......................................... 13 -- 13
---- --- ----
Goodwill, December 31, 2002......................... $144 $-- $144
==== === ====
48
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
7. RISK MANAGEMENT ACTIVITIES
Effective January 1, 2001, Solutia adopted SFAS No. 133, "Accounting
for Derivative Instruments and Hedging Activities," as amended, which
requires that all derivative instruments be reported on the balance
sheet at fair value and establishes criteria for designation and
effectiveness of hedging relationships. The cumulative effect of
adopting SFAS No. 133 as of January 1, 2001, resulted in a cumulative
addition to other comprehensive income of $2 million aftertax,
principally attributable to unrealized gains in commodity cash flow
hedges.
Solutia's business operations give rise to market risk exposures
that result from changes in currency exchange rates, interest rates and
certain commodity prices. To manage the volatility relating to these
exposures, Solutia enters into various hedging transactions that enable
it to alleviate the adverse effects of financial market risk.
Designation is performed on a specific exposure basis to support hedge
accounting. The changes in fair value of these hedging instruments are
offset in part or in whole by corresponding changes in the fair value or
cash flows of the underlying exposures being hedged. Solutia's hedging
transactions are carried out under policies and procedures approved by
the Audit and Finance Committee of the board of directors, which do not
permit the purchase or holding of any derivative financial instruments
for trading purposes.
Foreign Currency Exchange Rate Risk
Solutia manufactures and sells its products in a number of countries
throughout the world and, as a result, is exposed to movements in
foreign currency exchange rates. Solutia uses foreign currency hedging
instruments to manage the volatility associated with foreign currency
purchases of materials and other assets and liabilities created in the
normal course of business. Solutia primarily uses forward exchange
contracts and purchased options to hedge these risks with maturities of
less than 18 months.
Solutia also enters into certain foreign currency derivative
instruments primarily to protect against exposure related to
intercompany financing transactions. Solutia has chosen not to designate
these instruments as hedges and to allow the gains and losses that arise
from marking the contracts to market to be recorded in other income
(expense)--net in the period. The net impact of the related gains and
losses was not material.
No cash flow hedges were discontinued during the year due to changes
in expectations on the original forecasted transactions. Foreign
currency hedging activity is not material to Solutia's financial
statements.
Interest Rate Risk
Interest rate risk is primarily related to the changes in fair value
of fixed-rate long-term debt and short-term, floating rate debt. Solutia
believes its current debt structure appropriately protects the Company
from changes in interest rates and is not actively using any contracts
to manage interest rate risk.
Commodity Price Risk
Certain raw materials and energy sources used by Solutia are subject
to price volatility caused by weather, crude oil prices, supply
conditions, political and economic variables and other unpredictable
factors. Solutia routinely uses forward and option contracts to manage a
portion of the volatility related to anticipated energy purchases with
maturities up to 6 months. These market instruments are designated as
cash flow hedges. The mark-to-market gain or loss on qualifying hedges
is included in other comprehensive income (loss) to the extent
effective, and reclassified into cost of goods sold in the period during
which the hedged transaction affects earnings. The mark-to-market gains
or losses on ineffective portions of hedges are recognized in cost of
goods sold immediately. For the year ended December 31, 2002, the net
impact on other comprehensive income (loss) included approximately
$1 million aftertax for realized losses on cash flow hedges. Solutia
estimates that existing net unrealized losses of less than $1 million
will be reclassified to cost of goods sold within 12 months.
Credit Risk
Credit risk arising from the inability of a counterparty to meet the
terms of Solutia's financial instrument contracts is generally limited
to the amounts, if any, by which the counterparty's obligations exceed
the obligations of the Company. It is Solutia's policy to enter into
financial instruments with a number of creditworthy counterparties.
Therefore, Solutia does not expect to incur material credit losses on
its risk management or other financial statement instruments.
49
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
8. INVESTMENTS IN AFFILIATES
During the first quarter of 2002, Solutia sold its 50 percent
interest in the Advanced Elastomer Systems joint venture to ExxonMobil
Chemical Company, a division of Exxon Mobil Corporation and Exxon
Chemical Asset Management Partnership, a subsidiary of Exxon Mobil
Corporation for approximately $102 million. The sale resulted in a gain
of $5 million.
In April 2000, Astaris LLC, a joint venture between Solutia and FMC
Corporation, started operations to manufacture and market phosphorus
chemicals. Solutia contributed its Phosphorus Derivatives business to
the joint venture in exchange for a 50 percent ownership share. Net
assets contributed to the venture totaled approximately $87 million.
During the third quarter of 2000, Solutia received $85 million from
Astaris representing a cash distribution and repayment of working
capital loans. In connection with the completion of the external
financing agreement for Astaris, which expires in September of 2005,
Solutia and FMC contractually agreed to provide Astaris with funding in
the event the joint venture fails to meet certain financial benchmarks.
The financial benchmarks were based on forecasted earnings that were
developed when the joint venture was formed. Astaris' earnings have
fallen short of the forecast underlying its external financing agreement
due to numerous factors including significantly less than planned
utilization of its purified wet acid technology, lower sales volumes and
lower average selling prices due to the prolonged weak U.S. economy. As
a result of these earnings shortfalls versus the original expectations
developed at the time the venture was formed, Solutia has been required
to make additional investments of $30 million in 2002 and $31 million in
2001 to the joint venture. These payments have largely been used to
reduce debt outstanding within the venture. At December 31, 2002, net
debt (total debt less cash) for Astaris totaled $160 million, $59 million
lower than net debt at the end of the prior year. Solutia and FMC are
evaluating other financing alternatives for the joint venture. However,
if no new financing arrangements are in place for 2003, Solutia
anticipates required contributions of approximately $50 million for
2003. Contributions are recorded in the Investments in Affiliates line
on the Statement of Consolidated Financial Position.
At December 31, 2002, Solutia's investments in affiliates consisted
principally of its 50 percent interests in the Flexsys and Astaris joint
ventures for which Solutia uses the equity method of accounting. Solutia
received dividends from affiliates of approximately $25 million in 2002,
$30 million in 2001 and $45 million in 2000. Summarized combined
financial information for 100 percent of the Flexsys and Astaris joint
ventures and the results of operations for AES for the period up until
the sale during the first quarter of 2002 is as follows:
2002 2001 2000
---- ------ ------
Results of operations:
Net sales.......................................... $962 $1,241 $1,247
Gross profit........................................ 152 226 327
Operating income (loss)............................. 30 (63) 138
Net income (loss)................................... 12 (48) 95
Financial position:
Current assets...................................... $353 $ 493 $ 552
Noncurrent assets................................... 650 768 744
Current liabilities................................. 336 498 347
Noncurrent liabilities.............................. 273 205 334
9. INVENTORY VALUATION
The components of inventories were:
2002 2001
----- -----
Finished goods.............................................. $ 179 $ 163
Goods in process............................................ 101 101
Raw materials and supplies.................................. 83 81
----- -----
Inventories, at FIFO cost................................... 363 345
Excess of FIFO over LIFO cost............................... (101) (103)
----- -----
TOTAL....................................................... $ 262 $ 242
===== =====
Inventories at FIFO approximate current cost. The effects of LIFO
inventory liquidations were not significant.
50
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
10. INCOME TAXES
The components of income (loss) from continuing operations before
income taxes were:
2002 2001 2000
---- ----- ----
United States.............................................. $(53) $(137) $30
Outside United States...................................... 34 13 --
---- ----- ---
TOTAL...................................................... $(19) $(124) $30
==== ===== ===
The components of income tax expense (benefit) charged to continuing
operations were:
2002 2001 2000
---- ---- ----
Current:
U.S. federal............................................ $ -- $(30) $(48)
U.S. state.............................................. -- -- --
Outside United States................................... 27 23 7
---- ---- ----
27 (7) (41)
---- ---- ----
Deferred:
U.S. federal............................................ (23) (6) 46
U.S. state.............................................. (9) (13) (7)
Outside United States................................... (6) (17) (4)
---- ---- ----
(38) (36) 35
---- ---- ----
TOTAL....................................................... $(11) $(43) $ (6)
==== ==== ====
Factors causing Solutia's effective tax rate for continuing
operations to differ from the U.S. federal statutory rate were:
2002 2001 2000
---- ---- ----
U.S. federal statutory rate................................. (35)% (35)% 35%
U.S. state income taxes..................................... (32) (7) (15)
Export tax benefit.......................................... (17) (2) (18)
Taxes related to foreign income, net of credits............. 65 (7) (14)
Valuation allowances........................................ -- 9 25
Income from equity affiliates recorded net of tax........... (25) 3 (50)
Other....................................................... (14) 4 17
--- --- ---
EFFECTIVE INCOME TAX RATE................................... (58)% (35)% (20)%
=== === ===
Deferred income tax balances were related to:
2002 2001
----- -----
Property.................................................... $(191) $(178)
Postretirement benefits..................................... 426 367
Restructuring reserves...................................... 2 3
Environmental liabilities................................... 55 64
Inventory................................................... 12 18
Tax credit carryforward..................................... 7 54
Valuation allowances........................................ (5) (32)
Net operating losses........................................ 66 29
Other....................................................... 14 31
----- -----
NET DEFERRED TAX ASSETS..................................... $ 386 $ 356
===== =====
51
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
At December 31, 2002, foreign tax credit carryforwards available to
reduce possible future U.S. income taxes amounted to approximately
$7 million, all of which will expire in 2004 and 2005. At December 31,
2002, various federal, state and foreign net operating loss
carryforwards are available to offset future taxable income. These net
operating losses expire in years after 2004 or have an indefinite
carryforward period. Valuation allowances have been provided for the
foreign tax credit and net operating loss carryforwards that are not
likely to be utilized. Income taxes and remittance taxes have not been
recorded on $67 million in undistributed earnings of subsidiaries,
either because any taxes on dividends would be offset substantially by
foreign tax credits or because Solutia intends to reinvest those
earnings indefinitely. It is not practicable to estimate the tax effect
of remitting these earnings to the United States.
11. DEBT OBLIGATIONS
Solutia's debt obligations include borrowings against the amended
revolving credit facility, notes and debentures. The weighted average
interest rate on short-term debt outstanding at December 31, 2002, was
7.2 percent and 5.0 percent at December 31, 2001. The weighted average
interest rate on total debt outstanding at December 31, 2002, was
7.8 percent and 6.1 percent at December 31, 2001.
On December 2, 2002, Solutia signed a definitive agreement to sell
its resins, additives and adhesives businesses to UCB S.A. for
$500 million in cash, plus an upfront payment of $10 million for a
period of exclusivity. On January 31, 2003, the sale was completed.
Proceeds from the divestiture were used to pay down all of the
borrowings under the amended credit facility, provide $39 million cash
collateral for certain outstanding letters of credit and purchase the
co-generation facility at Pensacola, Florida in accordance with bank
agreements. Accordingly, all of the borrowings under the amended credit
facility are classified as short-term debt at December 31, 2002.
Amended Credit Facility
At December 31, 2002, the revolving credit facility had available
capacity to borrow up to $140 million, after $78 million of letters of
credit outstanding under the facility.
On July 25, 2002, Solutia and its bank syndicate amended Solutia's
revolving credit facility. The amendment extended the maturity of the
facility until August 2004. It also reduced the facility from
$800 million to $600 million and separated the facility into a $300 million
term loan and a $300 million revolving credit facility. The term loan
has been paid off with proceeds from the sale of the resins, additives
and adhesives businesses on January 31, 2003. The amended credit
facility required the Company to cash collateralize certain outstanding
letters of credit. Fees, expenses and other costs associated with the
amended credit facility and cash collateralization of letters of credit
totaled $33 million. The amended credit facility is available for
working capital and other general corporate purposes.
Borrowings under the amended credit facility bear interest at a
floating rate based on LIBOR, plus an applicable margin. The margin for
LIBOR loans is 5.75 percent and will increase by 50 basis points in July
2003 and an additional 50 basis points in January 2004. A premium in the
amount of 2 percent of the principal repaid on the term loan will apply
until July 25, 2003, and a premium of 1 percent will apply to such
principal payments thereafter.
In September 2002, Solutia negotiated an amendment to its revolving
credit facility which reduced the amount of debt outstanding as defined
in the credit agreement for purposes of the leverage covenant ratio.
Solutia deposited approximately $155 million from the proceeds of the
Senior Secured Notes offering which occurred in July 2002 with the
trustee for the $150 million of 6.5 percent notes due October 15, 2002,
to pay the principal and interest at maturity. However, the principal
amount of the 6.5 percent notes due October 15, 2002, was still
considered outstanding debt under the amended credit facility. The
amendment eliminated the $150 million of 6.5 percent notes due October 15,
2002, from consideration in the leverage covenant ratio. Without the
amendment, Solutia would not have been in compliance with the leverage
coverage ratio at September 30, 2002.
In order to facilitate the sale of the resins, additives and
adhesives businesses to UCB S.A. and to be in compliance with the
interest coverage ratio at December 31, 2002, the Company was required
to obtain amendments to its revolving credit facility. Effective
December 24, 2002, the facility was amended to modify certain financial
covenants, release any collateral that is subject to the divestiture and
release all liens upon the property of the European subsidiary borrowers
upon the repayment in full of the principal and interest of all amounts
outstanding in connection with the divestiture ("Amended Credit
Facility"). Without the amendment, Solutia would not have been able to
sell its resins, additives and adhesives businesses or been in
compliance with the interest coverage ratio at December 31, 2002.
Senior Secured Notes
On July 9, 2002, Solutia completed a private placement of
223,000 units consisting of $223 million of 11.25 percent senior secured
7-year notes (the "Notes") and warrants to purchase 5,533,522 shares of
common stock at an exercise price of $7.59 per share. The warrants are
exercisable at any time after their separation from the Notes and before
their expiration on July 15, 2009. The 7-year notes were issued by
52
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
SOI Funding Corp., a special purpose entity, and the offering resulted
in cash proceeds, net of estimated fees, of $193 million, which were
placed in escrow pending amendment of Solutia's credit facility, as
described under "Amended Credit Facility" above and assumption of SOI
Funding Corp.'s obligations under the notes. Both of these events
occurred on July 25, 2002, at which time the net offering proceeds were
released from escrow. Solutia deposited approximately $155 million of
the proceeds with the trustee for the $150 million of 6.5 percent notes
due October 15, 2002, to pay the principal and interest at maturity. The
remaining proceeds were used to pay fees, expenses and other costs
related to the Amended Credit Facility, cash collateralize existing
letters of credit and repay a portion of borrowings under Solutia's
Amended Credit Facility.
Solutia recorded the Notes and warrants based on their estimated
relative fair value at the time of their issuance. Accordingly, Solutia
recorded $182 million for the value of the Notes and $19 million for the
value of the warrants. The discount associated with this offering, which
includes the value given to the warrants, will be non-deductible for
income tax purposes.
On November 18, 2002, Solutia completed an exchange offer for all of
its outstanding 11.25% Senior Secured Notes due 2009 issued under Rule
144A for notes which are available to be traded freely.
Solutia's obligations and the obligations of its subsidiary
borrowers under the Amended Credit Facility and the Notes are guaranteed
by CPFilms Inc., Monchem International, Inc., Monchem, Inc., Solutia
Systems, Inc. and each of Solutia's subsequently acquired or organized
domestic subsidiaries, subject to certain exceptions. In addition,
Solutia Inc. guarantees the payment of amounts due from subsidiary
borrowers under the Amended Credit Facility. The Notes and the
guarantees are secured by either first or second priority liens on all
of the domestic collateral securing Solutia's bank obligations.
Long-Term Debt
Long-term debt consisted of the following:
2002 2001
---- ----
6.50% notes due 2002........................................ $ -- $150
6.72% debentures puttable 2004, due 2037.................... 150 150
6.25% euro notes due 2005................................... 208 177
11.25% notes due 2009....................................... 223 --
7.375% debentures due 2027.................................. 300 300
Other....................................................... -- 2
Unamortized debt discount................................... (42) (3)
---- ----
839 776
Less: Current portion of long-term debt..................... -- (150)
---- ----
TOTAL....................................................... $839 $626
==== ====
Interest is payable semiannually, on January 15 and July 15 for
the 11.25% notes and on April 15 and October 15 for the remaining
maturities. The holders of the 2037 debentures have the right to require
repayment on October 15, 2004. The notes and debentures contain provisions
that, among other things, restrict Solutia's ability to create liens on
assets and its ability to enter into sale and leaseback transactions.
12. FAIR VALUES OF FINANCIAL INSTRUMENTS
The estimated fair value of Solutia's long-term debt was $650 million
as of December 31, 2002, and $553 million as of December 31, 2001. These
estimates compare with the recorded amount of $839 million in 2002 and
$626 million in 2001.
The recorded amounts of cash, trade receivables, third-party
guarantees, accounts payable and short-term debt approximate their fair
values at both December 31, 2002, and December 31, 2001. The estimated
fair value of the Company's foreign currency forward contracts on
intercompany financing transactions was approximately $16 million at
December 31, 2002. Notional amounts for purchase contracts were
$413 million at December 31, 2002, and $308 million at December 31, 2001,
and for sell contracts the notional amounts were $413 million at
December 31, 2002, and $301 million at December 31, 2001.
53
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Fair values are estimated by the use of quoted market prices,
estimates obtained from brokers and other appropriate valuation
techniques and are based upon information available as of December 31,
2002, and December 31, 2001. The fair-value estimates do not necessarily
reflect the values Solutia could realize in the current market.
13. POSTRETIREMENT BENEFITS
Pension benefits are based on the employee's age, years of service
and/or compensation level. The qualified pension plan is funded in
accordance with Solutia's long-range projections of the plan's financial
conditions. These projections take into account benefits earned and
expected to be earned, anticipated returns on pension plan assets and
income tax and other regulations. Prior to the spinoff, the majority of
Solutia's employees participated in Monsanto's noncontributory pension
plans. In conjunction with the spinoff, Solutia assumed pension
liabilities and received related assets from those plans for its
applicable active employees and for certain former employees who left
Monsanto in earlier years.
Certain employees also participate in benefit programs that provide
certain health care and life insurance benefits for retired employees.
All regular, full-time U.S. employees and certain employees in other
countries, who were employed by the Company on or before December 31,
1998, may become eligible for these benefits if they reach retirement
age while employed by Solutia and have the required years of service.
These postretirement benefits are unfunded and are generally based on
the employee's age, years of service and/or compensation level. The
costs of postretirement benefits are accrued by the date the employees
become eligible for the benefits. In connection with the spinoff,
Solutia assumed retiree medical liabilities for its applicable active
employees and for approximately two-thirds of the retired U.S. employees
of Monsanto.
For 2002, 2001, and 2000, Solutia's pension and healthcare and other
benefit costs were as follows:
Healthcare and
Pension Benefits Other Benefits
----------------------------- --------------------------
2002 2001 2000 2002 2001 2000
----- ----- ----- ---- ---- ----
Service costs for benefits earned.......................... $ 26 $ 30 $ 32 $ 9 $ 10 $ 10
Interest cost on benefit obligation........................ 111 122 130 52 53 53
Assumed return on plan assets.............................. (129) (145) (144) -- -- --
Prior service costs........................................ 21 21 21 (13) (15) (18)
Transition asset........................................... -- (2) (10) -- -- --
Recognized net (gain)/loss................................. (6) (8) 4 9 10 7
Settlement................................................. 17 1 (23) -- -- --
----- ----- ----- ---- ---- ----
TOTAL...................................................... $ 40 $ 19 $ 10 $ 57 $ 58 $ 52
===== ===== ===== ==== ==== ====
54
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Components of the changes in fair value of plan assets, changes in
the benefit obligation and the funding status of Solutia's
postretirement plans were as follows:
Healthcare and
Pension Benefits Other Benefits
------------------- ----------------
2002 2001 2002 2001
------ ------ ----- ----
CHANGES IN FAIR VALUE OF PLAN ASSETS
Fair value of plan assets at January 1.................. $1,384 $1,724 $ -- $ --
Actual return on plan assets............................ (113) (81) -- --
Employer contributions.................................. 24 5 -- --
Settlements............................................. (10) -- -- --
Benefits paid........................................... (246) (264) -- --
------ ------ ----- ----
FAIR VALUE OF PLAN ASSETS AT DECEMBER 31................ $1,039 $1,384 $ -- $ --
------ ------ ----- ----
CHANGES IN BENEFIT OBLIGATION
Benefit obligation at January 1......................... $1,709 $1,751 $ 802 $730
Service costs........................................... 26 30 9 10
Interest cost........................................... 112 123 52 52
Participant contributions............................... -- -- 14 9
Actuarial losses........................................ 42 68 30 79
Settlements............................................. (13) -- -- --
Benefits paid........................................... (250) (265) (104) (96)
Plan amendments......................................... -- 2 -- 18
------ ------ ----- ----
BENEFIT OBLIGATION AT DECEMBER 31........................... $1,626 $1,709 $ 803 $802
====== ====== ===== ====
Plan assets consist principally of common stocks and U.S. government
and corporate obligations. As a result of the decline in the fair value
of our plan assets, and, to a lesser extent, higher benefit obligations
resulting from a lower discount rate, the amount of pension plan
underfunding in the pension plans increased to $587 million as of
December 31, 2002. As a result of the underfunded status of the pension
plans and in accordance with SFAS No. 87, "Employers' Accounting for
Pensions," Solutia recorded a non-cash minimum pension liability of
$262 million, an intangible asset of $68 million, an aftertax charge to
shareholders' deficit of $122 million and a related deferred tax asset
of $72 million at its measurement date of December 31, 2002.
The Company is actively managing the funding of the pension plan in
order to meet the requirements of the IRS and the Pension Benefits
Guarantee Corporation (a U.S. federal agency). In the third quarter of
2002, Solutia made discretionary contributions of $17 million to the
qualified pension plan to reduce the probability of larger contribution
requirements in the future and to utilize available tax benefits. The
Company also contributed $7 million in 2002 to fund its other benefit
plans. According to IRS funding rules, Solutia does not expect to be
required to make a pension contribution in 2003. However, future
discretionary contributions will be considered based on actual market
returns, pension cost projections and tax and other financial
considerations.
The funded status of Solutia's postretirement benefit plans at
December 31, 2002, and 2001 was as follows:
Healthcare and
Pension Benefits Other Benefits
----------------- -----------------
2002 2001 2002 2001
----- ----- ----- -----
FUNDED STATUS............................................... $(587) $(325) $(803) $(802)
Unrecognized actuarial loss................................. 298 27 151 132
Unrecognized prior service costs............................ 95 116 (92) (107)
----- ----- ----- -----
ACCRUED NET LIABILITY AT DECEMBER 31........................ $(194) $(182) $(744) $(777)
===== ===== ===== =====
55
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
The accrued net liability was included in:
Healthcare and
Pension Benefits Other Benefits
----------------- -----------------
2002 2001 2002 2001
----- ----- ----- -----
Prepaid benefit cost........................................ $ 18 $ 14 $ -- $ --
Accrued benefit cost........................................ (513) (235) (744) (777)
Intangible asset............................................ 99 31 -- --
Deferred tax asset.......................................... 75 3 -- --
Accumulated other comprehensive loss........................ 127 5 -- --
----- ----- ----- -----
ACCRUED NET LIABILITY....................................... $(194) $(182) $(744) $(777)
===== ===== ===== =====
The projected benefit obligation, accumulated benefit obligation and
fair value of plan assets for the pension plans with accumulated benefit
obligations in excess of plan assets were $1,601 million, $1,551 million
and $1,017 million, respectively, as of December 31, 2002, and
$1,643 million, $1,547 million and $1,313 million, respectively, as of
December 31, 2001.
The significant actuarial assumptions used to estimate the projected
benefit obligation for the Company's principal pension, healthcare and
other benefit plans were as follows:
Healthcare and
Pension Benefits Other Benefits
----------------- ----------------
2002 2001 2002 2001
----- ----- ----- ----
Discount rate............................................... 6.75% 7.00% 6.75% 7.00%
Assumed long-term rate of return on plan assets............. 9.25% 9.50% -- --
Annual rates of salary increase (for plans that base
benefits on final compensation level)..................... 3.75% 4.00% -- --
Assumed trend rate for healthcare costs(1).................. -- -- 10.00% 5.25%
Ultimate trend rate for healthcare costs.................... -- -- 5.00% 5.25%
- --------
(1) Five year trend rate assumption was adjusted in 2002 to reflect market trends. Rate is assumed to decrease to
5.0% by 2008 and remain at that level thereafter.
A 1 percent change in the assumed health care cost trend rates would
have the following effect as of December 31, 2002:
1-Percentage- 1-Percentage-
Point Increase Point Decrease
-------------- --------------
Effect on total service and interest cost components..... $ -- $ --
Effect on postretirement benefit obligation.............. 2 (2)
14. EMPLOYEE SAVINGS PLANS
In connection with the spinoff, Monsanto common stock held by the
Monsanto Employee Stock Ownership Plan (ESOP) and related Monsanto ESOP
borrowings were allocated between Solutia and Monsanto. As a result of
this allocation, Solutia received 2.4 million shares of Monsanto common
stock and assumed $29 million of ESOP debt to third parties.
Simultaneously, Solutia created its own ESOP, established a trust to
hold the Monsanto shares, and issued a $29 million loan to the trust.
The trust used the proceeds of the loan to repay the assumed third-party
debt. Subsequent to the spinoff, the ESOP trust was required by
government regulations to divest its holdings of Monsanto common stock
and to use the proceeds to acquire Solutia common stock. The divestiture
of Monsanto common stock and the purchase of Solutia common stock were
completed in early 1998. At inception, the trust held 10,737,097 shares
of Solutia common stock. As of December 31, 2002, there have been
10,737,097 shares allocated to participants. The ESOP loans to Solutia
were repaid in 2002. The ESOP is no longer leveraged. During 2002, the
ESOP purchased Solutia common stock on the open market to fund company
match. The ESOP will fulfill future matching obligations with the use of
treasury stock and open market purchases.
Substantially all U.S. employees of Solutia are eligible to
participate in the Solutia Inc. Savings and Investment Plan, a 401(k)
plan. Shares held in the ESOP were used to make Solutia's matching
contribution to eligible participants' accounts under this plan. The
number of shares released was computed on each pay date based on formula
that considers the participant contribution, the Solutia matching rate,
and Solutia's closing stock price. Shares allocated to participant
accounts totaled 433,536 shares in 2002, 1,160,203 shares in 2001, and
56
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
1,314,341 shares in 2000. The value of these contributions was
$4 million in 2002, $15 million in 2001 and $17 million in 2000. Company
cash contributions during 2002 were used to repay ESOP loans of
$2 million and to purchase Solutia common stock on the open market of
$11 million. Compensation expense is equal to the cost of the shares
allocated to participants and the cost to purchase Solutia's common
stock on the open market.
Information regarding the ESOP follows:
2002 2001 2000
---- ---- ----
Total ESOP expense.......................................... $13 $8 $10
Interest portion of total ESOP expense...................... -- 1 1
Cash contributions.......................................... 13 7 10
15. STOCK OPTION PLANS
Solutia has two stock-based incentive plans under which awards are
being granted to officers and employees, the Solutia Inc. 2000
Stock-Based Incentive Plan and the Solutia Inc. 1997 Stock-Based
Incentive Plan. The 2000 plan authorizes up to 5,400,000, and the 1997
plan up to 7,800,000, shares of Solutia common stock for grants of
non-qualified and incentive stock options, stock appreciation rights,
restricted stock awards and bonus stock awards. The shares used may be
newly issued shares, treasury shares or a combination. Under both plans,
the exercise price of a stock option must be no less than the fair
market value of Solutia's common stock on the option grant date.
Additionally, the plans provide that the term of any stock option
granted may not exceed 10 years. At December 31, 2002, approximately
2,036,196 shares from the 2000 plan and 146,772 shares from the 1997
plan remained available for grants.
During 2002, non-qualified options to purchase 393,000 shares of
Solutia common stock were granted under the plans to current executive
officers and other senior executives as a group, and non-qualified stock
options to purchase 1,179,800 shares were granted to other employees at
an average exercise price of $10.28 per share. Total shares covered by
options granted under the plans to current executive officers and other
senior executives as a group totaled 2,960,000 and other employees
totaled 9,080,318, through December 31, 2002. The options granted to
Solutia's executive officers and other senior executives are primarily
performance options that become exercisable upon the earlier of
achievement of specified share price targets or the ninth anniversary of
the option grant. The options granted to the other management employees
are time-based. They generally become exercisable in thirds, one-third
on each of the first three anniversaries of the option grant date.
The Solutia Inc. Non-Employee Director Compensation Plan provides
incentives to non-employee members of Solutia's board of directors. This
plan authorizes up to 400,000 shares for grants of non-qualified stock
options and for grants of deferred shares in payment of all or a portion
of the annual retainer for the non-employee directors. Only treasury
shares may be used. Under this plan, the exercise price of a stock
option must be no less than the fair market value of Solutia's common
stock on the grant date and the term of any stock option granted under
the plan may not exceed 10 years. At December 31, 2002, 65,650 shares of
Solutia's common stock remained available for grants under the plan.
Shares covered by options granted to non-employee directors totaled
24,833 in 2002, 25,167 in 2001 and 25,167 in 2000.
57
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
As permitted by SFAS No. 123, "Accounting for Stock-Based
Compensation," Solutia has elected to continue following the guidance of
Accounting Principles Board (APB) Opinion No. 25, "Accounting for Stock
Issued to Employees," for measurement and recognition of stock-based
transactions with employees. Accordingly, no compensation cost has been
recognized for Solutia's option plans in net income (loss), as all
options granted under the plans had an exercise price equal to the
market value of the Company's stock on the date of the grant. Had the
determination of compensation cost for these plans been based on the
fair value at the grant dates for awards under these plans, consistent
with the method of SFAS No. 123, Solutia's net income (loss) would have
been reduced (increased) to the pro forma amounts indicated below:
2002 2001 2000
------ ------ -----
NET INCOME (LOSS):
As reported......................................... $ (151) $ (59) $ 49
Deduct: Total stock-based employee compensation
expense determined using the Black-Scholes option-
pricing model for all awards, net of tax.......... (7) (8) (7)
------ ------ -----
Pro forma........................................... (158) (67) 42
EARNINGS (LOSS) PER SHARE:
Basic--as reported.................................. $(1.44) $(0.57) $0.46
Basic--pro forma.................................... $(1.51) $(0.64) $0.40
Diluted--as reported................................ $(1.44) $(0.57) $0.46
Diluted--pro forma.................................. $(1.51) $(0.64) $0.39
Compensation expense resulting from the fair value method of SFAS
No. 123 may not be representative of compensation expense to be incurred
on a pro forma basis in future years. The fair value of each option
grant is estimated on the date of grant by use of the Black-Scholes
option-pricing model.
The following weighted-average assumptions were used for grants of
Solutia options in 2002, 2001 and 2000:
2002 2001 2000
---- ---- ----
Expected dividend yield..................................... 0.4% 0.2% 0.2%
Expected volatility......................................... 54.7% 34.0% 34.0%
Risk-free interest rates.................................... 4.3% 5.8% 6.0%
Expected option lives (years)............................... 5.0 5.0 5.0
The weighted-average fair values of options granted were $5.08 in
2002, $5.57 in 2001 and $5.30 in 2000.
58
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
A summary of the status of Solutia's stock option plans for years
ended December 31, 2002, 2001 and 2000 follows:
Outstanding
---------------------------------
Exercisable Weighted-Average
Options Options Exercise Price
----------- ---------- ----------------
December 31, 1999........................ 18,878,930 26,764,505 $15.27
---------- ---------- ------
Granted.............................. 1,912,043 $13.98
Exercised............................ (379,687) 6.74
Expired.............................. (1,283,570) 17.21
---------- ---------- ------
December 31, 2000........................ 23,613,549 27,013,291 $15.21
---------- ---------- ------
Granted.............................. 1,762,417 $13.68
Exercised............................ (1,796,038) 6.14
Expired.............................. (1,278,689) 16.32
---------- ---------- ------
December 31, 2001........................ 22,015,711 25,700,981 $15.68
---------- ---------- ------
Granted.............................. 1,597,633 $10.23
Exercised............................ (365,394) 5.57
Expired.............................. (1,582,710) 15.99
---------- ---------- ------
DECEMBER 31, 2002........................ 21,712,940 25,350,510 $15.47
========== ========== ======
The following table summarizes information about stock options
outstanding at December 31, 2002:
OPTIONS OUTSTANDING:
Range of Weighted-Average
Exercise Remaining Weighted-Average
Prices Number Contractual Life Exercise Price
- ------------------------------------- ---------- ---------------- ----------------
$ 3 to 7............................. 2,271,237 1.1 $ 6.02
8 to 11............................ 1,559,246 8.9 10.30
12 to 15............................ 5,113,893 6.2 13.75
16 to 18............................ 10,203,056 4.1 16.47
19 to 22............................ 5,972,199 5.1 19.70
23 to 29............................ 230,879 5.3 27.35
---------- --- ------
$ 3 to 29............................ 25,350,510 4.8 $15.47
========== === ======
OPTIONS EXERCISABLE:
Range of Weighted-Average
Exercise Prices Number Exercise Price
- -------------------------------------------------------- ---------- ----------------
$ 3 to 7................................................ 2,257,604 $ 6.03
8 to 11............................................... 34,078 10.58
12 to 15............................................... 3,421,524 13.71
16 to 18............................................... 10,203,056 16.47
19 to 22............................................... 5,565,799 19.66
23 to 29............................................... 230,879 27.35
---------- ------
$ 3 to 29............................................... 21,712,940 $15.87
========== ======
16. CAPITAL STOCK
Solutia's board of directors declared a dividend of one preferred
stock purchase right for each share of Solutia's common stock issued in
the distribution of shares by Monsanto to its shareholders on the effective
date of the spinoff and authorized the issuance of one right for each share
of common stock issued after the effective date of the spinoff until the
earlier of the date the rights become exercisable and the
59
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
termination date of the rights plan. If a person or group acquires
beneficial ownership of 20 percent or more, or announces a tender offer
that would result in beneficial ownership of 20 percent or more, of
Solutia's outstanding common stock, the rights become exercisable. Then,
for every right held, the owner will be entitled to purchase one
one-hundredth of a share of a series of preferred stock for $125. If
Solutia is acquired in a business combination transaction while the
rights are outstanding, for every right held, the holder will be
entitled to purchase, for $125, common shares of the acquiring company
having a market value of $250. In addition, if a person or group
acquires beneficial ownership of 20 percent or more of Solutia's
outstanding common stock, for every right held, the holder (other than
such person or members of such group) will be entitled to purchase, for
$125, a number of shares of Solutia's common stock having a market value
of $250. Furthermore, at any time after a person or group acquires
beneficial ownership of 20 percent or more (but less than 50 percent) of
Solutia's outstanding common stock, Solutia's board of directors may, at
its option, exchange part or all of the rights (other than rights held
by the acquiring person or group) for shares of Solutia's common stock
on a one-share-for-every-one-right basis. At any time prior to the
acquisition of such a 20 percent position, Solutia can redeem each right
for $0.01. The board of directors is also authorized to reduce the
aforementioned 20 percent thresholds to not less than 10 percent. The
rights expire in the year 2007.
The Company has 10 million shares of preferred stock, par value
$0.01 per share, authorized. As of December 31, 2002, there were no
preferred shares issued or outstanding.
17. COMMITMENTS AND CONTINGENCIES
Commitments, principally in connection with uncompleted additions to
property, were approximately $7 million at December 31, 2002. Solutia
was contingently liable as a guarantor principally in connection with
bank loans totaling approximately $9 million in 2001. In addition, as of
December 31, 2002, the Company was contingently liable under letters of
credit, primarily related to environmental remediation, totaling
$128 million, $11 million of which were cash collaterized. Solutia
collaterized an additional $39 million of letters of credit on January 31,
2003, with proceeds from the divestiture of the resins, additives
and adhesives businesses. Solutia's future minimum payments under
noncancelable operating leases and unconditional purchase obligations
are $25 million for 2003, $26 million for 2004, $20 million for 2005,
$17 million for 2006, $50 million for 2007, and $66 million thereafter.
Solutia has entered into agreements with certain customers to supply
a guaranteed quantity of certain products annually at prices specified
in the agreements. In return, the customers have advanced funds to
Solutia to cover the costs of expanding capacity to provide the
guaranteed supply. Solutia has recorded the advances as deferred credits
and amortizes the amounts to income as the customers purchase the
products. The unamortized deferred credits were approximately
$161 million at December 31, 2002, and approximately $175 million at
December 31, 2001.
The more significant concentrations in Solutia's trade receivables
at year-end were:
2002
---------------------------------------------------------
North Europe/ Latin Asia
America Africa America Pacific Total
------- ------- ------- ------- -----
Glass.................................... $11 $38 $10 $11 $70
Chemicals................................ 42 18 2 9 71
Carpet................................... 28 1 -- 1 30
2001
---------------------------------------------------------
North Europe/ Latin Asia
America Africa America Pacific Total
------- ------- ------- ------- -----
Glass.................................... $12 $37 $10 $ 9 $68
Chemicals................................ 27 16 2 12 57
Carpet................................... 32 1 -- -- 33
Management does not anticipate losses on its trade receivables in
excess of established allowances.
Off-Balance Sheet Arrangements
In 1993, a co-generation facility was constructed at the Pensacola,
Florida manufacturing site to provide the plant with electricity and
steam. Solutia financed the construction by placing the co-generation
facility in a trust that was funded by a syndicate of commercial banks.
This arrangement enabled the Company to lease the facility rather than
acquire it. Solutia makes operating lease payments of approximately
$2 million annually and the lease term is co-terminous with the Amended
Credit Facility. As required by the Amended Credit
60
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Facility, Solutia used a portion of the expected proceeds from the sale
of the resins, additives and adhesives businesses to purchase the co-
generation facility from the trust for approximately $32 million during
the first quarter of 2003.
In 1999, the Company's corporate headquarters office building was
constructed in St. Louis, Missouri. Solutia financed the construction of
the building by placing the facility in a trust that was funded by a
syndicate of financial institutions. This arrangement enabled the
Company to lease the facility rather than acquire it. Solutia makes
operating lease payments of approximately $3 million annually. The lease
term expires in August 2007 at which time the Company has the option to
refinance the building through a similar lease arrangement, purchase the
building from the trust for the lease balance of approximately
$43 million or sell the building on behalf of the trust and deliver the
proceeds to the trust. Solutia has provided the trust a residual value
guaranty of approximately $35 million in the event that the building is
sold for less than the lease balance or cannot be sold. Although current
commercial real estate values in St. Louis, Missouri metropolitan area
have declined recently because of the general weakening of the economy
in the United States, the Company estimates that the fair value of the
building exceeds the residual value guaranty and will continue to do so
in the foreseeable future. As a result, the Company does not expect this
guarantee to have a financial statement impact. The Company intends to
refinance the building with a similar leasing arrangement when the
current lease expires. Based on the terms of the lease agreements and
the residual value guarantee Solutia provides to the trust, the Company
expects to be the primary beneficiary. As a result, Solutia would be
required to consolidate the assets and liabilities held by the trust in
the third quarter of 2003.
Contingencies
In connection with the completion of the external financing
agreement for Astaris, which expires in September of 2005, Solutia and
its equal partner in the venture, FMC Corporation, contractually agreed
to provide Astaris with funding in the event the joint venture fails to
meet certain financial benchmarks. The financial benchmarks were based
on forecasted earnings that were developed when the joint venture was
formed in April 2000. Astaris' earnings have fallen short of the
forecast underlying its external financing agreement due to numerous
factors including significantly less than planned utilization of its
purified wet acid technology, lower sales volumes and lower average
selling prices due to the prolonged weak U.S. economy. As a result of
these earnings shortfalls versus the original expectations developed at
the time the venture was formed, Solutia has been required to make
additional investments of $30 million in 2002 and $31 million in 2001 to
the joint venture. These payments have largely been used to reduce debt
outstanding within the venture. At December 31, 2002, net debt (total
debt less cash) for Astaris totaled $160 million, $59 million lower than
net debt at the end of the prior year. Solutia and FMC are evaluating
other financing alternatives for the joint venture. However, if no new
financing arrangements are in place for 2003, Solutia anticipates
required contributions of approximately $50 million for 2003.
Contributions are recorded in the Investments in Affiliates line on the
Statement of Consolidated Financial Position.
The Statement of Consolidated Financial Position included accrued
liabilities of $146 million at December 31, 2002, and $165 million at
December 31, 2001, for the remediation of identified waste disposal
sites. Expenditures related to remediation activities were $26 million
in 2002, $40 million in 2001, and $26 million in 2000. Solutia expects
to incur expenditures in the range of $30 million to $40 million
annually for remediation activities for the foreseeable future.
Uncertainties related to recorded environmental liabilities include
changing governmental policy and regulations, judicial proceedings, the
method and extent of remediation and future changes in technology. The
Company believes that these matters, when ultimately resolved, which may
be over an extended period of time, will not have a material adverse
effect on the consolidated financial position or liquidity, but could
have a material adverse effect on net income in any given period.
Mortgages on the plants located in Decatur, Alabama; Springfield,
Massachusetts; Trenton, Michigan; Greenwood, South Carolina; Alvin
(Chocolate Bayou), Texas; Pensacola, Florida; and Martinsville, Virginia
constitute a portion of the collateral securing the Amended Credit
Facility, publicly issued debt, and obligations under certain other
financing facilities. In addition, there is a mechanics' lien filed by
Fluor Daniel, a division of Fluor Enterprises, Inc., against the
Chocolate Bayou facility, currently in the amount of $10 million,
securing the remaining payments the Company has agreed to make to Fluor
Daniel over a three-year period in settlement of litigation arising out
of the construction of an acrylonitrile facility at the Chocolate Bayou
plant.
As discussed in Item 3 to this report, because of the size and
nature of its business, Solutia is a party to numerous legal
proceedings. Most of these proceedings have arisen in the ordinary
course of business and involve claims for money damages. In addition, at
the time we became an independent company, we assumed liabilities
related to specified legal proceedings from the former Monsanto Company
(now known as Pharmacia Corporation), under an agreement known as the
Distribution Agreement. As a result, although Monsanto remains the named
defendant, the Company is required to manage the litigation and
indemnify Monsanto for costs, expenses and judgments arising from the
litigation. While the results of litigation cannot be predicted with
certainty, the Company does not believe, based on currently available
facts, that the ultimate resolution of any of these preceding matters
will have a material adverse effect on our financial position or
61
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
liquidity in any one year. However, resolution in those cases described
below involving the alleged discharge of polychlorinated biphenyls
("PCBs") from the Anniston, Alabama plant site and the Penndot case,
also described below, may have a material adverse effect on net income
in a given year, although it is impossible at this time to estimate the
range or amount of any such liability. In addition, there cannot be any
assurance that any final judgment against the Company in the Anniston,
Alabama cases, if upheld on appeal, will not have a material adverse
effect on financial position and liquidity.
Monsanto manufactured PCBs at the Anniston, Alabama plant from 1935
to 1971. Solutia is defending a number of actions in state and federal
court in Alabama relating to the alleged emission of PCBs and other
allegedly hazardous materials from that plant. Plaintiffs claim to
suffer from various personal injuries and are allegedly fearful of
future illness. Some claim property damage. To date we have settled
approximately 5,900 PCB claims relating to Anniston. Four cases
originally filed on behalf of approximately 3,500 plaintiffs were
consolidated and a trial of the claims of 16 individuals and one
business from that group of plaintiffs is in progress. Plaintiffs in the
current trial are claiming property damage and mental anguish and are
seeking compensatory and punitive damages and injunctive relief. The
jury in that case has returned a verdict finding Solutia liable to
plaintiffs on theories of negligence, wantonness, suppression of the
truth, nuisance, trespass and outrage. The issue of damages has not yet
been submitted to the jury. The jury also determined that the
circumstances in Anniston constitute a public nuisance. The Alabama
Attorney General and the District Attorneys in four counties around
Anniston intervened in this matter as plaintiffs for the public nuisance
count. They seek an order compelling Solutia to pay for a study of the
impact of PCBs in the area, and formulating a plan and setting a
schedule for cleanup. In addition, the Alabama Department of
Environmental Management intervened in this matter to assure that any
decision reached has a sound scientific basis. Another Anniston case
pending in federal court in Birmingham, Alabama, filed on behalf of
1,116 minor plaintiffs, now involves approximately 17,000 adult and
minor plaintiffs. Those plaintiffs claim to suffer unspecified injuries
and assert their right to medical monitoring and testing, and seek
compensatory and punitive damages in unspecified amounts. The case will
proceed in phases, with trial of the claims of 8 Phase I plaintiffs
scheduled to begin after July 31, 2003. These cases are being vigorously
defended.
Solutia is also defending an action brought against Monsanto in the
Commonwealth Court of Pennsylvania relating to the discovery of low
levels of PCBs in the Transportation & Safety Building owned by the
Commonwealth in Harrisburg, Pennsylvania. The Commonwealth sought
recovery of costs it allegedly incurred in testing, monitoring, cleanup,
demolition and temporary relocation of Commonwealth employees allegedly
caused by the PCBs found in the building. In addition the Commonwealth
sought the cost of constructing a new building on the site of the T&S
Building. After trial a judgment was entered against Monsanto in the
amount of $59.5 million, and Solutia filed an appeal with the
Pennsylvania Supreme Court. This matter is being vigorously defended.
Liability, if any, that may result from litigation against Solutia is
not determinable. Management does not believe that the ultimate
resolution of these cases will have a material adverse impact on its
consolidated financial position or liquidity. However, it is possible
that a resolution of these cases may have a material adverse impact on
Solutia's net income in a given year, although it is impossible at this
time to estimate the range or amount of any such liability.
18. SUPPLEMENTAL DATA
Supplemental income statement data from continuing operations were:
2002 2001 2000
------ ------ ------
Raw material and energy costs........................... $1,008 $ 969 $1,045
Employee compensation and benefits...................... 693 706 746
Taxes other than income................................. 94 102 104
Rent expense............................................ 39 33 35
Provision for doubtful accounts......................... -- 11 11
Technological expenses:
Research and development............................ 39 43 57
Engineering, commercial development and patent...... 8 7 10
------ ------ ------
Total technological expenses............................ 47 50 67
Interest expense:
Total interest cost................................. 85 72 72
Less capitalized interest........................... 1 2 17
------ ------ ------
Net interest expense.................................... 84 70 55
62
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
19. SEGMENT AND GEOGRAPHIC DATA
In anticipation of the divestiture of the resins, additives and
adhesives businesses, Solutia reorganized its management structure and
realigned its reportable segments during the fourth quarter of 2002.
Solutia's new reportable segments and their major products are as
follows:
PERFORMANCE PRODUCTS AND SERVICES INTEGRATED NYLON
- ------------------------------------------------------------- ------------------------------------------------------------
SAFLEX(R) plastic interlayer Nylon intermediate "building block" chemicals
Polyvinyl butyral for KEEPSAFE(R), SAFLEX INSIDE(R) (in Merchant polymer and nylon extrusion polymers, including
Europe only) and KEEPSAFE MAXIMUM(R) laminated window VYDYNE(R) and ASCEND(R)
glass
LLUMAR(R), VISTA(R) and GILA(R) professional and retail Carpet fibers, including the WEAR-DATED(R) and ULTRON(R)
window films brands
VANCEVA(TM) films Industrial nylon fibers
Conductive and anti-reflective coated films and deep-dyed ACRILAN(R) acrylic fibers for apparel, upholstery fabrics,
films craft yarns and other applications
Industrial products, including THERMINOL(R) heat transfer
fluids, DEQUEST(R) water treatment chemicals, SKYDROL(R)
aviation hydraulic fluids, SKYKLEEN(R) aviation solvents,
and chlorobenzenes
Services for process research and development, scale-up
manufacturing and small volume licensed production for the
pharmaceutical industry
Solutia evaluates the performance of its operating segments based on
segment earnings before interest expense and income taxes (EBIT), which
includes marketing, administrative, technological, and amortization
expenses and other restructuring and asset impairment charges that can
be directly attributable to the segment profit/(loss). Certain expenses
and other items that are managed outside of the segments are excluded.
These unallocated items consist primarily of corporate expenses, equity
earnings (loss) from affiliates, interest expense, other income--net and
expense items, gains and losses from asset dispositions and
restructuring charges that are not directly attributable to the
operating segment.
Solutia's 2002, 2001 and 2000 segment information follows:
Year Ended December 31,
---------------------------------------------------------------------------------------
2002 2001 2000
------------------------- ------------------------- -------------------------
Inter- Inter- Inter-
Net segment Net segment Net segment
Sales Sales Profit Sales Sales Profit Sales Sales Profit
------ ------- ------ ------ ------- ------ ------ ------- ------
SEGMENT:
Performance Products and
Services.................... $ 945 $-- $ 78 $ 960 $-- $ 77 $1,128 $ 1 $ 111
Integrated Nylon.............. 1,296 -- 24 1,308 -- 6 1,490 -- (33)
------ --- ----- ------ --- ----- ------ --- -----
SEGMENT TOTALS.................... 2,241 -- 102 2,268 -- 83 2,618 1 78
RECONCILIATION TO CONSOLIDATED
TOTALS:
Sales eliminations............ (1) (1)
Corporate expenses............ (61) (121) (115)
Equity earnings (loss) from
affiliates.................. 14 (13) 37
Interest expense.............. (84) (70) (55)
Gain on sale of Polymer
Modifiers business.......... -- -- 73
Other income (expense)--net... 10 (3) 12
------ --- ------ --- ------ ---
CONSOLIDATED TOTALS:
NET SALES..................... $2,241 $-- $2,268 $-- $2,617 $--
====== === ----- ====== === ----- ====== === -----
INCOME (LOSS) BEFORE INCOME
TAXES....................... $ (19) $(124) $ 30
===== ===== =====
63
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Year Ended December 31,
--------------------------------------------------------------------
2002 2001
------------------------------- -------------------------------
Capital Depreciation Capital Depreciation
Expen- and Expen- and
Assets ditures Amortization Assets ditures Amortization
------ ------- ------------ ------ ------- ------------
SEGMENT:
Performance Products and
Services........................ $ 923 $35 $ 50 $ 889 $ 63 $ 56
Integrated Nylon.................. 882 21 79 901 20 83
------ --- ---- ------ ---- ----
SEGMENT TOTALS..................... $1,805 $56 $129 $1,790 $ 83 $139
RECONCILIATION TO CONSOLIDATED
TOTALS:
Unallocated amounts............... 901 3 5 877 - 4
------ --- ---- ------ ---- ----
CONSOLIDATED TOTALS................ $2,706 $59 $134 $2,667 $ 83 $143
====== === ==== ====== ==== ====
Year Ended December 31,
-------------------------------
2000
-------------------------------
Capital Depreciation
Expen- and
Assets ditures Amortization
------ ------- ------------
SEGMENT:
Performance Products and
Services........................ $ 904 $ 49 $ 66
Integrated Nylon.................. 1,102 159 83
------ ---- ----
SEGMENT TOTALS..................... $2,006 $208 $149
RECONCILIATION TO CONSOLIDATED
TOTALS:
Unallocated amounts............... 749 3 3
------ ---- ----
CONSOLIDATED TOTALS................ $2,755 $211 $152
====== ==== ====
Solutia's geographic information for 2002, 2001 and 2000 follows:
Net Sales Long-Lived Assets
-------------------------------- -------------------
2002 2001 2000 2002 2001
------ ------ ------ ------ ------
U.S..................................................... $1,382 $1,465 $1,803 $ 777 $ 824
Other countries......................................... 859 803 814 153 136
------ ------ ------ ------ ------
CONSOLIDATED TOTALS..................................... $2,241 $2,268 $2,617 $ 930 $ 960
====== ====== ====== ====== ======
64
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
20. QUARTERLY DATA--UNAUDITED
First Second Third Fourth Total
Quarter Quarter Quarter Quarter Year
------- ------- ------- ------- ------
Net Sales from Continuing Operations......... 2002 $ 520 $ 585 $ 574 $ 562 $2,241
Net Sales from Discontinued Operations....... 2002 $ 134 $ 151 $ 144 $ 130 $ 559
Net Sales Previously Reported on Form 10-Q... 2002 $ 654 $ 736 $ 718 $ 692 $2,800
Net Sales from Continuing Operations......... 2001 $ 594 $ 594 $ 562 $ 518 $2,268
Net Sales from Discontinued Operations....... 2001 $ 153 $ 143 $ 128 $ 125 $ 549
Net Sales Previously Reported on Form 10-Q... 2001 $ 747 $ 737 $ 690 $ 643 $2,817
Gross Profit from Continuing Operations...... 2002 87 96 86 94 363
Gross Profit from Discontinued Operations.... 2002 35 41 34 21 131
Gross Profit Previously Reported on Form 10-Q 2002 122 137 120 115 494
Gross Profit from Continuing Operations...... 2001 93 98 104 15 310
Gross Profit from Discontinued Operations.... 2001 35 30 25 29 119
Gross Profit Previously Reported on Form 10-Q 2001 128 128 129 44 429
Income (Loss) before Discontinued Operations
and Cumulative Effect of Change in
Accounting Principle....................... 2002 4 11 (6) (17) (8)
Income from Discontinued Operations.......... 2002 10 12 6 (4) 24
Income (Loss) before Cumulative Effect of
Change in Accounting Principle............. 2002 14 23 -- (21) 16
Income (Loss) before Discontinued Operations
and Cumulative Effect of Change in
Accounting Principle....................... 2001 5 8 8 (102) (81)
Income from Discontinued Operations.......... 2001 17 5 (1) 1 22
Income (Loss) before Cumulative Effect of
Change in Accounting Principle............. 2001 22 13 7 (101) (59)
Basic Earnings (Loss) per Share.............. 2002 0.13 0.22 -- (0.20) 0.15
2001 0.21 0.13 0.07 (0.97) (0.57)
Diluted Earnings (Loss) per Share............ 2002 0.13 0.22 -- (0.20) 0.15
2001 0.21 0.12 0.07 (0.97) (0.57)
Net Income (Loss)............................ 2002 (153) 23 -- (21) (151)
2001 22 13 7 (101) (59)
Common Stock Price:
2002..................................... HIGH 13.20 8.92 7.10 5.95 13.20
LOW 6.12 7.10 4.51 2.81 2.81
2001..................................... High 14.85 15.07 14.14 14.28 15.07
Low 12.06 12.03 11.25 11.71 11.25
Net loss in the first quarter of 2002 includes an aftertax gain of
$3 million from the sale of the Company's 50 percent interest in the
Advanced Elastomer Systems joint venture. Net income in the third
quarter of 2002 includes aftertax charges of $3 million related to the
resolution of a construction dispute with the contractor of the
acrylonitrile plant in Alvin, (Chocolate Bayou) Texas and an aftertax
charge of $8 million for a non-cash pension settlement loss because of
the significant amount of lump sum distributions from the pension plan.
Net loss in the fourth quarter of 2002 includes $4 million of charges
for the Flexsys joint venture related to the write-down of production
assets to fair market value at its Nitro, West Virginia, facility, and
an aftertax charge of $3 million for a non-cash pension settlement loss
because of the significant amount of lump sum distributions from the
pension plan.
Net loss in the fourth quarter of 2001 includes aftertax charges of
$96 million to cover Solutia's share of restructuring costs at its
Astaris and Flexsys joint ventures, increases to environmental and
self-insurance reserves, additional severance costs and the write down
of certain non-performing assets.
65
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Under SFAS No. 128, "Earnings per Share," the quarterly and total
year calculations of basic and diluted earnings (loss) per share are
based on weighted average shares outstanding for that quarterly or total
year period, respectively. As a result, the sum of diluted earnings
(loss) per share for the quarterly periods may not equal total year
earnings (loss) per share.
21. CONSOLIDATING CONDENSED FINANCIAL STATEMENTS
CPFilms, Inc., Monchem International, Inc., Monchem, Inc., and
Solutia Systems, Inc., wholly-owned subsidiaries of the Company (the
"Guarantors"), are guarantors of the Amended Credit Facility and the
Notes (see Note 11). The Guarantors fully and unconditionally guarantee
the Notes on a joint and several basis. The following consolidating
condensed financial statements present, in separate columns, financial
information for: Solutia Inc. on a parent only basis carrying its
investment in subsidiaries under the equity method; Guarantors on a
combined, or where appropriate, consolidated basis, carrying investments
in subsidiaries who do not guarantee the debt (the "Non-Guarantors")
under the equity method; Non-Guarantors on a combined, or where
appropriate, consolidated basis; eliminating adjustments; and
consolidated totals as of December 31, 2002 and December 31, 2001, and
for the years ended December 31, 2002, 2001 and 2000. The eliminating
adjustments primarily reflect intercompany transactions, such as
interest income and expense, accounts receivable and payable, advances,
short and long-term debt, royalties and profit in inventory
eliminations. The Company has not presented separate financial
statements and other disclosures concerning the Guarantors as such
information is not material and would substantially duplicate
disclosures included elsewhere in this report.
66
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
CONSOLIDATING STATEMENT OF LOSS
TWELVE MONTHS ENDED DECEMBER 31, 2002
(DOLLARS IN MILLIONS)
Parent Only Non- Consolidated
Solutia Inc. Guarantors Guarantors Eliminations Solutia Inc.
------------ ---------- ---------- ------------ ------------
NET SALES............................ $1,723 $ 153 $ 661 $(296) $2,241
Cost of goods sold................... 1,583 64 541 (310) 1,878
------ ----- ----- ----- ------
GROSS PROFIT......................... 140 89 120 14 363
Marketing expenses................... 103 19 25 -- 147
Administrative expenses.............. 91 7 30 -- 128
Technological expenses............... 43 2 2 -- 47
Amortization expense................. -- -- 3 -- 3
------ ----- ----- ----- ------
OPERATING INCOME (LOSS).............. (97) 61 60 14 38
Equity earnings (loss) from
affiliates--net of tax............. (36) (173) -- 222 13
Interest expense..................... (148) (8) (123) 195 (84)
Other income--net.................... 22 102 84 (194) 14
------ ----- ----- ----- ------
INCOME (LOSS) BEFORE INCOME TAXES.... (259) (18) 21 237 (19)
Income taxes (benefit)............... (86) 54 25 (4) (11)
------ ----- ----- ----- ------
LOSS FROM CONTINUING OPERATIONS
BEFORE CUMULATIVE EFFECT OF CHANGE
IN ACCOUNTING PRINCIPLE............ (173) (72) (4) 241 (8)
Income from Discontinued Operations,
net of tax......................... 24 59 57 (116) 24
Cumulative Effect of Change in
Accounting Principle............... (2) -- (165) -- (167)
------ ----- ----- ----- ------
NET LOSS............................. $ (151) $ (13) $(112) $ 125 $ (151)
====== ===== ===== ===== ======
CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)
TWELVE MONTHS ENDED DECEMBER 31, 2002
(DOLLARS IN MILLIONS)
Parent Only Non- Consolidated
Solutia Inc. Guarantors Guarantors Eliminations Solutia Inc.
------------ ---------- ---------- ------------ ------------
NET LOSS............................. $(151) $(13) $(112) $ 125 $(151)
OTHER COMPREHENSIVE INCOME (LOSS):
Currency translation adjustments..... 119 122 20 (142) 119
Net unrealized loss on derivative
instruments, net of tax............ 1 -- -- -- 1
Minimum pension liability
adjustments, net of tax............ (122) -- (11) 11 (122)
----- ---- ----- ----- -----
COMPREHENSIVE INCOME (LOSS).......... $(153) $109 $(103) $ (6) $(153)
===== ==== ===== ===== =====
67
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
CONSOLIDATING STATEMENT OF INCOME (LOSS)
TWELVE MONTHS ENDED DECEMBER 31, 2001
(DOLLARS IN MILLIONS)
Parent Only Non- Consolidated
Solutia Inc. Guarantors Guarantors Eliminations Solutia Inc.
------------ ---------- ---------- ------------ ------------
NET SALES............................ $1,773 $ 145 $ 664 $(314) $2,268
Cost of goods sold................... 1,678 63 546 (329) 1,958
------ ----- ----- ----- ------
GROSS PROFIT......................... 95 82 118 15 310
Marketing expenses................... 113 17 12 -- 142
Administrative expenses.............. 95 7 40 -- 142
Technological expenses............... 45 2 3 -- 50
Amortization expense................. -- 6 6 -- 12
------ ----- ----- ----- ------
OPERATING INCOME (LOSS).............. (158) 50 57 15 (36)
Equity earnings (loss) from
affiliates--net of tax............. 122 8 (4) (139) (13)
Interest expense..................... (132) (7) (140) 209 (70)
Other income (expense)--net.......... (19) 127 111 (224) (5)
------ ----- ----- ----- ------
INCOME (LOSS) BEFORE INCOME TAXES.... (187) 178 24 (139) (124)
Income taxes (benefit)............... (106) 54 9 -- (43)
------ ----- ----- ----- ------
INCOME (LOSS) FROM CONTINUING
OPERATIONS......................... (81) 124 15 (139) (81)
Income from Discontinued Operations,
net of tax......................... 22 45 45 (90) 22
------ ----- ----- ----- ------
NET INCOME (LOSS).................... $ (59) $ 169 $ 60 $(229) $ (59)
====== ===== ===== ===== ======
CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)
TWELVE MONTHS ENDED DECEMBER 31, 2001
(DOLLARS IN MILLIONS)
Parent Only Non- Consolidated
Solutia Inc. Guarantors Guarantors Eliminations Solutia Inc.
------------ ---------- ---------- ------------ ------------
NET INCOME (LOSS).................... $(59) $169 $ 60 $(229) $(59)
OTHER COMPREHENSIVE INCOME (LOSS):
Currency translation adjustments..... (37) (45) (12) 57 (37)
Cumulative effect of accounting
change, net of tax................. 2 -- -- -- 2
Net loss on derivative instruments,
net of tax......................... (3) -- -- -- (3)
Minimum pension liability
adjustments, net of tax............ 2 -- -- -- 2
---- ---- ---- ----- ----
COMPREHENSIVE INCOME (LOSS).......... $(95) $124 $ 48 $(172) $(95)
==== ==== ==== ===== ====
68
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
CONSOLIDATING STATEMENT OF INCOME
TWELVE MONTHS ENDED DECEMBER 31, 2000
(DOLLARS IN MILLIONS)
Parent Only Non- Consolidated
Solutia Inc. Guarantors Guarantors Eliminations Solutia Inc.
------------ ---------- ---------- ------------ ------------
NET SALES............................ $2,114 $144 $675 $(316) $2,617
Cost of goods sold................... 1,999 53 548 (331) 2,269
------ ---- ---- ----- ------
GROSS PROFIT......................... 115 91 127 15 348
Marketing expenses................... 130 15 (10) (1) 134
Administrative expenses.............. 84 7 60 -- 151
Technological expenses............... 47 2 18 -- 67
Amortization expense................. (21) 6 29 (3) 11
------ ---- ---- ----- ------
OPERATING INCOME (LOSS).............. (125) 61 30 19 (15)
Equity earnings (loss) from
affiliates--net of tax............. 135 (58) (9) (32) 35
Interest expense..................... (112) (9) (141) 207 (55)
Gain on sale of Polymer Modifiers
business........................... 73 -- -- -- 73
Other income--net.................... (11) 137 86 (221) (8)
------ ---- ---- ----- ------
INCOME (LOSS) BEFORE INCOME TAXES.... (40) 131 (34) (27) 30
Income taxes (benefit)............... (76) 44 27 (1) (6)
------ ---- ---- ----- ------
INCOME (LOSS) FROM CONTINUING
OPERATIONS......................... 36 87 (61) (26) 36
Income from Discontinued Operations,
net of tax......................... 13 97 98 (195) 13
------ ---- ---- ----- ------
NET INCOME........................... $ 49 $184 $ 37 $(221) $ 49
====== ==== ==== ===== ======
CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS)
TWELVE MONTHS ENDED DECEMBER 31, 2000
(DOLLARS IN MILLIONS)
Parent Only Non- Consolidated
Solutia Inc. Guarantors Guarantors Eliminations Solutia Inc.
------------ ---------- ---------- ------------ ------------
NET INCOME........................... $ 49 $184 $ 37 $(221) $ 49
OTHER COMPREHENSIVE INCOME (LOSS):
Currency translation adjustments..... (86) (76) (28) 104 (86)
Minimum pension liability
adjustments, net of tax............ 7 -- -- -- 7
---- ---- ---- ----- ----
COMPREHENSIVE INCOME (LOSS).......... $(30) $108 $ 9 $(117) $(30)
==== ==== ==== ===== ====
69
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
CONSOLIDATING BALANCE SHEET
DECEMBER 31, 2002
(DOLLARS IN MILLIONS)
Parent Only Non- Consolidated
Solutia Inc. Guarantors Guarantors Eliminations Solutia Inc.
------------ ---------- ---------- ------------ ------------
ASSETS
CURRENT ASSETS:
Cash and cash equivalents............ $ -- $ -- $ 17 $ -- $ 17
Trade receivables, net............... 12 146 112 -- 270
Intercompany receivables............. 28 567 357 (952) --
Miscellaneous receivables............ 69 -- 28 -- 97
Prepaid expenses..................... 14 1 2 -- 17
Deferred income tax benefit.......... 82 -- 19 7 108
Inventories.......................... 167 23 92 (20) 262
Current Assets--Discontinued
Operations......................... 85 10 541 -- 636
------ ------ ------ ------- ------
TOTAL CURRENT ASSETS......... 457 747 1,168 (965) 1,407
PROPERTY, PLANT AND EQUIPMENT:
Land................................. 17 -- 2 -- 19
Buildings............................ 266 25 84 -- 375
Machinery and equipment.............. 2,482 71 393 -- 2,946
Construction in progress............. 15 1 10 -- 26
------ ------ ------ ------- ------
Total property, plant and
equipment.......................... 2,780 97 489 -- 3,366
Less accumulated depreciation........ 2,082 19 335 -- 2,436
------ ------ ------ ------- ------
NET PROPERTY, PLANT AND EQUIPMENT.... 698 78 154 -- 930
INVESTMENTS IN AFFILIATES............ 2,990 33 30 (2,821) 232
GOODWILL............................. -- 72 72 -- 144
IDENTIFIED INTANGIBLE ASSETS, NET.... 3 26 37 -- 66
LONG-TERM DEFERRED INCOME TAX
BENEFIT............................ 278 -- 12 -- 290
INTERCOMPANY ADVANCES................ 128 2,126 1,461 (3,715) --
OTHER ASSETS......................... 241 1 31 -- 273
------ ------ ------ ------- ------
TOTAL ASSETS................. $4,795 $3,083 $2,965 $(7,501) $3,342
====== ====== ====== ======= ======
LIABILITIES AND SHAREHOLDERS' EQUITY
(DEFICIT)
CURRENT LIABILITIES:
Accounts payable..................... $ 191 $ 8 $ 35 $ -- $ 234
Intercompany payables................ 463 152 337 (952) --
Wages and benefits................... 20 -- 22 -- 42
Postretirement liabilities........... 92 -- 1 -- 93
Miscellaneous accruals............... 179 10 125 -- 314
Short-term debt...................... 233 -- 125 -- 358
Intercompany short-term debt......... 201 23 268 (492) --
Current Liabilities--Discontinued
Operations......................... 33 -- 132 -- 165
------ ------ ------ ------- ------
TOTAL CURRENT LIABILITIES............ 1,412 193 1,045 (1,444) 1,206
LONG-TERM DEBT....................... 630 -- 209 -- 839
INTERCOMPANY LONG-TERM DEBT.......... 1,586 98 1,539 (3,223) --
POSTRETIREMENT LIABILITIES........... 1,137 -- 27 -- 1,164
OTHER LIABILITIES.................... 279 -- 104 (1) 382
SHAREHOLDERS' EQUITY (DEFICIT):
Common stock......................... 1 -- -- -- 1
Additional contributed capital... 19 -- -- -- 19
Treasury stock................... (251) -- -- -- (251)
Net (deficiency) excess of assets
at spinoff and
subsidiary capital............. (113) 2,792 41 (2,833) (113)
Accumulated other comprehensive
loss............................... (146) -- -- -- (146)
Reinvested earnings.................. 241 -- -- -- 241
------ ------ ------ ------- ------
TOTAL SHAREHOLDERS' EQUITY
(DEFICIT).......................... (249) 2,792 41 (2,833) (249)
------ ------ ------ ------- ------
TOTAL LIABILITIES AND SHAREHOLDERS'
EQUITY (DEFICIT)................... $4,795 $3,083 $2,965 $(7,501) $3,342
====== ====== ====== ======= ======
70
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
CONSOLIDATING BALANCE SHEET
DECEMBER 31, 2001
(DOLLARS IN MILLIONS)
Parent Only Non- Consolidated
Solutia Inc. Guarantors Guarantors Eliminations Solutia Inc.
------------ ---------- ---------- ------------ ------------
ASSETS
CURRENT ASSETS:
Cash and cash equivalents............ $ 3 $ 1 $ 19 $ -- $ 23
Trade receivables, net............... (10) 172 102 -- 264
Intercompany receivables............. 2,899 3,354 133 (6,386) --
Miscellaneous receivables............ 76 -- 24 -- 100
Prepaid expenses..................... 12 -- 3 -- 15
Deferred income tax benefit.......... 95 -- 21 7 123
Inventories.......................... 148 22 90 (18) 242
Current Assets--Discontinued
Operations......................... 18 7 129 -- 154
------ ------ ------ -------- ------
TOTAL CURRENT ASSETS................. 3,241 3,556 521 (6,397) 921
PROPERTY, PLANT AND EQUIPMENT:
Land................................. 18 -- -- -- 18
Buildings............................ 268 22 72 -- 362
Machinery and equipment.............. 2,453 52 341 -- 2,846
Construction in progress............. 18 19 10 -- 47
------ ------ ------ -------- ------
Total property, plant and
equipment.......................... 2,757 93 423 -- 3,273
Less accumulated depreciation........ 2,010 14 289 -- 2,313
------ ------ ------ -------- ------
NET PROPERTY, PLANT AND EQUIPMENT.... 747 79 134 -- 960
INVESTMENTS IN AFFILIATES............ 3,139 206 26 (3,058) 313
GOODWILL, NET........................ -- 72 54 -- 126
IDENTIFIED INTANGIBLE ASSETS, NET.... 3 26 35 -- 64
LONG-TERM DEFERRED INCOME TAX
BENEFIT............................ 242 -- 9 -- 251
INTERCOMPANY ADVANCES................ 128 2,010 1,812 (3,950) --
LONG-TERM ASSETS--DISCONTINUED
OPERATIONS......................... 27 -- 560 -- 587
OTHER ASSETS......................... 161 -- 25 -- 186
------ ------ ------ -------- ------
TOTAL ASSETS................. $7,688 $5,949 $3,176 $(13,405) $3,408
====== ====== ====== ======== ======
LIABILITIES AND SHAREHOLDERS' EQUITY
(DEFICIT)
CURRENT LIABILITIES:
Accounts payable..................... $ 155 $ 9 $ 33 $ (2) $ 195
Intercompany payables................ 3,272 2,994 120 (6,386) --
Wages and benefits................... 22 -- 21 -- 43
Postretirement liabilities........... 81 -- 1 -- 82
Miscellaneous accruals............... 199 11 123 -- 333
Short-term debt...................... 682 -- 1 -- 683
Intercompany short-term debt......... 187 31 112 (330) --
Current Liabilities--Discontinued
Operations......................... 22 -- 58 -- 80
------ ------ ------ -------- ------
TOTAL CURRENT LIABILITIES............ 4,620 3,045 469 (6,718) 1,416
LONG-TERM DEBT....................... 448 -- 178 -- 626
INTERCOMPANY LONG-TERM DEBT.......... 1,494 45 2,080 (3,619) --
POSTRETIREMENT LIABILITIES........... 921 -- 8 -- 929
LONG-TERM LIABILITIES--DISCONTINUED
OPERATIONS......................... 5 -- 102 -- 107
OTHER LIABILITIES.................... 313 6 124 -- 443
SHAREHOLDERS' EQUITY (DEFICIT):
Common stock......................... 1 -- -- -- 1
Treasury stock................... (257) -- -- -- (257)
Net (deficiency) excess of assets
at spinoff and
subsidiary capital............. (113) 2,853 215 (3,068) (113)
Unearned ESOP shares................. (1) -- -- -- (1)
Accumulated other comprehensive
loss............................... (144) -- -- -- (144)
Reinvested earnings.................. 401 -- -- -- 401
------ ------ ------ -------- ------
TOTAL SHAREHOLDERS' EQUITY
(DEFICIT).......................... (113) 2,853 215 (3,068) (113)
------ ------ ------ -------- ------
TOTAL LIABILITIES AND SHAREHOLDERS'
EQUITY (DEFICIT)................... $7,688 $5,949 $3,176 $(13,405) $3,408
====== ====== ====== ======== ======
71
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
CONSOLIDATING CONDENSED STATEMENT OF CASH FLOWS
TWELVE MONTHS ENDED DECEMBER 31, 2002
(DOLLARS IN MILLIONS)
Parent Only Non- Consolidated
Solutia Inc. Guarantors Guarantors Eliminations Solutia Inc.
------------ ---------- ---------- ------------ ------------
CASH FROM (USED IN) OPERATIONS....... $ (72) $ 123 $ 120 $ -- $ 171
----- ----- ----- ----- -----
INVESTING ACTIVITIES:
Property, plant and equipment
purchases.......................... (36) (6) (26) -- (68)
Acquisition and investment payments,
net of cash acquired............... (37) -- -- -- (37)
Property disposals and investment
proceeds........................... 118 -- -- -- 118
----- ----- ----- ----- -----
CASH FROM (USED IN) INVESTING
ACTIVITIES......................... 45 (6) (26) -- 13
----- ----- ----- ----- -----
FINANCING ACTIVITIES:
Net change in short-term debt
obligations........................ (450) -- 123 -- (327)
Net change in long-term debt
obligations........................ 181 -- 1 -- 182
Issuance of stock warrants........... 19 -- -- -- 19
Common stock issued under employee
stock plans........................ 2 -- -- -- 2
Other financing activities........... (66) -- -- -- (66)
Changes in investments and advances
from (to) affiliates............... 338 (118) (220) -- --
----- ----- ----- ----- -----
CASH FROM (USED IN) FINANCING
ACTIVITIES......................... 24 (118) (96) -- (190)
----- ----- ----- ----- -----
DECREASE IN CASH AND CASH
EQUIVALENTS........................ (3) (1) (2) -- (6)
CASH AND CASH EQUIVALENTS:
BEGINNING OF YEAR.................... 3 1 19 -- 23
----- ----- ----- ----- -----
END OF PERIOD........................ $ -- $ -- $ 17 $ -- $ 17
===== ===== ===== ===== =====
72
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
CONSOLIDATING CONDENSED STATEMENT OF CASH FLOWS
TWELVE MONTHS ENDED DECEMBER 31, 2001
(DOLLARS IN MILLIONS)
Parent Only Non- Consolidated
Solutia Inc. Guarantors Guarantors Eliminations Solutia Inc.
------------ ---------- ---------- ------------ ------------
CASH FROM (USED IN) OPERATIONS....... $(130) $ 159 $ 16 $ (1) $ 44
----- ----- ----- ----- -----
INVESTING ACTIVITIES:
Property, plant and equipment
purchases.......................... (41) (11) (42) -- (94)
Acquisition and investment payments,
net of cash acquired............... (33) -- (2) -- (35)
Property disposals and investment
proceeds........................... 8 -- 35 -- 43
----- ----- ----- ----- -----
CASH USED IN INVESTING ACTIVITIES.... (66) (11) (9) -- (86)
----- ----- ----- ----- -----
FINANCING ACTIVITIES:
Net change in short-term debt
obligations........................ 48 -- (7) -- 41
Common stock issued under employee
stock plans........................ 13 -- -- -- 13
Deferred debt issuance costs......... (9) -- 1 -- (8)
Changes in investments and advances
from (to) affiliates............... 136 (147) 10 1 --
----- ----- ----- ----- -----
CASH FROM (USED IN) FINANCING
ACTIVITIES......................... 188 (147) 4 1 46
----- ----- ----- ----- -----
INCREASE (DECREASE) IN CASH AND CASH
EQUIVALENTS........................ (8) 1 11 -- 4
CASH AND CASH EQUIVALENTS:
BEGINNING OF YEAR.................... 11 -- 8 -- 19
----- ----- ----- ----- -----
END OF PERIOD........................ $ 3 $ 1 $ 19 $ -- $ 23
===== ===== ===== ===== =====
73
SOLUTIA INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
CONSOLIDATING CONDENSED STATEMENT OF CASH FLOWS
TWELVE MONTHS ENDED DECEMBER 31, 2000
(DOLLARS IN MILLIONS)
Parent Only Non- Consolidated
Solutia Inc. Guarantors Guarantors Eliminations Solutia Inc.
------------ ---------- ---------- ------------ ------------
CASH FROM (USED IN) OPERATIONS....... $ (90) $ 169 $ 172 $ (7) $ 244
----- ----- ----- ----- -----
INVESTING ACTIVITIES:
Property, plant and equipment
purchases.......................... (177) (11) (33) -- (221)
Acquisition and investment payments,
net of cash acquired............... (4) -- (106) -- (110)
Property disposals and investment
proceeds........................... 188 -- 32 -- 220
----- ----- ----- ----- -----
CASH FROM (USED IN) INVESTING
ACTIVITIES......................... 7 (11) (107) -- (111)
----- ----- ----- ----- -----
FINANCING ACTIVITIES:
Net change in short-term debt
obligations........................ (25) -- 3 -- (22)
Common stock issued under employee
stock plans........................ 4 -- -- -- 4
Other financing activities........... (313) -- 189 -- (124)
Changes in investments and advances
from (to) affiliates............... 294 (36) (265) 7 --
----- ----- ----- ----- -----
CASH USED IN FINANCING ACTIVITIES.... (40) (36) (73) 7 (142)
----- ----- ----- ----- -----
INCREASE (DECREASE) IN CASH AND CASH
EQUIVALENTS........................ (123) 122 (8) -- (9)
CASH AND CASH EQUIVALENTS:
BEGINNING OF YEAR.................... 134 (122) 16 -- 28
----- ----- ----- ----- -----
END OF PERIOD........................ $ 11 $ -- $ 8 $ -- $ 19
===== ===== ===== ===== =====
* * * * *
ITEM 9. CHANGES IN AND DISAGREEMENTS ON ACCOUNTING AND FINANCIAL
DISCLOSURE.
None.
74
PART III
ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT.
Information about directors and executive officers appearing under
"Election of Directors" on pages 5 through 7 of Solutia's definitive
Proxy Statement for its 2003 Annual Meeting of Stockholders, to be filed
with the SEC, is incorporated by reference. The following information
about Solutia's executive officers on March 6, 2003, is included
pursuant to Instruction 3 of Item 401(b) of Regulation S-K:
Year First
Became an
Present Position Executive
Name-Age with Registrant Officer Other Business Experience since January 1, 1998
- ----------------------------------------------------------------------------------------------------------------------------
John C. Hunter III, 56 Chairman, President, Chief 1997 President, Chief Operating Officer and Director,
Executive Officer and 1997-1999.
Director
Robert A. Clausen, 58 Vice Chairman, Chief 1997 Senior Vice President, Chief Financial Officer and
Financial Officer, Chief Advisory Director, 1997-2003.
Administrative Officer and
Director
Luc De Temmerman, 48 Vice President and General 2003 Worldwide Commercial Director for Laminated
Manager, Performance Films Glazing Products and Services, 2001-2002; Business
and Industrial Products Director, Saflex-Europe/Africa, 2000-2001;
Worldwide Director, Saflex Technology, 1997-2000.
Jeffry N. Quinn, 44 Senior Vice President, 2003 Executive Vice President, Chief Administrative
General Counsel and Officer and General Counsel, Premcor Inc.,
Secretary 2000-2002. Senior Vice President of Law and Human
Resources, Secretary and General Counsel, Arch
Coal, Inc., 1995-2000.
John F. Saucier, 49 Vice President and General 2001 Vice President, Strategic Planning, Mergers and
Manager, Integrated Nylon Acquisitions, 1997-2001.
The above listed individuals are elected to the offices set opposite
their names to hold office until their successors are duly elected and
have qualified, or until their earlier death, resignation or removal.
ITEM 11. EXECUTIVE COMPENSATION.
Information appearing under "Compensation of Directors" on page 9
and under "Summary Compensation Table," "Option Grants in 2002,"
"Aggregated Option Exercises in 2002 and Year-End Option Values,"
"Long-Term Incentive Plan--Awards in Last Fiscal Year," "Pension Plans,"
and "Agreements with Named Executive Officers" on pages 15 through 19 of
Solutia's 2003 Proxy Statement is incorporated here by reference.
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT.
Information appearing under "Ownership of Company Common Stock" on
pages 10 through 12 of Solutia's 2003 Proxy Statement is incorporated
here by reference.
75
EQUITY COMPENSATION PLAN INFORMATION
Number of Securities to be Issued Weighted-Average Exercise Price
upon Exercise of Outstanding of Outstanding Options,
Options, Warrants, and Rights Warrants, and Rights
Plan Category (a) (b)
- ------------------------------------------ --------------------------------- -------------------------------
Equity compensation plans approved by
security holders........................ 25,191,840 $15.46
Equity compensation plans not approved by
security holders(2)..................... 158,670 $16.50
Total................................. 25,350,510 $15.47
Number of Securities Remaining
Available for Future Issuance under
Equity Compensation Plans
(Excluding Securities Reflected in
Plan Category Column (a))
- ------------------------------------------ -----------------------------------
Equity compensation plans approved by
security holders........................ 2,182,968(1)
Equity compensation plans not approved by
security holders(2)..................... 65,650(3)
Total................................. 2,248,618
- --------
(1) In addition to options and stock appreciation rights, both the Solutia Inc. 2000 Stock-Based Incentive Plan
and the Solutia Inc. 1997 Stock-Based Incentive Plan provide for awards of restricted and unrestricted stock.
Of the shares remaining available for future issuance under the 2000 plan, up to 162,000 shares may be used
for awards of restricted stock. The 2000 plan does not limit the number of shares that may be used for awards
of unrestricted stock, but unrestricted shares may be awarded only in lieu of cash payments under other
incentive plans of Solutia and its subsidiaries. Because of forfeitures, 146,772 shares are available for
issuance under the 1997 plan. These may be used for awards of restricted or unrestricted stock or for stock
options.
(2) The Solutia Inc. Non-Employee Director Compensation Plan was not approved by Solutia's stockholders. This
plan authorizes the use of up to 400,000 treasury shares of Solutia common stock for non-qualified stock
options and deferred stock. Shares subject to awards that are forfeited or terminated may not be re-issued
under this plan. The participants in the plan are those directors of Solutia who are not employed by Solutia
or any subsidiary of Solutia.
Stock Options: The plan provides for an initial stock option grant on the date the director first becomes a
non-employee director. In addition, each director elected or continuing in office receives an annual stock
option grant on the date of the annual meeting of stockholders. If a director is first elected at a time
other than the date of the annual meeting, the director's annual grant for the first year is prorated to
reflect the number of months or partial months served before the next annual meeting of stockholders. The
exercise price of these options is equal to the fair market value of a share of Solutia common stock on the
grant date. The stock options become exercisable in three equal annual installments. The options have a term
of ten years but terminate two years after a director's board service ends for any reason, if earlier.
Deferred Stock: Half of a director's annual retainer is mandatorily credited to the director's deferred stock
account on a quarterly basis. The number of shares credited each quarter is determined by dividing the dollar
amount of 1/8 of the retainer by the value of a share of Solutia common stock on the first trading day in the
plan quarter. Each director may elect to receive the other half of the annual retainer in cash or to defer
all or a part into the deferred stock account, an interest-bearing cash account, or both.
(3) As described in note (2) above, the Solutia Inc. Non-Employee Director Compensation Plan authorizes deferred
stock units as well as stock options. Any of the shares remaining available for future issuance under this
plan may be used for either deferred stock units or for stock options.
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS.
None.
ITEM 14. CONTROLS AND PROCEDURES.
Within 90 days prior to the date of this report, we carried out an
evaluation, under the supervision and with the participation of our
management, including our chief executive officer and chief financial
officer, of the effectiveness of the design and operation of our
disclosure controls and procedures. Based on that evaluation, our chief
executive officer and chief financial officer concluded that our
disclosure controls and procedures are effective in timely alerting them
to material information that is required to be included in our filings
under the Securities Exchange Act of 1934.
There have not been any significant changes in our internal controls
or in other factors that could significantly affect these controls,
including any corrective actions with regard to significant deficiencies
or material weaknesses, since the date of our evaluation.
76
PART IV
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULE AND REPORTS ON FORM 8-K.
(a) Documents filed as part of this report:
1. Financial Statements--See the Index to Consolidated Financial
Statements and Financial Statement Schedule at page 34 of this
report.
2. The following supplemental schedule for the years ended
December 31, 2002, 2001 and 2000
II--Valuation and Qualifying Accounts
All other supplemental schedules are omitted because of the
absence of the conditions under which they are required.
3. Exhibits--See the Exhibit Index beginning at page 81 of this
report. For a listing of all management contracts and
compensatory plans or arrangements required to be filed as
exhibits to this report, see the exhibits listed under Exhibit
Nos. 10(a), 10(b), 10(d) through 10(n) on pages 82 and 83 of
the Exhibit Index. The following exhibits listed in the Exhibit
Index are filed with this report:
3(b) By-Laws of Solutia Inc., as amended February 26, 2003
10(k) Solutia Inc. Deferred Compensation Plan, as amended in 2002
10(r) Amendment No. 2, dated as of December 24, 2002, to Second
Amended and Restated Credit Agreement dated as of
July 25, 2002, between Solutia Inc., as Borrower, the
initial lenders named therein, Bank of America, N.A., as
Syndication Agent and Citibank, N.A., as Administrative
Agent
10(t) Amendment to Protocol Agreement, dated as of March 3, 2003,
by and among Pharmacia Corporation, Solutia Inc. and
Monsanto Company
12 Computation of the Ratio of Earnings to Fixed Charges
21 Subsidiaries of the Registrant
23 Independent Auditors' Consent
24(a) Powers of Attorney submitted by John C. Hunter III, Robert
A. Clausen, James M. Sullivan, Paul Donovan, Paul H.
Hatfield, Robert H. Jenkins, Philip R. Lochner, Jr., Frank
A. Metz, Jr., J. Patrick Mulcahy, Sally G. Narodick, William
D. Ruckelshaus and John B. Slaughter
24(b) Certified copy of board resolution authorizing Form 10-K
filing using powers of attorney
(b) Reports on Form 8-K during the quarter ended December 31, 2002:
Solutia filed a Form 8-K on November 18, 2002, to incorporate
certain audited financial statements into its filings under the
Securities Act of 1933.
Solutia filed a Form 8-K on December 3, 2002, to announce the
agreement to sell its resins, additives and adhesives businesses
to UCB S.A.
77
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused this
report to be signed on its behalf by the undersigned, thereunto duly
authorized.
SOLUTIA INC.
By: /s/ J. M. SULLIVAN
------------------------------
James M. Sullivan
Vice President and Controller
(Principal Accounting Officer)
Date: March 6, 2003
Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of
the registrant and in the capacities and on the dates indicated.
Signature Title Date
--------- ----- ----
* Chairman, President, Chief Executive Officer March 6, 2003
- --------------------------------------------- and Director (Principal Executive Officer)
John C. Hunter III
/s/ ROBERT A. CLAUSEN Vice Chairman, Chief Financial Officer, March 6, 2003
- --------------------------------------------- Chief Administrative Officer and Director
Robert A. Clausen (Principal Financial Officer)
/s/ J. M. SULLIVAN Vice President and Controller March 6, 2003
- --------------------------------------------- (Principal Accounting Officer)
James M. Sullivan
* Director March 6, 2003
- ---------------------------------------------
Paul Donovan
* Director March 6, 2003
- ---------------------------------------------
Paul H. Hatfield
* Director March 6, 2003
- ---------------------------------------------
Robert H. Jenkins
* Director March 6, 2003
- ---------------------------------------------
Philip R. Lochner, Jr.
* Director March 6, 2003
- ---------------------------------------------
Frank A. Metz, Jr.
* Director March 6, 2003
- ---------------------------------------------
J. Patrick Mulcahy
* Director March 6, 2003
- ---------------------------------------------
Sally G. Narodick
* Director March 6, 2003
- ---------------------------------------------
William D. Ruckelshaus
* Director March 6, 2003
- ---------------------------------------------
John B. Slaughter
*Jeffry N. Quinn, by signing his name hereto, does sign this document on behalf of the above noted individuals,
pursuant to powers of attorney duly executed by such individuals which have been filed as an Exhibit to this
Form 10-K.
/s/ JEFFRY N. QUINN
---------------------------------
Jeffry N. Quinn, Attorney-in-Fact
78
I, John C. Hunter III, certify that:
1. I have reviewed this annual report on Form 10-K of Solutia Inc.;
2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this annual report;
3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all
material respects the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in
this annual report;
4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
have:
a) designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this annual report is
being prepared;
b) evaluated the effectiveness of the registrant's disclosure controls
and procedures as of a date within 90 days prior to the filing date of
this annual report (the "Evaluation Date"); and
c) presented in this annual report our conclusions about the
effectiveness of the disclosure controls and procedures based on our
evaluation as of the Evaluation Date;
5. The registrant's other certifying officer and I have disclosed, based
on our most recent evaluation, to the registrant's auditors and the
audit committee of registrant's board of directors (or persons
performing the equivalent functions):
a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to
record, process, summarize and report financial data and have identified
for the registrant's auditors any material weaknesses in internal
controls; and
b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal
controls; and
6. The registrant's other certifying officer and I have indicated in
this annual report whether there were significant changes in internal
controls or in other factors that could significantly affect internal
controls subsequent to the date of our most recent evaluation, including
any corrective actions with regard to significant deficiencies and
material weaknesses.
Date: March 6, 2003
/s/ JOHN C. HUNTER III
-----------------------------------------------
John C. Hunter III
Chairman, President and Chief Executive Officer
79
I, Robert A. Clausen, certify that:
1. I have reviewed this annual report on Form 10-K of Solutia Inc.;
2. Based on my knowledge, this annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this annual report;
3. Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly present in all
material respects the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in
this annual report;
4. The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
have:
a) designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this annual report is
being prepared;
b) evaluated the effectiveness of the registrant's disclosure controls
and procedures as of a date within 90 days prior to the filing date of
this annual report (the "Evaluation Date"); and
c) presented in this annual report our conclusions about the
effectiveness of the disclosure controls and procedures based on our
evaluation as of the Evaluation Date;
5. The registrant's other certifying officer and I have disclosed, based
on our most recent evaluation, to the registrant's auditors and the
audit committee of registrant's board of directors (or persons
performing the equivalent functions):
a) all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to
record, process, summarize and report financial data and have identified
for the registrant's auditors any material weaknesses in internal
controls; and
b) any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal
controls; and
6. The registrant's other certifying officer and I have indicated in
this annual report whether there were significant changes in internal
controls or in other factors that could significantly affect internal
controls subsequent to the date of our most recent evaluation, including
any corrective actions with regard to significant deficiencies and
material weaknesses.
Date: March 6, 2003
/s/ ROBERT A. CLAUSEN
------------------------------------------
Robert A. Clausen
Vice Chairman, Chief Financial Officer and
Chief Administrative Officer
80
EXHIBIT INDEX
These exhibits are numbered in accordance with the Exhibit Table of
Item 601 of Regulation S-K.
Exhibit No. Description
- ----------- -----------
2(a) Distribution Agreement (incorporated by reference to
Exhibit 2 of Solutia's Registration Statement on Form S-1
(333-36355) filed September 25, 1997)
2(b) Amendment to Distribution Agreement, dated as of July 1,
2002, by and among Pharmacia Corporation, Solutia Inc., and
Monsanto Company (incorporated by reference to Exhibit 2 of
Solutia's Form 10-Q for the quarter ended June 30, 2002)
2(c) Joint Venture Agreement between Solutia Inc. and FMC
Corporation* (incorporated by reference to Exhibit 2(i) of
Solutia's Form 8-K filed on April 27, 2000)
2(d) First Amendment to Joint Venture Agreement between Solutia
Inc. and FMC Corporation (incorporated by reference to
Exhibit 2(ii) of Solutia's Form 8-K filed on April 27, 2000)
2(e) Second Amendment to Joint Venture Agreement between Solutia
Inc. and FMC Corporation (incorporated by reference to
Exhibit 2(iii) of Solutia's Form 8-K filed on April 27,
2000)
2(f) Third Amendment to Joint Venture Agreement between Solutia
Inc. and FMC Corporation (incorporated by reference to
Exhibit 2(iv) of Solutia's Form 8-K filed on April 27, 2000)
2(g) Stock and Asset Purchase Agreement by and between UCB S.A.
and Solutia Inc., dated as of December 2, 2002 (incorporated
by reference to Exhibit 2 of Solutia's Form 8-K filed on
February 18, 2003)
3(a) Restated Certificate of Incorporation of Solutia
(incorporated by reference to Exhibit 3(a) of Solutia's
Registration Statement on Form S-1 (333-36355) filed
September 25, 1997)
3(b) By-Laws of Solutia Inc., as amended February 26, 2003
4(a) Rights Agreement (incorporated by reference to Exhibit 4 of
Solutia's Registration Statement on Form 10 filed on
August 7, 1997)
4(b) Amendment to the Rights Agreement (incorporated by reference
to Exhibit 4.4, of Solutia's Registration Statement on
Form S-3 (333-75812) filed December 21, 2001)
4(c) Indenture dated as of October 1, 1997, between Solutia Inc.
and The Chase Manhattan Bank, as Trustee (incorporated by
reference to Exhibit 4.1 of Solutia's Form 10-Q for the
quarter ended September 30, 1997)
4(d) 7.375% Debentures due 2027 in the principal amount of
$200,000,000 (incorporated by reference to Exhibit 4.3 of
Solutia's Form 10-Q for the quarter ended September 30,
1997)
4(e) 7.375% Debentures due 2027 in the principal amount of
$100,000,000 (incorporated by reference to Exhibit 4.4 of
Solutia's Form 10-Q for the quarter ended September 30,
1997)
4(f) 6.72% Debentures due 2037 in the principal amount of
$150,000,000 (incorporated by reference to Exhibit 4.5 of
Solutia's Form 10-Q for the quarter ended September 30,
1997)
4(g) Registrant agrees to furnish to the Securities and Exchange
Commission upon request copies of instruments defining the
rights of holders of certain unregistered long-term debt of
the registrant and its consolidated subsidiaries.
4(h) Warrant Agreement between Solutia Inc. and HSBC Bank USA as
Warrant Agent, dated as of July 9, 2002 (incorporated by
reference to Exhibit 4 of Solutia's Form 10-Q for the
quarter ended June 30, 2002)
4(i) Indenture dated as of July 9, 2002, between SOI Funding
Corp. and HSBC Bank USA, as Trustee (incorporated by
reference to Exhibit 4.2 of Solutia's Form S-4 (333-99699)
filed September 17, 2002)
- ------------
*Confidential treatment has been granted for a portion of this exhibit.
81
EXHIBIT INDEX (CONTINUED)
Exhibit No. Description
- ----------- -----------
4(j) First Supplemental Indenture, dated as if July 25, 2002,
among Solutia Inc., SOI Funding Corp., the Subsidiary
Guarantors and HSBC Bank USA, as Trustee (incorporated
by reference to Exhibit 4.3 of Solutia's Form S-4
(333-99699) filed September 17, 2002)
4(k) Second Supplemental Indenture, dated as of October 24, 2002,
among Solutia Inc., the subsidiary guarantors named therein
and HSBC Bank USA (incorporated by reference to Exhibit 4 of
Solutia's Form 10-Q for the quarter ended September 30,
2002)
4(l) Restated Intercreditor and Collateral Agency Agreement, dated
as of July 25, 2002, between Solutia Inc., the subsidiary
guarantors named therein, and Citibank, N.A. (incorporated by
reference to Exhibit 4.8 of Solutia's Form S-4 (333-99699)
filed September 17, 2002)
4(m) Restated Security and Guarantee Agreement, dated as of July 25,
2002, between Solutia Inc., the subsidiary guarantors named
therein, and Citibank, N.A. (incorporated by reference to
Exhibit 4.9 of Solutia's Form S-4 (333-99699) filed
September 17, 2002)
4(n) Intercreditor and Collateral Trust Agreement, dated as of
July 25, 2002, between Solutia Inc., the subsidiary guarantors
named therein, and Citibank, N.A. (incorporated by reference
to Exhibit 4.10 of Solutia's Form S-4 (333-99699) filed
September 17, 2002)
4(o) Sharing Security Agreement, dated as of July 25, 2002, between
Solutia Inc., the subsidiary guarantors named therein, and
HSBC Bank USA (incorporated by reference to Exhibit 4.11 of
Solutia's Form S-4 (333-99699) filed September 17, 2002)
4(p) Junior Intercreditor Agreement, dated as of July 25, 2002,
between Solutia Inc., the subsidiary guarantors named therein,
and Citibank, N.A. (incorporated by reference to Exhibit 4.12
of Solutia's Form S-4 (333-99699) filed September 17, 2002)
4(q) Junior Security Agreement, dated as of July 25, 2002, between
Solutia Inc., the subsidiary guarantors named therein, and
Citibank, N.A. (incorporated by reference to Exhibit 4.13 of
Solutia's Form S-4 (333-99699) filed September 17, 2002)
9 Omitted--Inapplicable
10(a) Financial Planning and Tax Preparation Services Program for
the Executive Leadership Team (incorporated by reference to
Exhibit 10(a) of Solutia's Form 10-K for the year ended
December 31, 1997)
10(b) Employee Benefits Allocation Agreement (incorporated by
reference to Exhibit 10(a) of Solutia's Registration Statement
on Form S-1 (333-36355) filed September 25, 1997)
10(c) Tax Sharing and Indemnification Agreement (incorporated by
reference to Exhibit 10(b) of Solutia's Registration Statement
on Form S-1 (333-36355) filed September 25, 1997)
10(d) Solutia Inc. Management Incentive Replacement Plan as amended
in 1999 (incorporated by reference to Exhibit 10(2) of
Solutia's Form 10-Q for the quarter ended June 30, 1999)
10(e) Solutia Inc. 1997 Stock-Based Incentive Plan as amended in
1999 and 2000 (incorporated by reference to Exhibit 10(1) of
Solutia's Form 10-Q for the quarter ended June 30, 2000)
10(f) Solutia Inc. Non-Employee Director Compensation Plan, as
amended in 1999, 2000, and 2001 (incorporated by reference to
Exhibit 10 of Solutia's Form 10-Q for the quarter ended
June 30, 2001)
10(g) Form of Employment Agreement with certain Named Executive
Officers (incorporated by reference to Exhibit 10(1) of
Solutia's Form 10-Q for the quarter ended March 31, 1998)
10(h) Form of Employment Agreement with other executive officers
(incorporated by reference to Exhibit 10(2) of Solutia's
Form 10-Q for the quarter ended March 31, 1998)
10(i) Solutia Inc. Annual Incentive Plan (incorporated by reference
to Appendix B of the Solutia Inc. Notice of Annual Meeting
and Proxy Statement dated March 9, 2000)
82
EXHIBIT INDEX (CONTINUED)
Exhibit No. Description
- ----------- -----------
10(j) Solutia Inc. Long-Term Incentive Plan (incorporated by
reference to Appendix C of the Solutia Inc. Notice of Annual
Meeting and Proxy Statement dated March 9, 2000)
10(k) Solutia Inc. Deferred Compensation Plan, as amended in 2002
10(l) Solutia Inc. 2000 Stock-Based Incentive Plan (incorporated by
reference to Appendix A of the Solutia Inc. Notice of
Annual Meeting and Proxy Statement dated March 9, 2000)
10(m) Solutia Inc. 2002-2006 Long-Term Incentive Plan (incorporated
by reference to Appendix A of the Solutia Inc. Notice of
Annual Meeting and Proxy Statement dated March 14, 2002)
10(n) Letter Agreement between Solutia Inc. and Russell J. Belle
dated January 14, 2002 (incorporated by reference to
Exhibit 10 of Solutia's Form 10-Q for the quarter ended
March 31, 2002)
10(o) Protocol Agreement, dated as of July 1, 2002, by and among
Pharmacia Corporation, Solutia Inc., and Monsanto Company
(incorporated by reference to Exhibit 10(b) of Solutia's
Form 10-Q for the quarter ended June 30, 2002)
10(p) Second Amended and Restated Credit Agreement, dated as of
July 25, 2002, between Solutia Inc., as Borrower, the initial
lenders named therein, Bank of America, N.A., as Syndication
Agent and Citibank, N.A. as Administrative Agent
(incorporated by reference to Exhibit 10(c) of Solutia's
Form 10-Q for the quarter ended June 30, 2002)
10(q) Amendment No. 1, dated as of September 26, 2002, to Second
Amended and Restated Credit Agreement dated as of July 25,
2002, between Solutia Inc., as Borrower, the initial lenders
named therein, Bank of America, N.A. as Syndication Agent
and Citibank, N.A., as Administrative Agent (incorporated by
reference to Exhibit 10 of Solutia's Form 10-Q for the
quarter ended September 30, 2002)
10(r) Amendment No. 2, dated as of December 24, 2002, to Second
Amended and Restated Credit Agreement dated as of July 25,
2002, between Solutia Inc., as Borrower, the initial lenders
named therein, Bank of America, N.A., as Syndication Agent
and Citibank, N.A., as Administrative Agent
10(s) Protocol Agreement, dated as of November 15, 2002, by and
among Pharmacia Corporation, Solutia Inc. and Monsanto Company
(incorporated by reference to Exhibit 10.1 of Solutia's
Form 8-K filed November 18, 2002)
10(t) Amendment to Protocol Agreement, dated as of March 3, 2003,
by and among Pharmacia Corporation, Solutia Inc. and Monsanto
Company
11 Omitted--Inapplicable; see "Statement of Consolidated Income
(Loss)" on page 36
12 Computation of the Ratio of Earnings to Fixed Charges (see
page 84)
16 Omitted--Inapplicable
18 Omitted--Inapplicable
21 Subsidiaries of the Registrant (see page 85)
22 Omitted--Inapplicable
23 Independent Auditors' Consent (see page 86)
24(a) Powers of Attorney submitted by John C. Hunter III, Robert A.
Clausen, James M. Sullivan, Paul Donovan, Paul H. Hatfield,
Robert H. Jenkins, Philip R. Lochner, Jr., Frank A. Metz, Jr.,
J. Patrick Mulcahy, Sally G. Narodick, William D.
Ruckelshaus and John B. Slaughter
24(b) Certified copy of Board resolution authorizing Form 10-K filing
utilizing powers of attorney
- --------
Only Exhibit Nos. 12, 21 and 23 have been included in the printed copy of this
report.
83